matchedPattern,context,lineNumber,columnNumber,publicationName
c.1483C>T,1	14	c.1483C>T	p.R495X	34	F	9	Yes	Yes	L	No,37,6,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1561C>T,3	15	c.1561C>T	p.R521C	33	M	10	NA	Yes	NA	No,39,6,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1540A>G,7	15	c.1540A>G	p.R514G	60	M	>96	NA	Yes	B	No,45,6,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.840+2T>A,"...C>T, p.Arg110*) and a donor splice‐site mutation (c.840+2T>A, p.Glu281_Leu282Ins8), both of which ca...",42,273,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.840+2T>A,"...C>T, p.Arg110*) and a donor splice‐site mutation (c.840+2T>A, p.Glu281_Leu282Ins8), both of which ca...",42,273,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.328C>T,"...1001150.2) causing a premature translational stop c.328C>T, p.Arg110* at genomic position chr22: 32 ...",82,265,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.840+2T>A,"...(b) A donor splice‐site mutation (NM_001001150.2) c.840+2T>A, p.Glu281_Leu282Ins8 at position chr22:...",84,274,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.840+2T>A,"...(b) A donor splice‐site mutation (NM_001001150.2) c.840+2T>A, p.Glu281_Leu282Ins8 at position chr22:...",84,274,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.840+2T>A,"... (chr22: 32 322 242a) and the splice‐site variant c.840+2T>A, p.Glu281_Leu282Ins8 (chr22: 32 297 683...",88,128,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.1326T>G,"The SNP c.1326T>G in the non‐SMC condensin I complex, subu...",1143,9,Anim_Sci_J_2016_Feb_11_87(2)_159-167.txt
c.2095C>A,...erozygous polymorphisms: c.1698C>T in exon 10 and c.2095C>A in exon 12. The FACE1 (ZMPSTE24) sequenc...,26,314,Ann_Dermatol_2013_Nov_30_25(4)_483-488.txt
c.1538-1G>A,"..., had a homozygous acceptor splice site mutation, c.1538-1G>A. The third case, from Pakistan, had a ...",48,400,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1883G>C,"...rom Pakistan, had a homozygous missense mutation, c.1883G>C (p.Arg628Pro) that occurred within the e...",48,480,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1045G>T,"...erlands) was also a homozygous missense mutation, c.1045G>T (p.Ala-349Ser)16, as was the mutation in...",48,703,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1538-1G>A,"...eleterious effects of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 integrin struc...",51,1441,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1538-1G>A,"...eleterious effects of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 integrin struc...",51,1441,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1312C>T,"...5 gene was performed and the pathogenic mutation, c.1312C>T (p.Arg438Cys), was identified. Interesti...",3,1961,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
c.1312C>T,"...5 gene was performed and the pathogenic mutation, c.1312C>T (p.Arg438Cys), was identified. Interesti...",3,1961,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
c.1312C>T,... analysis of GDF5 revealed a missense mutation at c.1312C>T that resulted in a change in the protein...,17,487,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
c.1312C>T,...ysis of the GDF5 gene. A heterozygous mutation of c.1312C>T in exon 2 is noted,30,71,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
c.1312C>T,...ysis of the GDF5 gene. A heterozygous mutation of c.1312C>T in exon 2 is noted,30,71,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
c.3766C>T,"...pG, and the father carried the nonsense mutation, c.3766C>T).13 Ten additional sporadic PCH case pat...",18,607,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.3766C>T,"...pG, and the father carried the nonsense mutation, c.3766C>T).13 Ten additional sporadic PCH case pat...",18,607,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.860-1G>A,"...ient had a compound heterozygous splice mutation (c.860-1G>A) and a nonsense mutation, c.3438C>T (p....",18,865,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.860-1G>A,"...ient had a compound heterozygous splice mutation (c.860-1G>A) and a nonsense mutation, c.3438C>T (p....",18,865,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.3438C>T,"...ce mutation (c.860-1G>A) and a nonsense mutation, c.3438C>T (p.Arg1150X). No mutations were identifi...",18,902,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.3438C>T,"...ce mutation (c.860-1G>A) and a nonsense mutation, c.3438C>T (p.Arg1150X). No mutations were identifi...",18,902,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.388G>A,"...ing beef flavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2...",8,560,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"...ing beef flavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2...",8,560,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...lavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2, 3 and 4 ...",8,570,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...lavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2, 3 and 4 ...",8,570,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...r types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2, 3 and 4 of the FABP4 ...",8,583,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...h has a high proportion of saturated fatty acids, c.408G>C SNP was the highest at 25.61, 25.79 in GG...",45,817,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...h has a high proportion of saturated fatty acids, c.408G>C SNP was the highest at 25.61, 25.79 in GG...",45,817,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,... the highest at 45.08 and 54.43 in GG genotype of c.280A>G SNP (p<0.05) and 44.56 and 53.84 in GG ge...,47,185,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,... the highest at 45.08 and 54.43 in GG genotype of c.280A>G SNP (p<0.05) and 44.56 and 53.84 in GG ge...,47,185,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,... the highest at 45.08 and 54.43 in GG genotype of c.280A>G SNP (p<0.05) and 44.56 and 53.84 in GG ge...,47,185,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"...NP (p<0.05) and 44.56 and 53.84 in GG genotype of c.388G>A SNP (p<0.05). Also, they had higher conte...",47,245,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...es, since their composition in the CC genotype of c.408G>C SNP, GG genotype of c.456A>G SNP were 45....",47,405,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...es, since their composition in the CC genotype of c.408G>C SNP, GG genotype of c.456A>G SNP were 45....",47,405,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...es, since their composition in the CC genotype of c.408G>C SNP, GG genotype of c.456A>G SNP were 45....",47,405,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...n the CC genotype of c.408G>C SNP, GG genotype of c.456A>G SNP were 45.71, 54.74 and 45.06, 54.40, r...",47,434,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"Haplotype block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon ...",51,26,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"Haplotype block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon ...",51,26,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"...id and MUFA among the fatty acids. In particular, c.280A>G SNP had an association with back fat thic...",54,259,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"...sociation with back fat thickness, and in case of c.388G>A SNP, with marbling score. Also, it has be...",54,331,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"...sociation with back fat thickness, and in case of c.388G>A SNP, with marbling score. Also, it has be...",54,331,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,...the encoded amino acid from isoleucine to valine. c.388G>A SNP is also a non-synonymous SNP where va...,58,277,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,...the encoded amino acid from isoleucine to valine. c.388G>A SNP is also a non-synonymous SNP where va...,58,277,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,...the encoded amino acid from isoleucine to valine. c.388G>A SNP is also a non-synonymous SNP where va...,58,277,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...G nucleotide changes into ATG. On the other hand, c.408G>C and c.456A>G are synonymous SNPs, which d...",58,407,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...changes into ATG. On the other hand, c.408G>C and c.456A>G are synonymous SNPs, which do not have ch...",58,420,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...changes into ATG. On the other hand, c.408G>C and c.456A>G are synonymous SNPs, which do not have ch...",58,420,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...do have nucleotide changes. These two novel SNPs (c.408G>C, c.456A>G) were not found to have an asso...",58,545,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...cleotide changes. These two novel SNPs (c.408G>C, c.456A>G) were not found to have an association wi...",58,555,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...cleotide changes. These two novel SNPs (c.408G>C, c.456A>G) were not found to have an association wi...",58,555,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"... genotypes with G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased p...",62,81,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"... with G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased proportion ...",62,91,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"... and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased proportion of oleic acid...",62,104,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"...ordingly, it is expected that haplotype blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at ...",66,54,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.181T>G,c.181T>G	2	F1	TTGACATTTTTCTTTTCCCAAC	200,99,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.181T>G,c.181T>G	2	F1	TTGACATTTTTCTTTTCCCAAC	200,99,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.181T>G,c.181T>G	2	F1	TTGACATTTTTCTTTTCCCAAC	200,99,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.212C>A,c.212C>A	2	F	TATAGGCGTGGGCTTTGCTA	202,105,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,c.280A>G	2	F	GGGGTGTGGTCACCATTAAA	178,108,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,c.408G>C	3	F	CATCGTAAACTTAGATGAAGGTGCT	200,120,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,c.408G>C	3	F	CATCGTAAACTTAGATGAAGGTGCT	200,120,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.181T>G,c.181T>G	2	L41V	T,135,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.181T>G,c.181T>G	2	L41V	T,135,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.181T>G,c.181T>G	2	L41V	T,135,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.193T>G,c.193T>G	2	L45V	T,139,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.212C>A,c.212C>A	2	T51N	C,143,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,c.388G>A	3	V110M	G,159,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,c.388G>A	3	V110M	G,159,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,c.408G>C	3	L116L	G,163,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,c.456A>G	4	A132A	A,167,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,c.456A>G	4	A132A	A,167,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,23,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,23,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,32,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,32,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,7,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,16,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,25,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.349T>C,...o et al. (2011) reported that the polymorphism of c.349T>C in the CRBP II gene would be genetically ...,47,1289,Asian-Australas_J_Anim_Sci_2014_Mar_27(3)_310-315.txt
c.12669G>A,"...D). The association of the APOB gene polymorphism c.12669G>A, p.Gln4154Lys with the risk of CAD vari...",3,1287,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.12669G>A,"...D). The association of the APOB gene polymorphism c.12669G>A, p.Gln4154Lys with the risk of CAD vari...",3,1287,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.12669G>A,"...able variation in linking APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) with CAD risk in differen...",8,1384,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.12669G>A,"...nt study, the role of the APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) was studied in native Ind...",28,63,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.1523A>T,... in a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive...,193,129,Biomed_Res_Int_2013_Jul_11_2013_283985.txt
c.9C>G,"...ne whether there is a link between the rs2073618 (c.9C>G, G1181C) and rs3134069 (g.119964988A>C, T24...",22,107,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
c.1799T>A, c.1799T>A	p.V600E	56 (29.9),189,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.1801A>G, c.1801A>G	p.K601E	11 (5.9),192,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	34 (18.2),196,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61K	5 (2.7),197,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61K	5 (2.7),197,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	7 (3.7),199,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.183G>T, c.183G>T	p.Q61H	1 (0.5),201,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.183G>T, c.183G>T	p.Q61H	1 (0.5),201,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	8 (4.3),203,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61H	1 (0.5),204,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.1799T>A, c.1799T>A	p.V600E	51,244,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.1801A>G, c.1801A>G	p.K601E	6,246,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.1801A>G, c.1801A>G	p.K601E	6,246,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.34G>A, c.34G>A	p.G12S	1,248,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	29,250,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	29,250,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61K	3,254,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.80G>A,... on the absence of association between the common c.80G>A polymorphism (rs1051266) of the gene codin...,19,187,Biomed_Res_Int_2015_Jan_14_2015_135931.txt
c.80G>A,... on the absence of association between the common c.80G>A polymorphism (rs1051266) of the gene codin...,19,187,Biomed_Res_Int_2015_Jan_14_2015_135931.txt
c.769C>T,"...58	21OH, SCC, AADC, GAD	C, HP, A, V, Al,	c.769C>T/c.769C>T",21,56,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.879+1G>A,"A2	M	47	AADC, GAD, TPH	HP, D, V	c.879+1G>A/c.879+1G>A",22,44,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"A4	F	25	21OH, 17OH	A	c.769C>T / c.1242_1243insA",24,22,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"A5	F	20	21OH, SCC, 17OH	C, A, V, N, G	c.769C>T/c.1242_1243insA",25,39,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"...6	M	21	21OH, SCC, 17OH, AADC	C, HP, A, K	c.769C>T/c.769C>T",26,52,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"...6	M	21	21OH, SCC, 17OH, AADC	C, HP, A, K	c.769C>T/c.769C>T",26,52,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.1273C>T,"... mutations are a well-known etiology of aHUS, the c.1273C>T mutation has never been reported in Cauc...",12,62,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,...e suspect that the pathogenesis of aHUS caused by c.1273C>T is likely to be associated with dysregul...,27,144,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,...orphism analysis of our patient with heterozygote c.1273C>T mutation in C3 gene showing 250 bp produ...,36,91,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.35G>T,... genomic hybridization. A KRAS codon 12 mutation (c.35G>T; p.G12V) was detected in the pyloric gland...,7,891,BMC_Cancer_2012_Dec_4_12_570.txt
c.1699G>A,c.1699G>A	p.Ala567Thr	rs1803274,41,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.-238C>T,c.-238C>T		rs1800849,47,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.-238C>T,c.-238C>T		rs1800849,47,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.599C>T,c.599C>T	p.Pro200Leu	rs1050450,50,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.300C>T,c.300C>T	p.Asp100=	rs1799986,71,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.81C>T,c.81C>T	p.Cys27=	rs2228671,74,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.451C>T,"...ent (e.g. the allele frequency of the T allele of c.451C>T, p.R151C, was 1.9% in Greece but 10.2% in...",171,663,BMC_Genet_2008_Apr_10_9_31.txt
c.2881C>T,"...eceptor (EGFR) inhibitors; however, a KDR p.R961W c.2881C>T mutation was noted as a variant of unkno...",9,1250,Cureus_8(2)_e478.txt
c.2881C>T,"...eceptor (EGFR) inhibitors; however, a KDR p.R961W c.2881C>T mutation was noted as a variant of unkno...",9,1250,Cureus_8(2)_e478.txt
c.2881C>T,...biomarker of response to regorafenib. KDR p.R961W c.2881C>T mutation has been reported twice in COSM...,50,1099,Cureus_8(2)_e478.txt
c.475C>T,...T (p.Arg110>Cys) in two families (family A&B) and c.475C>T (p.Arg133>Cys) mutation in family C,12,447,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.475C>T,...T (p.Arg110>Cys) in two families (family A&B) and c.475C>T (p.Arg133>Cys) mutation in family C,12,447,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.406C>T,...OTCH3 gene; revealed the presence of heterozygous c.406C>T (p.Arg110>Cys) pathogenic mutation in exo...,58,729,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.807G>A,"...the single nucleotide substitutions, c.471G>A and c.807G>A and the insertion (c.388+3insT) were clos...",12,400,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,I	P	F	35	2.4	2.9	1212	8.80	896	+/-	c.471G>A/del exon5,47,36,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,I	P	F	35	2.4	2.9	1212	8.80	896	+/-	c.471G>A/del exon5,47,36,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,III	P	F	35	9.2	21.6	4032	7.80	485	+/+	c.808-1G>C/r.spl?,52,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,C	F	28	1.1	0.8	97	1.70	127	-/-	c.808-1G>C/r.spl?,53,33,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,C	F	28	1.1	0.8	97	1.70	127	-/-	c.808-1G>C/r.spl?,53,33,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,Si	F	31	1.2	2.1	539	6.00	1208	+/-	c.101A>T/p.E34V,57,36,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,D	F	15	0.9	1.4	34	1.28 (619)	ND	-/-	c.670T>G/p.W224R,69,38,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,D	F	15	0.9	1.4	34	1.28 (619)	ND	-/-	c.670T>G/p.W224R,69,38,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,D	F	15	0.9	1.4	34	1.28 (619)	ND	-/-	c.670T>G/p.W224R,69,38,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.503G>A,XXIII	P	F	24	6.4	8.2	1108	7.10	1529	+/+	c.503G>A/p.R168H,109,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.532T>G,XXV	P	F	27	3.1	4.0	870	5.40	1592	+/-	c.532T>G/p.L178V,117,38,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.317A>C,XXVI	P	F	39	4.4	6.2	307	5.33	1214	+/-	c.317A>C/p.H106P,118,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.317A>C,XXVI	P	F	39	4.4	6.2	307	5.33	1214	+/-	c.317A>C/p.H106P,118,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,...e G to A transitions in the last bases of exon 5 (c.471G>A) (Figure 2a) and exon 7 (c.807 G>A) (Figu...,181,216,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,...e G to A transitions in the last bases of exon 5 (c.471G>A) (Figure 2a) and exon 7 (c.807 G>A) (Figu...,181,216,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,III	P	13.15	39.55	c.808-1G>C/r.spl?,193,19,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,V	P	18.48	55.58	c.101A>T/p.E34V,197,17,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,VIII	P	16.95	50.98	c.670T>G/p.W224R,201,20,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,D	18.12	54.19	c.670T>G/p.W224R,202,16,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,...e was a T to G change at nucleotide position 670 (c.670T>G) leading to a tryptophan to a glycine sub...,209,583,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,...e was a T to G change at nucleotide position 670 (c.670T>G) leading to a tryptophan to a glycine sub...,209,583,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,"...nucleotide substitutions, c.471G>A, c.807 G>A and c.808-1G>C and the other was a small insertion. In...",238,316,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,"...cryptic splicing site [34]. However, only for the c.471G>A mutation (Figure 2a), which affects the d...",238,532,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,"...cryptic splicing site [34]. However, only for the c.471G>A mutation (Figure 2a), which affects the d...",238,532,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.995G>C,"...ng to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and 10 respectively. They w...",240,115,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.995G>C,"...ng to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and 10 respectively. They w...",240,115,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.-27A>C,"...leotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T...",12,60,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...tutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T>C mutation, G...",12,74,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"The c.-22T>C mutation, which was observed frequently i...",15,5,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"The c.-22T>C mutation, which was observed frequently i...",15,5,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,...-3') primer was used to confirm the c.-179A>G and c.-27A>C mutations. We screened 101 healthy adults...,36,448,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"...as confirmed by performing PCR-RFLP (Fig. 1). For c.-179A>G, 56 subjects with A/A genotype, 5 with A...",49,554,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"...as confirmed by performing PCR-RFLP (Fig. 1). For c.-179A>G, 56 subjects with A/A genotype, 5 with A...",49,554,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...type and 2 with G/G genotype were identified. For c.-27A>C, 61 individuals had A/A genotype and 2 sh...",49,661,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"...101 normal individuals, suggesting that two SNPs, c.-179A>G and c.-27A>C, are benign sequence variat...",49,896,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"...101 normal individuals, suggesting that two SNPs, c.-179A>G and c.-27A>C, are benign sequence variat...",49,896,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...ividuals, suggesting that two SNPs, c.-179A>G and c.-27A>C, are benign sequence variations. In terms...",49,910,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...type distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did not deviate from those exp...",49,1283,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,c.-179A>G	A/A	56	117.2 ± 41.7	0.012	1.39 ± 2.06	0....,56,1,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,c.-27A>C	A/A	61	112.1 ± 41.7	0.173	1.34 ± 0.46	0.4...,60,1,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,c.-27A>C	A/A	61	112.1 ± 41.7	0.173	1.34 ± 0.46	0.4...,60,1,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,...Sequencing revealed the presence of a mutation of c.-22T>C (A). Gel electrophoresis patterns of PCR ...,69,128,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,...Sequencing revealed the presence of a mutation of c.-22T>C (A). Gel electrophoresis patterns of PCR ...,69,128,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"To test if c.-22T>C affected transcription, reporter analysis...",80,12,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...fold increase (Fig. 3). In terms of c.-179A>G and c.-27A>C, the relative luciferase activity was not...",80,485,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...fold increase (Fig. 3). In terms of c.-179A>G and c.-27A>C, the relative luciferase activity was not...",80,485,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,... determine if the elevated luciferase activity of c.-22T>C was due to alterations in the binding of ...,84,72,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...ar proteins that bind to the GALK1 promoter, with c.-22T>C, will be necessary to elucidate the mecha...",97,368,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.1849G>T,...veral groups have reported a somatically acquired c.1849G>T point mutation in exon 14 of JAK2 gene (...,18,524,BMC_Med_Genet_2010_Apr_1_11_54.txt
c.1780G>A,"...ariants (c.1740delC, c.2975_2978delAG, c.1194T>A, c.1780G>A, c.4819C > T) were identified in the gro...",10,83,BMC_Med_Genet_2010_May_26_11_79.txt
c.1780G>A,"... c.1194T > A/p.D398E, c.1740delC/p.s581PfsX40 and c.1780G>A/p.E594K. Two columns are sequencing chro...",52,180,BMC_Med_Genet_2010_May_26_11_79.txt
c.2206-2A>G,...change that disrupts the 3'splice site of IVS 16 (c.2206-2A>G). Both the father and sister of the pa...,38,309,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"... of the patient were shown to be carriers for the c.2206-2A>G mutation, whereas her mother was shown...",38,399,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,"...reas her mother was shown to be a carrier for the c.574+1G>C mutation. To the best of our knowledge,...",38,474,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>A,...t change affecting the first nucleotide of IVS 5 (c.574+1G>A) has been reported in an earlier study ...,38,694,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,To assess the consequences of the c.574+1G>C and c.2206-2A>G mutations on NTRK1 spli...,40,35,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"To assess the consequences of the c.574+1G>C and c.2206-2A>G mutations on NTRK1 splicing, we carrie...",40,50,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"To assess the consequences of the c.574+1G>C and c.2206-2A>G mutations on NTRK1 splicing, we carrie...",40,50,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"To assess the consequences of the c.574+1G>C and c.2206-2A>G mutations on NTRK1 splicing, we carrie...",40,50,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...deletion of the first 21 bp of exon 17. Thus, the c.2206-2A>G mutation leads to the production of tw...",42,1016,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,"...e mother of the patient, who is a carrier for the c.574+1G>C mutation, whereas the mRNA variants wit...",42,1698,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>A,"...ote, a different mutation of the same nucleotide (c.574+1G>A) was previously detected in a patient w...",44,410,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>A,"...ote, a different mutation of the same nucleotide (c.574+1G>A) was previously detected in a patient w...",44,410,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...5. The second mutation identified in our patient (c.2206-2A>G) disrupts the 3'splice site of IVS 16,...",44,716,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...5. The second mutation identified in our patient (c.2206-2A>G) disrupts the 3'splice site of IVS 16,...",44,716,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...5. The second mutation identified in our patient (c.2206-2A>G) disrupts the 3'splice site of IVS 16,...",44,716,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...ed, non-functional NTRK1 protein (Figure 2B). The c.2206-2A>G mutation is of greater interest in the...",44,1456,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...ed, non-functional NTRK1 protein (Figure 2B). The c.2206-2A>G mutation is of greater interest in the...",44,1456,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2944C>T,"...ion and sequence change. For example, NM_020975.4:c.2944C>T refers a C→T substitution happened at po...",40,293,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
c.458C>G,...he heterozygous c.1204C>T mutation in exon 11 and c.458C>G mutation in exon 4 of Parkin). In the lit...,183,633,BMC_Neurosci_2016_Feb_1_17_6.txt
c.458C>G,...he heterozygous c.1204C>T mutation in exon 11 and c.458C>G mutation in exon 4 of Parkin). In the lit...,183,633,BMC_Neurosci_2016_Feb_1_17_6.txt
c.799G>A,"c.799G>A/c.85C > A		(mean 12.34, range 0.88-23.80)...",87,1,BMC_Pediatr_2010_Nov_17_10_82.txt
c.278C>T,3	TCA>TTA	c.278C>T	Ser93Leu	Hydrophilic to hydrophobic	In pr...,90,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1086C>G,4	GGC>GGG	c.1086C>G	Gly362Gly	Silent	Polymorphism,96,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1250C>T,4	Ccg>Ctg	c.1250C>T	Pro417Leu	Potential tertiary structure c...,97,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1541G>A,6	GGG>GAG	c.1541G>A	Gly514Glu	Small hydrophobic to acidic	On...,99,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1541G>A,6	GGG>GAG	c.1541G>A	Gly514Glu	Small hydrophobic to acidic	On...,99,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1809T>C,9	TTC>TTT	c.1809T>C	Phe603Leu	Aromatic to aliphatic	Polymorp...,100,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1809T>C,9	TTC>TTT	c.1809T>C	Phe603Leu	Aromatic to aliphatic	Polymorp...,100,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1998C>T,11	CAC>CAT	c.1998C>T	His666His	Silent	Polymorphism,101,12,BMC_Womens_Health_2005_May_26_5_8.txt
c.1541G>A,...uding brain tumors and leukemias). The underlying c.1541G>A nucleotide substitution was detected in ...,107,793,BMC_Womens_Health_2005_May_26_5_8.txt
c.936+919G>A,... a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,491,104,BMJ_Open_2016_Apr_8_6(4)_e010422.txt
c.936+919G>A,... a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,491,104,BMJ_Open_2016_Apr_8_6(4)_e010422.txt
c.154A>C,"...agic telangiectasia type 2 with a novel mutation, c.154A>C (p.Thr52Pro), in the ALK1/ACVRL1 gene Neu...",240,139,Bone_Res_2015_Apr_14_3_15005.txt
c.154A>C,"...agic telangiectasia type 2 with a novel mutation, c.154A>C (p.Thr52Pro), in the ALK1/ACVRL1 gene Neu...",240,139,Bone_Res_2015_Apr_14_3_15005.txt
c.564T>C,"... GTL2 promoter DMR, heterozygosity at a DLK1 SNP (c.564T>C) (n=−2) or at closely linked microsatelli...",36,572,Br_J_Cancer_2005_Apr_25_92(8)_1574-1580.txt
c.564T>C,"... GTL2 promoter DMR, heterozygosity at a DLK1 SNP (c.564T>C) (n=−2) or at closely linked microsatelli...",36,572,Br_J_Cancer_2005_Apr_25_92(8)_1574-1580.txt
c.1A>G,...sense ATM mutation c.8672G>A (p.Gly2891Asp) and a c.1A>G substitution were identified. In the modell...,10,394,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...sense ATM mutation c.8672G>A (p.Gly2891Asp) and a c.1A>G substitution were identified. In the modell...,10,394,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"Two ATM mutations, c.8672G>A. (p.Gly2891Asp) and c.1A>G (Figure 3), were identified in the cells fr...",56,50,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"Two ATM mutations, c.8672G>A. (p.Gly2891Asp) and c.1A>G (Figure 3), were identified in the cells fr...",56,50,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"Two ATM mutations, c.8672G>A. (p.Gly2891Asp) and c.1A>G (Figure 3), were identified in the cells fr...",56,50,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,"... was carried on each allele of chromosome 11, the c.8672G>A mutation was paternal and the c.1A>G mut...",56,391,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,"... was carried on each allele of chromosome 11, the c.8672G>A mutation was paternal and the c.1A>G mut...",56,391,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"...nt A-T86, carrying the initiating codon mutation, c.2T>C, on one allele and a null mutation on the s...",66,108,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"...nt A-T86, carrying the initiating codon mutation, c.2T>C, on one allele and a null mutation on the s...",66,108,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...n a truncated protein. In translational terms the c.1A>G mutation in A-T213 would be expected to beh...,66,506,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...on in A-T213 would be expected to behave like the c.2T>C mutation as both mutations are in the initi...,66,569,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"... than that immunoprecipitated from cells from the c.2T>C patient A-T86 (Figure 5, lanes 7 and 8) but...",68,165,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"... than that immunoprecipitated from cells from the c.2T>C patient A-T86 (Figure 5, lanes 7 and 8) but...",68,165,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...rotein in cells from patient A-T213 came from the c.8672G>A (p.Gly2891Asp) allele. Truncated ATM ass...,68,441,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...rotein in cells from patient A-T213 came from the c.8672G>A (p.Gly2891Asp) allele. Truncated ATM ass...,68,441,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...Truncated ATM associated with the presence of the c.1A>G mutation was not detected, probably because...",68,524,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,"...e it was obscured by the full-length ATM from the c.8672G>A (p.Gly2891Asp) allele (Figure 5, compare...",68,623,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...e finding that the ATM protein expressed from the c.2T>C mutant allele in the LCL from patient A-T18...,68,795,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.9139C>T,"...lele that was essentially full-length p.Arg3047X (c.9139C>T) (Figure 5, lanes 9 and 10)",68,965,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"...precipitated from A-T cells carrying the mutation c.2T>C, which did not demonstrate any in vitro kin...",70,152,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"...precipitated from A-T cells carrying the mutation c.2T>C, which did not demonstrate any in vitro kin...",70,152,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"...precipitated from A-T cells carrying the mutation c.2T>C, which did not demonstrate any in vitro kin...",70,152,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...e activity in cells of patient A-T213 is from the c.8672G>A (p.Gly2891Asp) allele,70,316,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...e activity in cells of patient A-T213 is from the c.8672G>A (p.Gly2891Asp) allele,70,316,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...rotein are shown in Figure 6A. Interestingly, the c.1A>G protein was of lower molecular weight than ...",72,328,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...rotein are shown in Figure 6A. Interestingly, the c.1A>G protein was of lower molecular weight than ...",72,328,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"... mutant protein was significantly higher than the c.1A>G protein (Figure 6A, lanes 4 and 5). We were...",72,643,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"... mutant protein was significantly higher than the c.1A>G protein (Figure 6A, lanes 4 and 5). We were...",72,643,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...ssed from the c.1A>G mutation. Indeed, the mutant c.1A>G ATM cloned into pMEP4 was expressed as a lo...",74,305,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...ssed from the c.1A>G mutation. Indeed, the mutant c.1A>G ATM cloned into pMEP4 was expressed as a lo...",74,305,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...e two ATM mutations, c.8672G>A (p.Gly2891Asp) and c.1A>G, in patient A-T213 are both of considerable...",77,686,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,"Interestingly, the c.8672G>A missense mutation was reported in one of...",79,20,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,... ATM protein derived from the allele carrying the c.1A>G mutation affecting the initiating methionin...,81,54,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,... in the same codon. Cells from a patient with the c.2T>C and an ATM-null mutation expressed a trunca...,81,237,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...ar weight of ATM immunoprecipitated from both the c.2T>C mutant cells and the modelled c.1A>G is con...,81,676,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...rom both the c.2T>C mutant cells and the modelled c.1A>G is consistent with this,81,713,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...that the truncated ATM protein expressed from the c.1A>G and c.2T>C mutant alleles is the result of ...,83,140,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...uncated ATM protein expressed from the c.1A>G and c.2T>C mutant alleles is the result of uncharacter...,83,151,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...uncated ATM protein expressed from the c.1A>G and c.2T>C mutant alleles is the result of uncharacter...,83,151,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.7271T>G,"...east cancer, were homozygous for the ATM mutation c.7271T>G (p.Val2424Gly). The mutation was also id...",85,1041,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1918A>T,...utations in novel premature termination mutation (c.1918A>T (Lys640Stop)) and a (c.1066-6T>G (IVS10-...,87,284,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1066-6T>G,"...mination mutation (c.1918A>T (Lys640Stop)) and a (c.1066-6T>G (IVS10-6T-G)), which has previously be...",87,315,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...of two mutant ATM proteins, (p.Gly2891Asp and the c.1A>G derived protein) raises the possibility of ...",89,334,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...of two mutant ATM proteins, (p.Gly2891Asp and the c.1A>G derived protein) raises the possibility of ...",89,334,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,... evidence of a significant effect of the inactive c.1A>G derived protein in reducing the activity of...,89,524,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"...th, the ATM in an LCL from patient A-T86 with the c.2T>C mutation (and also null mutation c.7665deli...",112,507,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...es 7 and 8). It is likely that truncated ATM from c.2T>C in patient AT187 is obscured by the p.Arg30...,112,659,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.9139C>T,...C in patient AT187 is obscured by the p.Arg3047X (c.9139C>T) mutant protein (lanes 9 and 10) and the...,112,714,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.9139C>T,...C in patient AT187 is obscured by the p.Arg3047X (c.9139C>T) mutant protein (lanes 9 and 10) and the...,112,714,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...otein (lanes 9 and 10) and the truncated ATM from c.1A>G in patient A-T213 is obscured by the p.Gly2...,112,784,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...n patient A-T213 is obscured by the p.Gly2891Asp (c.8672G>A) mutant protein (lanes 5 and 6). Immunop...,112,842,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.7271T>G,...st cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Br...,131,290,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1066-6T>G,...s associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Fa...,131,304,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.280C>T,"...A patient carrying a heterozygous RPS19 mutation (c.280C>T, p.Arg94X), and healthy control samples w...",77,279,Br_J_Haematol_2015_Nov_25_171(4)_517-529.txt
c.5882G>A,ARDM-240	15	13	0.2	0.16	STGD	c.5882G>A(42)	p.Gly1961Glu	c.2285C>A(15)	p.Ala762G...,77,30,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.2285C>A,...40	15	13	0.2	0.16	STGD	c.5882G>A(42)	p.Gly1961Glu	c.2285C>A(15)	p.Ala762Glu	Yes,77,57,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.2285C>A,...40	15	13	0.2	0.16	STGD	c.5882G>A(42)	p.Gly1961Glu	c.2285C>A(15)	p.Ala762Glu	Yes,77,57,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5882G>A,ARDM-225	32	25	0.25	0.50	STGD	c.5882G>A(42)	p.Gly1961Glu	c.6559C>T(48)	p.Gln2187...,78,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.6559C>T,...5	32	25	0.25	0.50	STGD	c.5882G>A(42)	p.Gly1961Glu	c.6559C>T(48)	p.Gln2187X	Yes,78,58,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3386G>T,ARDM-164	21	11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Y...,79,24,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.6140T>A,...46	32	13	0.06	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.6140T>A(44)	p.Ile2047Asn	Yes,86,57,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.6140T>A,...46	32	13	0.06	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.6140T>A(44)	p.Ile2047Asn	Yes,86,57,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3943C>T,...M-40	46	9	0.1	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	Yes,87,54,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3943C>T,...M-40	46	9	0.1	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	Yes,87,54,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3943C>T,...M-40	46	9	0.1	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	Yes,87,54,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5929G>A,ARDM-90	26	8	Hand moving	STGD	c.5929G>A (43)	p.Gly1977Ser	IVS21-2A>T		Yes,88,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3323G>A,ARDM-181	57	16	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,30,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3323G>A,ARDM-181	57	16	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,30,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.4793C>A,ARDM-197	35	15	0.1	0.1	STGD	c.4793C>A(34) (false +)	p.Ala1598Asp (false +)	c.5...,90,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5172G>T,...GD	c.4793C>A(34) (false +)	p.Ala1598Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	Yes,90,76,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5172G>T,...GD	c.4793C>A(34) (false +)	p.Ala1598Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	Yes,90,76,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5929G>A,...63	55	0.150	0.175	STGD	c.6079C>T(44)	p.Leu2027Phe	c.5929G>A(43) (false –)	p.Gly1977Ser (false –)	NP,91,60,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.6320G>A,ARDM-166	42	39	NA	STGD	c.6320G>A(46)	p.Arg2107His	ND	ND	Yes,94,24,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.2791G>A,ARDM-222	26	23	NA	STGD	c.2791G>A(19)	p.Val931Met	ND	ND	NP,95,24,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3386G>T,ARDM-247	30	12	0.05	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137...,99,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.466A>G,RP-959	53	10	0.1	0.1	RP	c.466A>G(5)	p.Ile156Val	ND	ND	Yes,105,25,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.466A>G,RP-959	53	10	0.1	0.1	RP	c.466A>G(5)	p.Ile156Val	ND	ND	Yes,105,25,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.4297G>A,RP-1058	37	6	0.2	0.6	RP	c.4297G>A(29)	p.Val1433Ile	ND	ND	NP,106,25,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.1029T>C,8	c.1029T>C	p.Asn343Asn	This study,117,3,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.446C>T,4	2	Reduced	Traces	Mild reduction	Exome	Exon 2: c.446C>T; p.(Pro149Leu)	Exon 3: c.643C>T; p.(Gln21...,98,49,Brain_2013_Jan_3_136(1)_269-281.txt
c.643C>T,...ion	Exome	Exon 2: c.446C>T; p.(Pro149Leu)	Exon 3: c.643C>T; p.(Gln215*),98,81,Brain_2013_Jan_3_136(1)_269-281.txt
c.1183A>T,...Exon 8: c.1114_1116del; p.(Val372del)	Exon 9: Het c.1183A>T; p.(Arg395*),99,167,Brain_2013_Jan_3_136(1)_269-281.txt
c.677A>G,...Sanger	Exon 1: c.53dup; p.(Ser19Glufs*97)	Exon 3: c.677A>G; p.(Tyr226Cys),102,96,Brain_2013_Jan_3_136(1)_269-281.txt
c.2T>G,"...gous mutation affecting the start codon in exon 1 c.2T>G, leading to p.M1_R59del or p.M1?, was ident...",116,987,Brain_2013_Jan_3_136(1)_269-281.txt
c.677A>G,...dupT) in exon 1 and a missense mutation in exon 3 c.677A>G (p.Tyr226Cys). The heterozygous carrier s...,123,629,Brain_2013_Jan_3_136(1)_269-281.txt
c.364-1G>A,...n Patient 1) in cis with the splice site mutation c.364-1G>A (IVS3-1g>a). Previous expression studie...,153,945,Brain_2014_May_18_137(5)_1350-1360.txt
c.364-1G>A,...n Patient 1) in cis with the splice site mutation c.364-1G>A (IVS3-1g>a). Previous expression studie...,153,945,Brain_2014_May_18_137(5)_1350-1360.txt
c.7271T>G,...al population-based study of a specific mutation (c.7271T>G) in ATM [18] and the recent report of tw...,64,780,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
c.7271T>G,...st cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Br...,128,285,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
c.1066-6T>G,...s associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Fa...,128,299,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
c.-87T>C,"...n of the exon 4 (rs2016520, referred as T+294C or c.-87T>C); this polymorphism is located at the lin...",114,640,Cardiovasc_Diabetol_2008_Jul_25_7_23.txt
c.2575C>T,c.2575C>T,61,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.829C>T,"c.829C>T, p.Arg277Ter",65,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.829C>T,"c.829C>T, p.Arg277Ter",65,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2455C>T,"c.2455C>T, p.Arg630X",68,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2687G>A,"c.2687G>A, p.R896Q",89,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.1567C>T,"c.1567C>T, p.Arg523Ter	Kurban et al., 2010 [17]",96,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.1567C>T,"c.1567C>T, p.Arg523Ter",112,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.1567C>T,"c.1567C>T, p.Arg523Ter",112,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.1567C>T,"c.1567C>T, p.Arg523Ter",112,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.1567C>T,"c.1567C>T, p.Arg523Ter",112,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.3598G>A,"...ected a heterozygous mutation in the COL2A1 gene (c.3598G>A; p.Gly1200Ser). This missense mutation, ...",26,163,Case_Rep_Obstet_Gynecol_2015_Sep_8_2015_935204.txt
c.3113C>T,"...BCA4 gene with complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozygous state",15,679,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.3113C>T,"... 12 and 21 of the ABCA4 gene (c.1622T>C, p.L541P; c.3113C>T, p.A1038V), (2) a heterozygous variant i...",29,608,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.227G>A,"...heterozygous variant in exon 2 of the NR2E3 gene (c.227G>A, p.R760), and (3) a heterozygous variant ...",29,686,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.227G>A,"...heterozygous variant in exon 2 of the NR2E3 gene (c.227G>A, p.R760), and (3) a heterozygous variant ...",29,686,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.747A>T,...a heterozygous variant in exon 6 of the RGR gene (c.747A>T p.K249N). Based on previous knowledge of ...,29,763,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.1622T>C,"...genes, it was concluded that the ABCA4 mutations (c.1622T>C, p.L541P; c.3113C>T, p.A1038V) were thos...",29,875,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.3113C>T,"... (c.1622T>C, p.Leu541Pro, rs61751392) and A1038V (c.3113C>T, p.Ala1038Val, rs61751374), were identif...",33,230,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.335G>A,"... the nucleotide position 5234 (exon 2: g.5234G>A, c.335G>A, p.Arg112His) described in the literature...",46,381,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
c.1299G>A,...Omenn’s syndrome in which this missense mutation (c.1299G>A) was detectable in a patient who was het...,34,360,Cases_J_2009_Jul_30_2_8391.txt
c.1565C>T,"...prisingly, only 1 missense mutation (rs138651238; c.1565C>T and p.T522M) was discovered (Fig. 6). In...",87,217,Cell_Adh_Migr_2016_Feb_6_10(1-2)_395-55.txt
c.1432A>G,"...nt or function. The homozygous missense mutation (c.1432A>G, N478D) in the MTPAP gene was singled ou...",21,1168,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
c.1432A>G,"...nt or function. The homozygous missense mutation (c.1432A>G, N478D) in the MTPAP gene was singled ou...",21,1168,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
c.542G>A,"...nce of four and a half LIM domain 1 isoforms. The c.542G>A locates on exon 6, the resultant p.Trp181...",22,89,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
c.542G>A,"...ese case of FHL1 mutation associated HCM, and the c.542G>A (p.181W>X) is a novel nonsense mutation. ...",24,118,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
c.760G>A,"...ated in exon six, and another mutation in ACVRL1, c.760G>A (p.D254N. These mutations are described f...",33,225,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.760G>A,...red pathogenic by all but Polyphen‐2 software and c.760G>A by all but Pmut software. The other genes...,33,698,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.760G>A,...red pathogenic by all but Polyphen‐2 software and c.760G>A by all but Pmut software. The other genes...,33,698,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.731T>C,A c.731T>C CAPN5 mutation resulted in a p.Leu244Pro ...,10,3,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
c.731T>C,"...and one brother (Figure 1). This family carried a c.731T>C, p.Leu244Pro mutation in the CAPN5 gene.1...",28,211,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
c.2830G>A,c.2830G>,50,1,Cold_Spring_Harb_Mol_Case_Stud_2016_Jul_2(4)_a000885.txt
c.-949C>T,"... of NFKB1 c.-798_-795delATTG (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL...",9,77,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-854T>C,"...49C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), a...",9,131,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-854T>C,"...49C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), a...",9,131,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-418G>A,"...352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629...",9,158,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-488G>A,"...>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) polymorphisms with breast ca...",9,188,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-949C>T,"... of NFKB1 c.-798_-795delATTG (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL...",22,619,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-949C>T,"... of NFKB1 c.-798_-795delATTG (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL...",22,619,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-854T>C,"...49C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), a...",22,673,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-854T>C,"...49C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), a...",22,673,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-488G>A,"...>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) polymorphisms with breast ca...",22,730,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-854T>C,"For IL-10 c.-854T>C (rs1800871) polymorphism, the forward pr...",35,11,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-488G>A,"For TNF c.-488G>A (rs1800629) polymorphism, the primers us...",39,9,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-488G>A,"...NF c.-418G>A polymorphism, and GA genotype of TNF c.-488G>A polymorphism significantly reduced breas...",320,285,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-488G>A,"...NF c.-418G>A polymorphism, and GA genotype of TNF c.-488G>A polymorphism significantly reduced breas...",320,285,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.1A>T,"1	c.1A>T, c. 13G>A",288,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1A>T,"1	c.1A>T, c. 13G>A",288,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.34G>C,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.43G>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.43G>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.52G>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,30,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.110C>T,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.110C>T,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.124C>T,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.125G>A,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,31,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.125G>A,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,31,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.125G>C,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.125G>C,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.136G>C,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.160T>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,47,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.160T>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,47,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.160T>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,47,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.160T>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,47,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.167T>A,"c.164C>T, c.167T>A",297,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.235G>T,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, ...",298,19,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.235G>T,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, ...",298,19,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.256G>A,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376del40, c.39...",298,39,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.434G>A,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.483A>T,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.497G>A,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.574A>C,"5	c.536delG, c.574A>C, c.574A>G, c.600C>G",302,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.633A>T,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.635G>A,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,44,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.645C>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.714G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,31,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.719C>G,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.758G>A,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, ...",308,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.759C>G,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.766C>T,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.794A>G,"...c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,53,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.794A>G,"...c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,53,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.794A>G,"...c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,53,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.814C>A,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,31,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.818A>G,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.818A>G,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.818A>G,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.818A>G,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.892A>C,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.892A>C,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.893T>G,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.930G>C,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.930G>C,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.931C>T,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1000C>T,"9	c.968_973delGTGTCC, c.971delT, c.983G>A, c.1000C>T",314,44,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1001G>A,"c.1001G>A, c.1015G>T, c.1041_1042delGA, c.1046_104...",316,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1001G>A,"c.1001G>A, c.1015G>T, c.1041_1042delGA, c.1046_104...",316,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1001G>A,"c.1001G>A, c.1015G>T, c.1041_1042delGA, c.1046_104...",316,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1051A>C,"c.1051A>C, c.1076G>A",318,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1076G>A,"c.1051A>C, c.1076G>A",318,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1138G>C,"10	c.1096C>T, c.1097G>A, c.1138G>C",319,26,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1138G>C,"10	c.1096C>T, c.1097G>A, c.1138G>C",319,26,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1180G>A,"11	c.1175_1176delGA, c.1180G>A, c.1183G>T, c.1186A>G",320,22,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1192G>A,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1205G>A,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1252T>C,"c.1244C>A, c.1252T>C, c.1283_1284insA",324,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1286G>A,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321...",325,4,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1289G>A,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330...",325,15,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1321T>C,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,48,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1358G>A,"c.1335G>A, c.1358G>A, c.1372A>C, c.1378_1379insG, c.1393G>A",327,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.111G>A,"Screening for P37L and P37= (c.110C>T, c.111G>A) in exon 2 and E310D in exon 8 of PRKN wa...",28,40,Curr_Genomics_2015_Aug_16(4)_215-223.txt
c.1120C>T,"...o IPS were identified recently: missense mutation c.1120C>T in a highly conserved region of exon 8,1...",66,972,Dermatoendocrinol_2011_Apr_1_Apr-Jun_3(2)_53-61.txt
c.99+1G>A,... This revealed a splice site variant in intron 1 (c.99+1G>A) in both the index individual and in the...,31,1194,Dev_Med_Child_Neurol_2014_Nov_29_56(11)_1124-1128.txt
c.99+1G>A,... This revealed a splice site variant in intron 1 (c.99+1G>A) in both the index individual and in the...,31,1194,Dev_Med_Child_Neurol_2014_Nov_29_56(11)_1124-1128.txt
c.675C>G,"...Asp), E248 K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), and G261R and D217N (c.781...",34,193,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.781G>A,"... and c.675C>G, p.Ile225Met), and G261R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). ...",34,238,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.781G>A,"... and c.675C>G, p.Ile225Met), and G261R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). ...",34,238,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.781G>A,"... and c.675C>G, p.Ile225Met), and G261R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). ...",34,238,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.272T>C,2	c.272T>C	p.Leu91Pro	CGL2	[27],102,3,Diagn_Pathol_2013_May_9_8_78.txt
c.565G>T,4	c.565G>T	p.Glu189X	CGL2	[14],105,3,Diagn_Pathol_2013_May_9_8_78.txt
c.684C>G,6	c.684C>G	p. Tyr228X	CGL2	[7],107,3,Diagn_Pathol_2013_May_9_8_78.txt
c.-2548G>A,"...imentel MMG   LEPR p.Q223R, β 3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjec...",142,109,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
c.-2548G>A,"...imentel MMG   LEPR p.Q223R, β 3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjec...",142,109,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
c.57C>T,"...tions in the DYF13 gene, a one-base substitution (c.57C>T) and a one-base deletion (c.59delC; Figure...",94,909,eLife_2014_Mar_4_3_e01566.txt
c.745C>A,"... L239P, R263Q, R263X, E425X, L613F, L626Q, L626V, c.745C>A, c.228-16C>G, c.228-22T>A	Antonellis & Gr...",24,166,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
c.745C>A,"... L239P, R263Q, R263X, E425X, L613F, L626Q, L626V, c.745C>A, c.228-16C>G, c.228-22T>A	Antonellis & Gr...",24,166,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
c.228-16C>G,"...63Q, R263X, E425X, L613F, L626Q, L626V, c.745C>A, c.228-16C>G, c.228-22T>A	Antonellis & Green (2008)...",24,176,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
c.673C>T,"...we found a homozygous nucleotide change in XRCC4 (c.673C>T), predicted to introduce a premature stop...",9,794,EMBO_Mol_Med_2015_Jul_14_7(7)_918-929.txt
c.673C>T,"...we found a homozygous nucleotide change in XRCC4 (c.673C>T), predicted to introduce a premature stop...",9,794,EMBO_Mol_Med_2015_Jul_14_7(7)_918-929.txt
c.673C>T,...The most severe variant was the nucleotide change c.673C>T in XRCC4. Two different isoforms of XRCC4...,88,677,EMBO_Mol_Med_2015_Jul_14_7(7)_918-929.txt
c.1342C>T,c.1342C>T	p.Arg448Trp	Juxta-membrane domain	Diseas...,144,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.2314C>T,c.2314C>T	p.Pro772Ser	C-terminal tail	Disease-caus...,147,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.743G>A,c.743G>A	p.Arg248Glu	Third intracellular loop	Poly...,156,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.554G>A,"De novo heterozygous c.554G>A (R185Q)	Saline, furosemide, and pamidrona...",114,22,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.206G>A,"...90 mg daily	6 years	6 years	Inherited, homozygous c.206G>A (R69H)	Pamidronate, phosphate, hydration	...",117,87,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.554G>A,"De novo heterozygous c.554G>A (R185Q)	Saline, low calcium formula, phos...",119,22,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.2753T>C,"...n our case a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy) was detected by targeted n...",4,1178,Endocrinol_Diabetes_Metab_Case_Rep_2016_Jan_18_2016_150117.txt
c.1621G>A,...ing peripheral leukocytes revealed a heterozygous c.1621G>A mutation in the MEN1 gene that was previ...,10,70,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.1621G>A,"...nd direct DNA sequencing, we found a heterozygous c.1621G>A (Ala541Thr) mutation at exon 10 of the M...",56,91,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.1621G>A,"...nd direct DNA sequencing, we found a heterozygous c.1621G>A (Ala541Thr) mutation at exon 10 of the M...",56,91,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.1621G>A,"...y identified [9]. In this patient, a heterozygous c.1621G>A (Ala541Thr) mutation was found on exon 1...",63,586,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.1621G>A,...olyPhen-2 report indicates that the heterogeneous c.1621G>A (Ala541Thr) mutation is predicted to be ...,86,199,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.582T>A,"...hermore, two other TMPRSS3 mutations (NM_024022.2:c.582T>A; NP_076927.1:p.C194* and NM_024022.2:c.58...",10,977,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
c.581G>T,...2.2:c.582T>A; NP_076927.1:p.C194* and NM_024022.2:c.581G>T; NP_076927.1:p.C194F) were detected in th...,10,1023,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
c.521T>C,"...re found in more and more studies. Specially, the c.521T>C (p.Val174Ala) SNP has been associated wit...",150,113,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
c.521T>C,"...re found in more and more studies. Specially, the c.521T>C (p.Val174Ala) SNP has been associated wit...",150,113,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
c.388A>G,The c.388A>G and the c.521T>C variants occur in allele...,162,5,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
c.521T>C,...er LE  Uitterlinden AG  Klungel OH    The SLCO1B1 c.521T>C polymorphism is associated with dose decr...,974,96,Eur_J_Epidemiol_2015_Sep_19_30_661-708.txt
c.151+1G>T,"...ction (LOF) single-nucleotide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1...",3,1987,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,"...leotide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one gain-o...",3,2009,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...ymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one gain-of-function ...",3,2020,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,...3A>C and c.1729T>A) and one gain-of-function SNP (c.489C>T). The purpose of this study was to determ...,3,2075,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,...3A>C and c.1729T>A) and one gain-of-function SNP (c.489C>T). The purpose of this study was to determ...,3,2075,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...icking of the receptor to the cell surface,35 the c.946G>A variant (p.Arg307Gln) abolishes ATP bindi...",18,600,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...icking of the receptor to the cell surface,35 the c.946G>A variant (p.Arg307Gln) abolishes ATP bindi...",18,600,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,...regulation of P2X7R expression32 and the intronic c.151+1G>T variant results in a null allele.37 The...,18,837,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,...regulation of P2X7R expression32 and the intronic c.151+1G>T variant results in a null allele.37 The...,18,837,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,"...F variants results in ablated ATP response.37 The c.489C>T variant (p.His155Tyr), located in the ext...",18,1170,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,"...F variants results in ablated ATP response.37 The c.489C>T variant (p.His155Tyr), located in the ext...",18,1170,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...her c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while having major alleles at the other ...",34,113,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,"Overall, SNP call rates were 97% for c.151+1G>T (rs35933842), c.946G>A (rs28360457), c....",41,38,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,"Overall, SNP call rates were 97% for c.151+1G>T (rs35933842), c.946G>A (rs28360457), c....",41,38,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"... call rates were 97% for c.151+1G>T (rs35933842), c.946G>A (rs28360457), c.1096C>G (rs2230911) and c...",41,63,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,...(rs2230911) and c.1729T>A (rs1653624) and 95% for c.489C>T (rs208294) and c.1513A>C (rs3751143). Tab...,41,146,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,... change in LS-BMD did not differ significantly by c.946G>A genotype (−0.39%/year (SEM 0.06) for GG s...,44,735,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,"...ions (n=84), subjects who had a LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.172...",47,135,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,"...ions (n=84), subjects who had a LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.172...",47,135,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,"... who had a LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (n=48) had almos...",47,156,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (n=48) had almost ninefold ...",47,167,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...endorff et al22 demonstrated that two P2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), a...",50,860,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,...ounding effects on bone loss or baseline BMD. The c.946G>A polymorphism changes arginine to glutamin...,52,606,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...one turnover. Indeed, the profound effects of the c.946G>A SNP on bone are further highlighted and r...",52,1340,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,...found that subjects who were heterozygous for the c.946G>A (Arg307Gln variant) had >40% greater bone...,52,1501,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,...found that subjects who were heterozygous for the c.946G>A (Arg307Gln variant) had >40% greater bone...,52,1501,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,... with total hip replacement revision and that the c.946G>A allele increased cumulative hazard of tot...,52,1875,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...MD, while neither of the most prevalent variants, c.1513A>C, nor c.1729T>A polymorphisms alone showe...",52,2103,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...er of the most prevalent variants, c.1513A>C, nor c.1729T>A polymorphisms alone showed any significa...",52,2118,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...er of the most prevalent variants, c.1513A>C, nor c.1729T>A polymorphisms alone showed any significa...",52,2118,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,...fracture risk. As the observed effect size of the c.946G>A is quiet large (β=0.12) compared with pre...,60,178,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...xamine rare genetic variants, including the P2RX7 c.946G>A, which has a population frequency of arou...",60,849,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,rs35933842	c.151+1G>T	0.01	0.97 (0.01)	0.93 (0.03)	*	0.3	−0.0...,105,12,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,rs35933842	c.151+1G>T	0.01	0.97 (0.01)	0.93 (0.03)	*	0.3	−0.0...,105,12,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,rs35933842	c.151+1G>T	0.01	0.97 (0.01)	0.93 (0.03)	*	0.3	−0.0...,105,12,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,rs35933842	c.151+1G>T	0.01	0.97 (0.01)	0.93 (0.03)	*	0.3	−0.0...,105,12,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,rs208294	c.489C>T (p.H155Y)	0.43	0.96 (0.01)	0.98 (0.01)	0....,106,10,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,rs2230911	c.1096C>G (p.T357S)	0.07	0.97 (0.01)	0.98 (0.02)	1...,108,11,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.913G>T,"...ntified to date are c.458C>T (p.(Pro153Leu))1 and c.913G>T (p.(Glu305*)),2 in individuals of Europea...",21,505,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.913G>T,"...ntified to date are c.458C>T (p.(Pro153Leu))1 and c.913G>T (p.(Glu305*)),2 in individuals of Europea...",21,505,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.472G>A,"... However, some polymorphic variants, for example, c.472G>A (p.(Glu158Lys)) and c.923A>G (p.(Glu308Gl...",21,1368,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.472G>A,"... However, some polymorphic variants, for example, c.472G>A (p.(Glu158Lys)) and c.923A>G (p.(Glu308Gl...",21,1368,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.472G>A,"... However, some polymorphic variants, for example, c.472G>A (p.(Glu158Lys)) and c.923A>G (p.(Glu308Gl...",21,1368,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.923A>G,"...riants, for example, c.472G>A (p.(Glu158Lys)) and c.923A>G (p.(Glu308Gly)), when present in cis, can...",21,1397,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.1624G>T, G542X	c.1624G>T	p.Gly542*,162,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1624G>T, G542X	c.1624G>T	p.Gly542*,162,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1652G>A, G551D	c.1652G>A	p.Gly551Asp,163,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3909C>G, N1303K	c.3909C>G	p.Asn1303Lys,164,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3909C>G, N1303K	c.3909C>G	p.Asn1303Lys,164,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3909C>G, N1303K	c.3909C>G	p.Asn1303Lys,164,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3846G>A, W1282X	c.3846G>A	p.Trp1282*,165,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.178G>T, E60X	c.178G>T	p.Glu60*,168,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.254G>A, G85E	c.254G>A	p.Gly85Glu,169,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.254G>A, G85E	c.254G>A	p.Gly85Glu,169,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1657C>T, R553X	c.1657C>T	p.Arg553*,176,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1679G>C, R560T	c.1679G>C	p.Arg560Thr,177,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1766+1G>A, 1898+1G>A	c.1766+1G>A	 ,178,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.223C>T, R75X	c.223C>T	p.Arg75*,188,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.274G>T, E92X	c.274G>T	p.Glu92*,191,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.274G>T, E92X	c.274G>T	p.Glu92*,191,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.274G>A, E92K	c.274G>A	p.Glu92Lys,192,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.274G>A, E92K	c.274G>A	p.Glu92Lys,192,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.292C>T, Q98X	c.292C>T	p.Gln98*,193,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.328G>C, D110H	c.328G>C	p.Asp110His,195,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.349C>T, R117C	c.349C>T	p.Arg117Cys,196,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.532G>A, G178R	c.532G>A	p.Gly178Arg,201,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.579+5G>A, 711+5G>A	c.579+5G>A	 ,203,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.579+5G>A, 711+5G>A	c.579+5G>A	 ,203,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.595C>T, H199Y	c.595C>T	p.His199Tyr,205,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.613C>T, P205S	c.613C>T	p.Pro205Ser,206,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.988G>T, G330X	c.988G>T	p.Gly330*,211,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.988G>T, G330X	c.988G>T	p.Gly330*,211,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.988G>T, G330X	c.988G>T	p.Gly330*,211,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.988G>T, G330X	c.988G>T	p.Gly330*,211,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1000C>T, R334W	c.1000C>T	p.Arg334Trp,212,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1116+1G>A, 1248+1G>A	c.1116+1G>A	 ,219,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1209+1G>A, 1341+1G>A	c.1209+1G>A	 ,223,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1209+1G>A, 1341+1G>A	c.1209+1G>A	 ,223,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1393-1G>A, 1525-1G>A	c.1393-1G>A	 ,225,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1558G>T, V520F	c.1558G>T	p.Val520Phe,231,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1585-1G>A, 1717-1G>A	c.1585-1G>A	 ,232,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1654C>T, Q552X	c.1654C>T	p.Gln552*,237,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1675G>A, A559T	c.1675G>A	p.Ala559Thr,238,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2125C>T, R709X	c.2125C>T	p.Arg709*,247,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2464G>T, E822X	c.2464G>T	p.Glu822*,254,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2464G>T, E822X	c.2464G>T	p.Glu822*,254,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2491G>T, E831X	c.2491G>T	p.Glu831*,256,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2537G>A, W846X	c.2537G>A	p.Trp846*,257,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2537G>A, W846X	c.2537G>A	p.Trp846*,257,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2551C>T, R851X	c.2551C>T	p.Arg851*,259,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2668C>T, Q890X	c.2668C>T	p.Gln890*,263,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2668C>T, Q890X	c.2668C>T	p.Gln890*,263,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2908G>C, G970R	c.2908G>C	p.Gly970Arg,266,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2908G>C, G970R	c.2908G>C	p.Gly970Arg,266,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3197G>A, R1066H	c.3197G>A	p.Arg1066His,273,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3310G>T, E1104X	c.3310G>T	p.Glu1104*,277,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3472C>T, R1158X	c.3472C>T	p.Arg1158*,278,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3472C>T, R1158X	c.3472C>T	p.Arg1158*,278,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3587C>G, S1196X	c.3587C>G	p.Ser1196*,279,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3587C>G, S1196X	c.3587C>G	p.Ser1196*,279,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3937C>T, Q1313X	c.3937C>T	p.Gln1313*,290,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.350G>A, R117H	c.350G>A	p.Arg117His,296,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3205G>A, G1069R	c.3205G>A	p.Gly1069Arg,305,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.91C>T, R31C	c.91C>T	p.Arg31Cys,312,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.220C>T, R74W	c.220C>T	p.Arg74Trp,313,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.224G>A, R75Q	c.224G>A	p.Arg75Gln,314,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.224G>A, R75Q	c.224G>A	p.Arg75Gln,314,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1727G>C, G576A	c.1727G>C	p.Gly576Ala,317,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1727G>C, G576A	c.1727G>C	p.Gly576Ala,317,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1727G>C, G576A	c.1727G>C	p.Gly576Ala,317,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1727G>C, G576A	c.1727G>C	p.Gly576Ala,317,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2260G>A, V754M	c.2260G>A	p.Val754Met,319,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2260G>A, V754M	c.2260G>A	p.Val754Met,319,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3208C>T, R1070W	c.3208C>T	p.Arg1070Trp,322,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3208C>T, R1070W	c.3208C>T	p.Arg1070Trp,322,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3808G>A, D1270N	c.3808G>A	p.Asp1270Asn,325,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3208C>T,[R74W;R1070W;D1270N]c.[220C>T;c.3208C>T;3808G>A,341,31,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2657+5G>A,"...y542★…); LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with variable dise...",396,113,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2657+5G>A,"...y542★…); LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with variable dise...",396,113,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1523T>G,...e508del due to the presence of the variant F508C (c.1523T>G); false homozygosity for p.Ile507del due...,480,230,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1523T>G,...e508del due to the presence of the variant F508C (c.1523T>G); false homozygosity for p.Ile507del due...,480,230,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.161A>G,...eflecting an earlier report of NM_022437.2(ABCG8):c.161A>G (p.Tyr54Cys) (r2~0.2 between rs4299376:G>...,92,1069,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
c.1810C>G,... in intron 10 and rs6720173:G>C NM_022436.2(ABCG5)c.1810C>G (p.Gln604Glu). The ABCG5/ABCG8 transport...,92,1293,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
c.404C>A,"HSPB1 was identified, a c.404C>A transversion resulted in p.(Ser135Tyr) am...",83,25,F1000Res_2015_Feb_26_4_53.txt
c.5682C>G,11	c.1291_1292insT	1	11	c.5682C>G	1,61,25,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.191G>A,5	c.191G>A	1	6	c.516 + 1G>T	1,70,3,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.514C>T,8	c.514C>T	1	8	c.658_659delGT	2,71,3,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5080G>T,18	c.5080G>T	1	10	c.1813insA	1,73,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5346G>A,22	c.5346G>A	1	15	c.7436_7437-2delAGAT	1,75,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5503C>T,24	c.5503C>T	1	16	c.7734_7740del6ins9	2,76,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.9117G>A,23	c.9117G>A	2,80,7,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.692C>T,11	c.692C>T	1	10	c.1385A>G	1,83,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1258G>T,11	c.1258G>T	1	15	c.7469T>C	1,84,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1258G>T,11	c.1258G>T	1	15	c.7469T>C	1,84,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.7469T>C,11	c.1258G>T	1	15	c.7469T>C	1,84,19,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.7469T>C,11	c.1258G>T	1	15	c.7469T>C	1,84,19,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.7469T>C,11	c.1258G>T	1	15	c.7469T>C	1,84,19,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.8111C>T,11	c.1486C>T	1	18	c.8111C>T	1,85,19,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5194-25A>C,19(I)	c.5194-25A>C	1,87,7,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5435C>G,23	c.5435C>G	1,89,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5435C>G,23	c.5435C>G	1,89,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.4987-3C>G,"...Vs had mutation probabilities below 20%. The UVs: c.4987-3C>G (putative splice variant), and c.5216A...",152,130,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1258G>T,11	c.1258G>T	p.D420Y	1	6.5	10.5	Y	N/Y	3	ND	N	Unknown	...,157,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1486C>T,11	c.1486C>T	p.R496C	1	0.3	3.4	Y	N/N	43	ND	Y	Neutral	...,158,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1486C>T,11	c.1486C>T	p.R496C	1	0.3	3.4	Y	N/N	43	ND	Y	Neutral	...,158,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1486C>T,11	c.1486C>T	p.R496C	1	0.3	3.4	Y	N/N	43	ND	Y	Neutral	...,158,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.4987-3C>G,17	c.4987-3C>G	NA		96.9	37.6	–	–	0	ND	ND,159,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.4987-3C>G,17	c.4987-3C>G	NA		96.9	37.6	–	–	0	ND	ND,159,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5194-25A>C,20	c.5194-25A>C	NA	1	14.0	17.4	–	–	0	ND	ND,160,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.7469T>C,15	c.7469T>C	p.I2490T	1	13.6	19.9	Y	N/N	238	ND	ND,166,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.8111C>T,18	c.8111C>T	p.S2704F	1	11.5	7.3	Y	N/N	1	ND	ND,167,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.8723T>G,21	c.8723T>G	p.V2908G	1	1.2	9.8	N	Y/N	8	N	N	Neutral	[...,168,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1935C>A,"... Hirschhorn and Huie, 1999), and a common defect, c.1935C>A (p.Asp645Glu), is shared by Chinese pati...",25,149,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
c.2560C>T,"...). The most common mutation in African-Americans, c.2560C>T (p.Arg854Ter), most likely originated in...",25,284,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
c.-135T>C,NM_145740.3:c.-135T>C,186,14,Front_Genet_2014_Nov_14_5_391.txt
c.331A>G,"...2755:c.167A>C_p.Q56P (0.13,1125, PIK3CA:NM 006218:c.331A>G p.K111E [0.13,765]), and CTNNB1:NM_001904...",77,191,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
c.295G>C,...nding chromosomal region. Cases S25 and S8 (MCCC2 c.295G>C mutation) had identical genotypes at all ...,50,1446,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1065A>T,...ting identity by descent. Cases A7 and A11 (MCCC2 c.1065A>T mutation) had identical genotypes at 35 ...,50,1561,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1015G>A,...S9 and S10 (both compound heterozygotes for MCCC2 c.1015G>A mutation) had dissimilar genotypes in th...,50,1709,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1894C>T,c.1894C>T	p.Gln584X,90,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1731+4A>G,"A4	F	Homozygous	c.1731+4A>G	Intronic, splice region	UNK	This study...",92,17,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1731+4A>G,"A4	F	Homozygous	c.1731+4A>G	Intronic, splice region	UNK	This study...",92,17,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.841C>T,A9	F	Compound Het.	c.841C>T; c.558delA	p.Arg281X,96,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.834A>G,c.834A>G	p.Val397Glyfs*19,99,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.974T>G,2	S20	M	Compound Het.	c.866C>T; c.974T>G*	p.Ala289Val,107,33,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1155A>C,"3	S4	F	Homozygous	c.1155A>C*	p.Arg385Ser	Nonsyn	Refs. 15,16",110,19,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1594G>C,S5	F	Homozygous	c.1594G>C*	p.Asp532His	Nonsyn/splicing	Ref. 15,111,17,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1882G>T,c.1882G>T	p.Gln372X,114,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1882G>T,c.1882G>T	p.Gln372X,114,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1065A>T,A11	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,119,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.302C>T,A13	F	Compound Het.	c.302C>T; UND	p.Ser101Phe	Nonsyn	This study,120,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1367C>T,A16	F	Homozygous	c.1367C>T	p.Ala456Val	Nonsyn	Ref. 6,122,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1367C>T,A16	F	Homozygous	c.1367C>T	p.Ala456Val	Nonsyn	Ref. 6,122,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.599T>A,c.599T>A*	p.Ser173Phefs*25,124,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.599T>A,c.599T>A*	p.Ser173Phefs*25,124,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.295G>C,S25	F	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Ref. 15,137,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.295G>C,"3	S8	M	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Refs. 3,15",139,19,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.116C>T,S28	M	Homozygous	c.116C>T	p.Ser39Phe	Nonsyn	Ref. 19,144,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.116C>T,S28	M	Homozygous	c.116C>T	p.Ser39Phe	Nonsyn	Ref. 19,144,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1537C>T,1	CH	c.1537C>,226,6,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1543G>A,c.1543G>A	p.R512,228,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1543G>A,c.1543G>A	p.R512,228,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1543G>A,c.1543G>A	p.R512,228,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1543G>A,c.1543G>A	p.R512,228,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1543G>A,MTI-498	1	H	c.1543G>A,238,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1535G>A,JS_D	1	H	c.1535G>A	p.R512Q	Yes,244,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1535G>A,JS_D	1	H	c.1535G>A	p.R512Q	Yes,244,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1600T>G,JBS-011	2	CH	c.1600T>,248,15,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1600T>G,JBS-011	2	CH	c.1600T>,248,15,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1600T>G,JBS-011	2	CH	c.1600T>,248,15,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1688G>A,MTI-008	4	H	c.1688G>A	p.R563H	Yes,258,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1688G>A,MTI-008	4	H	c.1688G>A	p.R563H	Yes,258,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1688G>A,MTI-008	4	H	c.1688G>A	p.R563H	Yes,258,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1738A>G,MTI-627	3 (1 died)	H	c.1738A>G	p.K580E	Yes,264,23,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1921T>C,c.1921T>,271,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1921T>C,c.1921T>,281,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1303C>T,c.1303C>T	p.R435*	Yes,308,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1303C>T,c.1303C>T	p.R435*	Yes,308,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,325,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,345,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,345,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1922T>A,c.1922T>,355,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2156A>G,K8103	2	H	c.2156A>G	p.D719G	Yes,370,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.4714G>T,JS_3	1	H	c.4714G>T	p.E1572*	Yes,403,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,410,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,447,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,455,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,455,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5932G>A,c.5932G>A,457,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5932G>A,c.5932G>A,457,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5824C>T,MTI-133	2 (2 died)	H	c.5824C>T	p.Q1942*	Yes,463,23,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2161C>T,JBS-006	1	H	c.2161C>T	p.P721S	Yes,491,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.3056G>A,c.3056G>,511,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.3364C>T,c.3364C>,521,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.3364C>T,c.3364C>,521,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.3364C>T,c.3364C>,532,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.3364C>T,c.3364C>,532,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.4582C>T,c.4582C>T	p.R1528C	Yes,548,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.4258G>A,MTI-127	1	CH	c.4258G>,554,15,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.4258G>A,MTI-127	1	CH	c.4258G>,554,15,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.342-2A>G,c.342-2A>,600,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.342-2A>G,c.342-2A>,611,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.342-2A>G,c.342-2A>,611,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.33+2T>G,MTI-429	5 (1 died)	H	c.33+2T>G	ND	Yes,637,23,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.33+2T>G,MTI-429	5 (1 died)	H	c.33+2T>G	ND	Yes,637,23,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.376G>A,c.376G>,650,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.389A>G,c.389A>,677,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.389A>G,c.389A>,677,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.128+5G>A,c.128+5G>,706,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.128+5G>A,c.128+5G>,706,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.128+5G>A,c.128+5G>,706,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.128+5G>A,c.128+5G>,706,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.128+5G>A,c.128+5G>,706,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.128+5G>A,c.128+5G>,713,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.128+5G>A,c.128+5G>,713,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.7978C>T,c.7978C>T	p.R2660*	Yes,717,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2773C>T,ND	1	H	c.2773C>T	p.R925*	Yes,753,9,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.875T>C,"...ons.9 Sequencing FRMD7 revealed a T>C transition (c.875T>C) in exon 9 (Figure 1b), which causes a co...",21,727,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,"...idelines.10,11 We accordingly speculated that the c.875T>C variant of FRMD7 is associated with ICN i...",21,1593,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,The missense variant c.875T>C has a single-nucleotide polymorphism (SNP...,23,22,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,"... by II:1, II:2 and II:3. Arrow marks the variant, c.875T>C. (c) Cross-species multiple alignment of ...",39,398,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,"... by II:1, II:2 and II:3. Arrow marks the variant, c.875T>C. (c) Cross-species multiple alignment of ...",39,398,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.207C>A,"...ase. Here, we report a novel hemizygous mutation, c.207C>A (Phe69 Leu), which caused a mild/late-ons...",14,1082,Hum_Genome_Var_2015_Nov_12_2_15044.txt
c.307C>T,"...imit in Patient no. 19. Patient no. 12, who had a c.307C>T mutation in the paired domain (PD), exhib...",23,1021,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.802G>T,"...reduction of amplitude. Patient no. 19, who had a c.802G>T mutation in the proline/serine/threonine-...",23,1168,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.802G>T,"...reduction of amplitude. Patient no. 19, who had a c.802G>T mutation in the proline/serine/threonine-...",23,1168,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.949C>T,"... a normal ERG response. Patient no. 21, who had a c.949C>T mutation in PST, exhibited subnormal cone...",23,1296,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.79C>T,"...ings (data not shown). Novel mutations, including c.79C>T (p.Gln27X), c.109_110insG (p.Ala2GlyfsX19)...",26,696,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.79C>T,"...ings (data not shown). Novel mutations, including c.79C>T (p.Gln27X), c.109_110insG (p.Ala2GlyfsX19)...",26,696,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.802G>T,"...+1G>T, IVS5+2T>G, c.551_552insG (p.Glu9ArgfsX15), c.802G>T (p.Glu268X) and IVS11+1G>T, were identifi...",26,802,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.802G>T,"...+1G>T, IVS5+2T>G, c.551_552insG (p.Glu9ArgfsX15), c.802G>T (p.Glu268X) and IVS11+1G>T, were identifi...",26,802,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.802G>T,"...+1G>T, IVS5+2T>G, c.551_552insG (p.Glu9ArgfsX15), c.802G>T (p.Glu268X) and IVS11+1G>T, were identifi...",26,802,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.131G>A,"...s previously reported, the two missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) wer...",26,928,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.50A>G,... two missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) were found in two sporadic pa...,26,954,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.50A>G,1	 	Sporadic	Exon5	c.50A>G	Missense	p.Asn17Ser	PD	No	9	F	Total/total	...,51,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.50A>G,1	 	Sporadic	Exon5	c.50A>G	Missense	p.Asn17Ser	PD	No	9	F	Total/total	...,51,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.50A>G,1	 	Sporadic	Exon5	c.50A>G	Missense	p.Asn17Ser	PD	No	9	F	Total/total	...,51,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.607C>T,15	 	Sporadic	Exon8	c.607C>T	Nonsense	p.Arg203X	LNK	Yes	9	F	Partial/pa...,66,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.718C>T,16	 	Sporadic	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	27	F	Total/tota...,67,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.718C>T,17	4	Familial	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	29	M	Total/tota...,68,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.718C>T,17	4	Familial	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	29	M	Total/tota...,68,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.718C>T,17	4	Familial	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	29	M	Total/tota...,68,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.718C>T,18	4	 	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	5	F	Total/total...,69,14,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.802G>T,19	 	Sporadic	Exon10	c.802G>T	Nonsense	p.Glu268X	PST	Yes	6	F	Total/tota...,70,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.949C>T,21	 	Sporadic	Exon11	c.949C>T	Nonsense	p.Arg317X	PST	Yes	10	M	Total/tot...,72,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.949C>T,21	 	Sporadic	Exon11	c.949C>T	Nonsense	p.Arg317X	PST	Yes	10	M	Total/tot...,72,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.2386C>T,"...tted variant predicted a premature stop mutation (c.2386C>T; p.R796X), whereas the maternally transm...",3,2449,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.2386C>T,"...tted variant predicted a premature stop mutation (c.2386C>T; p.R796X), whereas the maternally transm...",3,2449,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.2386C>T,...ritance pattern. The first variant in PI4KA was a c.2386C>T mutation in exon 20 (NM_058004.3) that i...,46,1447,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,"...n of translation (p.R796X). The second variant, a c.5560G>A in exon 48 is predicted to result in a m...",46,1592,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...ith c.2386C>T inherited from the father (I-1) and c.5560G>A from the mother (I-2) (Fig. 2B),46,2482,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...ith c.2386C>T inherited from the father (I-1) and c.5560G>A from the mother (I-2) (Fig. 2B),46,2482,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.2386C>T,"...nces does not extend to the region harbouring the c.2386C>T variant, when viewing the exome data for...",67,255,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.2386C>T,"...nces does not extend to the region harbouring the c.2386C>T variant, when viewing the exome data for...",67,255,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,"...6C>T variant, when viewing the exome data for the c.5560G>A variant in IGV one sees a small percenta...",67,310,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,"...6C>T variant, when viewing the exome data for the c.5560G>A variant in IGV one sees a small percenta...",67,310,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...udogene sequences at its 3′ end (Fig. 2D) and the c.5560G>A variant was still clearly visible (Suppl...,67,898,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.1824C>T,...l nuclei after 70 weeks of expression of the LMNA c.1824C>T mutation showed severe distortion with m...,5,1579,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,HGPS animals expressed the LMNA c.1824C>T mutation from embryonic day 12.5 until p...,32,33,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,"... 1). In spite of long-term expression of the LMNA c.1824C>T mutation, 90-week HGPS animals did not e...",37,437,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,"... 1). In spite of long-term expression of the LMNA c.1824C>T mutation, 90-week HGPS animals did not e...",37,437,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,...imals (Fig. 1P and Q). Twenty or 90 weeks of LMNA c.1824C>T mutation expression did not cause any ma...,37,1510,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,...imals (Fig. 1P and Q). Twenty or 90 weeks of LMNA c.1824C>T mutation expression did not cause any ma...,37,1510,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,...defects in the heart after 20 or 74 weeks of LMNA c.1824C>T mutation expression (Supplementary Mater...,37,2647,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,"...on of the common progeroid lamin A mutation, LMNA c.1824C>T; p.G608G, to test the hypothesis that ne...",87,540,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.913G>A,p.G305R	c.913G>A	3.58	4.90	B	1,18,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.919G>A,p.G307S	c.919G>A	0.16	0.50	B	88	ECE: undetectable activity...,19,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.785C>G,p.T262R	c.785C>G	0.14	0.20	B	1,21,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.430G>A,Other locations in active core	p.E144K	c.430G>A	0.10	0.20	B	12	ECE: <1%WT activity [Dawso...,23,40,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.494G>A,p.C165Y	c.494G>A	1.85	3.00	B	8	ECE: 0–3%WT activity [Gordo...,24,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.684C>G,"p.N228K	c.684C>G/A	0.06	0.10	B	4	ECE: aggregates, 0% WT ac...",25,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.374G>A,p.R125Q	c.374G>A	8.57	16.60	S	13	ECE: 0–1.9%WT activity [M...,29,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.904G>A,p.E302K	c.904G>A	15.03	24.50	S	6	ECE: shorter product -par...,31,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.539T>C,p.V180A	c.539T>C	5.15	15.50	S	1	ECE: 3–8% WT activity [Klu...,36,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.539T>C,p.V180A	c.539T>C	5.15	15.50	S	1	ECE: 3–8% WT activity [Klu...,36,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.1265C>T,"Regulatory domain-first CBS domain	p.P422L	c.1265C>T	4.89	8.70	B	1	ECE: ∼160% WT activity, 0....",38,44,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.1304T>C,p.I435T	c.1304T>C	16.11	38.50	S	1	ECE: tetramer [Janosik e...,39,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.1397C>T,"p.S466L	c.1397C>T	0.23	0.40	B	1	ECE: ∼310% WT activity, 0....",42,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.1616T>C,Regulatory domain-second CBS domain	p.L539S	c.1616T>C	1.93	5.70	B	2,43,45,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.1616T>C,Regulatory domain-second CBS domain	p.L539S	c.1616T>C	1.93	5.70	B	2,43,45,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.4A>G,"...zzanti et al., 2003], and caused by the invariant c.4A>G missense change (p.Ser2Gly) in SHOC2 [Corde...",12,2258,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
c.4A>G,"...1 lesion, five NS/LAH subjects with the invariant c.4A>G SHOC2 mutation, and 21 age- and sex-matched...",28,522,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
c.4A>G,"... because of the invariant occurrence of the SHOC2 c.4A>G mutation underlying this disorder, and appe...",31,766,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
c.19G>A,... of HbA caused by an amino acid substitution (HBB c.19G>A; p.Glu6Lys) occurring at the same position...,27,84,Hum_Mutat_2013_Jul_8_34(7)_937-944.txt
c.-28A>G,...he pathogenicity of previously reported variants (c.-28A>G and c.-7C>T) within the MLH1 5′untranslat...,8,774,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...ity of previously reported variants (c.-28A>G and c.-7C>T) within the MLH1 5′untranslated region (UT...,8,787,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...ity of previously reported variants (c.-28A>G and c.-7C>T) within the MLH1 5′untranslated region (UT...,8,787,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...ons at the promoter. Sequencing revealed that the c.-28A>G and c.-7C>T variants were the only potent...,8,1189,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-64G>T,"...syndrome, namely, c.-411_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, ...",15,145,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-64G>T,"...syndrome, namely, c.-411_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, ...",15,145,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-27C>A,"...c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et al., 200...",15,195,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...2C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et al., 2003; Hitchins et al., 2011...",15,219,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...no analysis of the potential pathogenicity of the c.-28A>G or c.-7C>T variants has been undertaken, ...",15,1390,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...of the potential pathogenicity of the c.-28A>G or c.-7C>T variants has been undertaken, despite the ...",15,1402,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...y, we aimed to determine the pathogenicity of the c.-28A>G and c.-7C>T variants within the MLH1 5′ u...",17,63,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...y, we aimed to determine the pathogenicity of the c.-28A>G and c.-7C>T variants within the MLH1 5′ u...",17,63,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...o determine the pathogenicity of the c.-28A>G and c.-7C>T variants within the MLH1 5′ untranslated r...,17,76,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...bands (Proband 32 and Proband N; Fig. 1) with the c.-28A>G and c.-7C>T variants (all nucleotide numb...,21,58,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...d 32 and Proband N; Fig. 1) with the c.-28A>G and c.-7C>T variants (all nucleotide numbering used th...,21,71,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...detected in the MLH1 or PMS2 genes except for the c.-28A>G and c.-7C>T heterozygous variants in the ...,21,1202,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...he MLH1 or PMS2 genes except for the c.-28A>G and c.-7C>T heterozygous variants in the MLH1 5′UTR. T...,21,1215,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...re 1 Identification of two probands with the MLH1 c.-28A>G and c.-7C>T variants from two unrelated c...,23,55,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...re 1 Identification of two probands with the MLH1 c.-28A>G and c.-7C>T variants from two unrelated c...,23,55,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...re 1 Identification of two probands with the MLH1 c.-28A>G and c.-7C>T variants from two unrelated c...,23,55,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655G>A,...) and allele specificity was determined using the c.655G>A site,35,819,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655G>A,...) and allele specificity was determined using the c.655G>A site,35,819,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"To confirm the presence of the c.-28A>G and c.-7C>T variants, we performed sequen...",48,32,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-93G>A,"...d identified three heterozygous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). ...",48,268,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...ed three heterozygous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). No further...",48,278,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...ozygous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). No further sequence vari...",48,292,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...ozygous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). No further sequence vari...",48,292,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"... the c.-93G>A is a common and benign variant, the c.-28A>G and c.-7C>T are described as Class 3 vari...",48,434,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"... the c.-93G>A is a common and benign variant, the c.-28A>G and c.-7C>T are described as Class 3 vari...",48,434,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"... is a common and benign variant, the c.-28A>G and c.-7C>T are described as Class 3 variants of uncer...",48,447,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,To determine whether the c.-28A>G and c.-7C>T variants were in cis with ano...,51,26,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,To determine whether the c.-28A>G and c.-7C>T variants were in cis with another pathogen...,51,39,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...were detected across the MLH1 gene other than the c.-28A>G and c.-7C>T variants,51,945,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,... within the MLH1 gene other than the c.-28A>G and c.-7C>T variants. A: The locations of the 15 genes...,53,144,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-93G>A,"...escribed in Supp. Figure S2 cosegregated with the c.-93G>A, c.-28A>G, c.-7C>T, and VILL c.1164del va...",57,1554,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-93G>A,"...escribed in Supp. Figure S2 cosegregated with the c.-93G>A, c.-28A>G, c.-7C>T, and VILL c.1164del va...",57,1554,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...n Supp. Figure S2 cosegregated with the c.-93G>A, c.-28A>G, c.-7C>T, and VILL c.1164del variants in ...",57,1564,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...s within or flanking the MLH1 gene other than the c.-28A>G and c.-7C>T variants prompted us to inves...,60,108,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...lanking the MLH1 gene other than the c.-28A>G and c.-7C>T variants prompted us to investigate their ...,60,121,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...lanking the MLH1 gene other than the c.-28A>G and c.-7C>T variants prompted us to investigate their ...,60,121,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655G>A,"...ns 1a and 9 followed by pyrosequencing across the c.655G>A site (Fig. 3A). In Proband 32, the propor...",60,446,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655G>A,"...ns 1a and 9 followed by pyrosequencing across the c.655G>A site (Fig. 3A). In Proband 32, the propor...",60,446,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655G>A,... control PBMCs that were also heterozygous at the c.655G>A site (Fig. 3D; mean normal allelic balanc...,60,1188,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...ed t-test). These data show that the c.-28A>G and c.-7C>T variants are associated with partial loss ...,60,1362,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655A>G,... primer used to assess allelic balance across the c.655A>G site (Pyro R). B and C: Representative py...,62,458,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655A>G,... from healthy donors that were informative at the c.655A>G site. ****P < 0.0001 (paired t-test). All...,62,912,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-93G>A,...ncing of individual promoter molecules across the c.-93G>A variant confirmed the lack of methylation...,65,644,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-93G>A,...ncing of individual promoter molecules across the c.-93G>A variant confirmed the lack of methylation...,65,644,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...vertical bars), and the sequence encompassing the c.-7C>T site. The presence of the c.-7C>T variant ...",67,309,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...ncompassing the c.-7C>T site. The presence of the c.-7C>T variant abolishes a HhaI restriction site....,67,343,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...cording to allele of origin, as determined by the c.-7C>T variant (yellow diamond). Black arrows ind...",67,1294,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...cording to allele of origin, as determined by the c.-7C>T variant (yellow diamond). Black arrows ind...",67,1294,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655A>G,"...-93, c.-28 or c.-7 sites, we sequenced across the c.655A>G variant to determine the allele of transc...",69,435,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655A>G,"...-93, c.-28 or c.-7 sites, we sequenced across the c.655A>G variant to determine the allele of transc...",69,435,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...ter were located in the immediate vicinity of the c.-28A>G and c.-7C>T variants. However, comparison...",69,1016,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...ression from the variant allele, we show that the c.-28A>G and c.-7C>T variants are not associated w...",72,785,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...the variant allele, we show that the c.-28A>G and c.-7C>T variants are not associated with promoter ...",72,798,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...ncy. These findings suggest that the c.-28A>G and c.-7C>T variants may be pathogenic due to allelic ...,72,950,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...ncy. These findings suggest that the c.-28A>G and c.-7C>T variants may be pathogenic due to allelic ...,72,950,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...ncy. These findings suggest that the c.-28A>G and c.-7C>T variants may be pathogenic due to allelic ...,72,950,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-42C>T,...wild-type allele. Green et al. (2003) described a c.-42C>T variant within the MLH1 gene associated w...,74,398,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-42C>T,...wild-type allele. Green et al. (2003) described a c.-42C>T variant within the MLH1 gene associated w...,74,398,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...defective transcription. Our observation that the c.-28A>G and c.-7C>T variants are associated with ...,74,1091,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...defective transcription. Our observation that the c.-28A>G and c.-7C>T variants are associated with ...,74,1091,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...defective transcription. Our observation that the c.-28A>G and c.-7C>T variants are associated with ...,74,1091,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...defective transcription. Our observation that the c.-28A>G and c.-7C>T variants are associated with ...,74,1091,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...nscription. Our observation that the c.-28A>G and c.-7C>T variants are associated with partial const...,74,1104,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...riable age of onset of cancer associated with the c.-28A>G and c.-7C>T variants was evident from the...,76,57,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...riable age of onset of cancer associated with the c.-28A>G and c.-7C>T variants was evident from the...,76,57,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,... onset of cancer associated with the c.-28A>G and c.-7C>T variants was evident from the two families...,76,70,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...able to ascertain whether the grandfather had the c.-28A>G and c.-7C>T variants. This variable penet...,76,438,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...tain whether the grandfather had the c.-28A>G and c.-7C>T variants. This variable penetrance may be ...,76,451,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-42C>T,...analyses of the tumor from an individual with the c.-42C>T variant revealed deletion of the MLH1 all...,76,879,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,Further evidence that the c.-28A>G and c.-7C>T variants are the most likely ...,78,27,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,Further evidence that the c.-28A>G and c.-7C>T variants are the most likely ...,78,27,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...g VILL gene. The cosegregation of the c.1164del1, c.-28A>G, and c.-7C>T variants in a first-degree r...",78,661,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...g VILL gene. The cosegregation of the c.1164del1, c.-28A>G, and c.-7C>T variants in a first-degree r...",78,661,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...he cosegregation of the c.1164del1, c.-28A>G, and c.-7C>T variants in a first-degree relative of Pro...",78,675,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...he cosegregation of the c.1164del1, c.-28A>G, and c.-7C>T variants in a first-degree relative of Pro...",78,675,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...he cosegregation of the c.1164del1, c.-28A>G, and c.-7C>T variants in a first-degree relative of Pro...",78,675,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...he cosegregation of the c.1164del1, c.-28A>G, and c.-7C>T variants in a first-degree relative of Pro...",78,675,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"... of this haplotype. For example, the c.-28A>G and c.-7C>T variants have an identical MAF of 0.0003, ...",78,931,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"... was absent in Family N in which the c.-28A>G and c.-7C>T variants cosegregated. Therefore, the c.-2...",78,1902,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...S2 negative and BRAF wild-type. Separate from the c.-7C>T and c.-28A>G variants, no constitutional m...",80,380,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...S2 negative and BRAF wild-type. Separate from the c.-7C>T and c.-28A>G variants, no constitutional m...",80,380,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...and BRAF wild-type. Separate from the c.-7C>T and c.-28A>G variants, no constitutional mutations in ...",80,392,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...ovided. Therefore, the rarity of the c.-28A>G and c.-7C>T haplotype at the population level, but its...",80,697,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...tain whether both or only one are pathogenic. The c.-7C>T variant was found in a member of a heredit...,82,118,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...tain whether both or only one are pathogenic. The c.-7C>T variant was found in a member of a heredit...,82,118,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>T,...ption of a case of CRC that was associated with a c.-28A>T variant in a 29-year-old individual from ...,82,328,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>T,...ption of a case of CRC that was associated with a c.-28A>T variant in a 29-year-old individual from ...,82,328,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>T,... c.-28A nucleotide may be pathogenic. Whether the c.-28A>T variant in this family was associated wit...,82,522,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-93G>A,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants...",84,21,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in both probands al...",84,41,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in both probands al...",84,41,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in both probands al...",84,41,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...d Lynch syndrome associated with the c.-28A>G and c.-7C>T variants. Our analysis shows that these va...,86,108,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"Figure S4. Co-segregation of the c.-93G>A, c.-28A>G, c.-7C>T and VILL c.1164del1 variants in ...",99,44,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-27C>A,...adabaum U  McKinnon WC  Greenblatt MS    The MLH1 c.-27C>A and c.85G>T variants are linked to domina...,131,162,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.185C>G,"...e present investigation, five mutations of TFAP2B c.185C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A...",35,184,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
c.673C>T,"...investigation, five mutations of TFAP2B c.185C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A, c.865C>T...",35,194,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
c.865C>T,"...185C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A, c.865C>T were screened Table IIIin 100 CHD cases a...",35,236,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
c.865C>T,"...185C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A, c.865C>T were screened Table IIIin 100 CHD cases a...",35,236,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
c.1222A>G,"...d G allele. Conclusion: The presence of rs628031 (c.1222A>G, M408V) and rs2306283 (c.388A>G, N130D) ...",2391,1218,Indian_J_Pharmacol_2015_Dec_47(Suppl_1)_S57-S177.txt
c.388A>G,"...nce of rs628031 (c.1222A>G, M408V) and rs2306283 (c.388A>G, N130D) polymorphism significantly affect...",2391,1251,Indian_J_Pharmacol_2015_Dec_47(Suppl_1)_S57-S177.txt
c.10326C>T,...and 10228G>T) and two coding SNPs (AAFC02034082.1:c.10326C>T and 10364A>G). The latter coding SNP (A...,43,784,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
c.10364A>G,... 10364A>G). The latter coding SNP (AAFC02034082.1:c.10364A>G) changes an amino acid from aspartic ac...,43,848,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
c.10364A>G,...rend was also observed for markers AAFC02034082.1:c.10364A>G and g.9419A>C (P=0.0055). The marbling ...,48,974,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
c.10364A>G,"...mation of interaction effects between markers: A, c.10364A>G and g.9367G>C, and B, c.10364A>G and g....",64,73,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
c.10364A>G,"...ween markers: A, c.10364A>G and g.9367G>C, and B, c.10364A>G and g.9419A>C, on beef marbling scores ...",64,106,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
c.157G>T,c.157G>T (rs7208693)	Val53Phe,285,1,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
c.2149T>C,c.2149T>C (rs2759)	Ile717Val,288,1,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
c.287C>T,c.287C>T (rs2856857)	Non-coding,310,1,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
c.1502T>G,... that the two sisters were homozygous for a novel c.1502T>G mutation. The mutation is predicted to s...,17,996,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.769G>T,"... addition, other documented polymorphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2...",42,289,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.769G>T,"... addition, other documented polymorphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2...",42,289,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1193G>C,"... other documented polymorphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2540T>C) in...",42,299,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.2145C>T,"...mented polymorphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2540T>C) in exons 1, 7...",42,310,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.2173A>C,"...morphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2540T>C) in exons 1, 7, 8, 12, an...",42,321,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,...In Silico Predictions of Functional Impact of the c.1502T>G on the TPO Protei,44,56,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,...In Silico Predictions of Functional Impact of the c.1502T>G on the TPO Protei,44,56,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,"... present study, we identified a novel, homozygous c.1502T>G mutation in the TPO gene in two siblings...",51,193,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,"... present study, we identified a novel, homozygous c.1502T>G mutation in the TPO gene in two siblings...",51,193,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,... normal unrelated individuals suggesting that the c.1502T>G alteration is not a polymorphism,51,518,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,... normal unrelated individuals suggesting that the c.1502T>G alteration is not a polymorphism,51,518,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,...single nucleotide transition at location 1502 bp (c.1502T>G) is indicated by an arrow. The nucleotid...,66,255,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.4072G>A,"and c.4072G>A (p.Gly1358Lys), and an intronic transver...",133,21,Int_J_Med_Sci_2008_Jul_8_5(4)_197-202.txt
c.1043C>T,1	IDH3B	chr20:2640199	NM_174855	Exon11	c.1043C>T	p.A348V	Damaging	Het	–	AR	RP46,70,40,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.50G>A,CNGB1	chr16:58001141	NM_001135639	Exon2	c.50G>A	p.R17Q	Tolerated	Het	–	AR	RP45,76,42,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.50G>A,CNGB1	chr16:58001141	NM_001135639	Exon2	c.50G>A	p.R17Q	Tolerated	Het	–	AR	RP45,76,42,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.2980C>G,EYS	chr6:65596602	NM_001142800	Exon19	c.2980C>G	p.P994A	Probably damaging	Het	0.0010	AR	...,77,40,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.2980C>G,EYS	chr6:65596602	NM_001142800	Exon19	c.2980C>G	p.P994A	Probably damaging	Het	0.0010	AR	...,77,40,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.2980C>G,EYS	chr6:65596602	NM_001142800	Exon19	c.2980C>G	p.P994A	Probably damaging	Het	0.0010	AR	...,77,40,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.1082A>G,NR2E3	chr15:72106440	NM_014249	Exon8	c.1082A>G	p.H361R	Tolerated	Het	0.0023	AD/AR	RP37,79,39,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.1082A>G,NR2E3	chr15:72106440	NM_014249	Exon8	c.1082A>G	p.H361R	Tolerated	Het	0.0023	AD/AR	RP37,79,39,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.1082A>G,NR2E3	chr15:72106440	NM_014249	Exon8	c.1082A>G	p.H361R	Tolerated	Het	0.0023	AD/AR	RP37,79,39,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.467C>T,OPA1	chr3:193336676	NM_130831	Exon4	c.467C>T	p.A156V	Probably damaging	Het	0.0103	AD	O...,80,38,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.14350G>A,USH2A	chr1:215822102	NM_206933	Exon66	c.14350G>A	p.E4784K	Probably damaging	Het	–	AR	RP3...,82,40,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.14350G>A,USH2A	chr1:215822102	NM_206933	Exon66	c.14350G>A	p.E4784K	Probably damaging	Het	–	AR	RP3...,82,40,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.682T>G,...fferent populations. The only missense mutation 6 c.682T>G (p.Gly228Trp) was reported in an Italian ...,14,399,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
c.231C>A,... amino acid positions are not drawn to scale. The c.231C>A mutation causes a premature stop within t...,46,618,Int_J_Pediatr_Endocrinol_2011_Jul_6_2011(1)_5.txt
c.775G>T,...lar finding of a heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. She and her mothe...,9,136,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
c.775G>T,...lar finding of a heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. She and her mothe...,9,136,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
c.775G>T,...irmed MODY3 with heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. The patient was i...,16,126,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
c.98C>T,...ned the association between of ACE I/D and GPIIIa c.98C>T polymorphisms in women from the northern o...,29,198,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...e and 190 bp for D allele (Figure 1A). The GPIIIa c.98C>T Alleles were also determined by bands; 395...,53,137,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...ype in 33% and ACE DD genotype in 44%. The GPIIIa c.98C>T wild-type genotype (TT) was observed in 84...,53,846,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...tween genotypic and allelic frequencies of GPIIIa c.98C>T polymorphism and RPL in case and control g...,55,220,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,GPIIIa c.98C>T 		NG_008332.2,69,8,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...ble III Allelic frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RP,105,53,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...ble III Allelic frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RP,105,53,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,GPIIIa c.98C>T,119,8,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...ble IV Combination analysis of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RP,130,53,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...ble IV Combination analysis of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RP,130,53,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...ble IV Combination analysis of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RP,130,53,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,"Concerning the GPIIIa c.98C>T polymorphism, it seems to increase suscept...",159,23,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.1757A>C,"...I, with the exception of the novel point mutation c.1757A>C in DSP (encoding desmoplakin) predicting...",52,725,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
c.6208G>A,"...he proband and his father were heterozygous for a c.6208G>A missense SNP in DSP, predicting the prot...",56,83,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
c.1757A>C,"...he proband has the heterozygous missense mutation c.1757A>C (indicated by the arrow), predicting the...",98,259,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
c.1387C>T,"...tation in myosin-binding protein C (MYBPC3) gene (c.1387C>T, p.Q463X) (Figure5A) was identified in p...",72,64,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.1000G>A,"....12 Patient 4 carried a missense MYBPC3 mutation (c.1000G>A, p.E334K) (Figure5B), which was already ...",72,768,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.1000G>A,"....12 Patient 4 carried a missense MYBPC3 mutation (c.1000G>A, p.E334K) (Figure5B), which was already ...",72,768,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.1000G>A,"....12 Patient 4 carried a missense MYBPC3 mutation (c.1000G>A, p.E334K) (Figure5B), which was already ...",72,768,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.1387C>T,"...tein C gene for (A) relative III4 and her family (c.1387C>T, p. Q463X) and (B) patient 4 (c.1000G>A,...",74,90,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.1387C>T,"...tein C gene for (A) relative III4 and her family (c.1387C>T, p. Q463X) and (B) patient 4 (c.1000G>A,...",74,90,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.581C>T,11 Mostowska A  Biedziak B  Trzeciak WH   A novel c.581C>T transition localized in a highly conserve...,98,51,J_Appl_Oral_Sci_2007_Oct_15(5)_382-386.txt
c.581C>T,11 Mostowska A  Biedziak B  Trzeciak WH   A novel c.581C>T transition localized in a highly conserve...,98,51,J_Appl_Oral_Sci_2007_Oct_15(5)_382-386.txt
c.724G>A,"...issense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), a...",51,873,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.530C>A,...ried a novel heterozygous nonsense SOST mutation (c.530C>A; p.Ser177X) predicted to prematurely trun...,51,1313,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.530C>A,...ried a novel heterozygous nonsense SOST mutation (c.530C>A; p.Ser177X) predicted to prematurely trun...,51,1313,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.593A>G,"...ree previously reported missense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [...",81,163,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.266A>G,"...c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated with HBM in 11 ...",81,213,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.266A>G,"...c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated with HBM in 11 ...",81,213,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.266A>G,"...c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated with HBM in 11 ...",81,213,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.518C>T,...p osteoarthritis; he has never fractured. A novel c.518C>T; p.Thr173Met mutation was identified in a...,357,160,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.28G>A,"...ted SNP in exon 1 in eight HBM cases (rs17882143, c.28G>A; p.Val10Ile, MAF T = 0.047%), predicted to...",380,90,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.28G>A,"...ted SNP in exon 1 in eight HBM cases (rs17882143, c.28G>A; p.Val10Ile, MAF T = 0.047%), predicted to...",380,90,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.1372C>T,... identified four deleterious mutations in exon 6 (c.1372C>,286,61,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
c.1372C>T,... identified four deleterious mutations in exon 6 (c.1372C>,286,61,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
c.1451T>G,c.1451T>G in patients with breast cancer) compared...,288,1,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
c.879+1G>A,...phenotype was associated with the splice mutation c.879+1G>A. Primary adrenocortical insufficiency a...,15,738,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
c.769C>T,"...979del13 found in 45% of the alleles, followed by c.769C>T, and c.879+1G>A (Figure 3 and Supplementa...",133,272,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
c.769C>T,"...979del13 found in 45% of the alleles, followed by c.769C>T, and c.879+1G>A (Figure 3 and Supplementa...",133,272,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
c.769C>T,"...979del13 found in 45% of the alleles, followed by c.769C>T, and c.879+1G>A (Figure 3 and Supplementa...",133,272,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
c.879+1C>G,"...us and one heterozygous for the splicing mutation c.879+1C>G (patients 29, 30, 31, and 48) presented...",133,1175,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
c.22C>T,"...nts from childhood and was compound heterozygous (c.22C>T/c.967_979del13) for two AIRE mutations, bu...",156,826,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
c.22C>T,"...nts from childhood and was compound heterozygous (c.22C>T/c.967_979del13) for two AIRE mutations, bu...",156,826,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
c.22C>T,"...nts from childhood and was compound heterozygous (c.22C>T/c.967_979del13) for two AIRE mutations, bu...",156,826,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
c.22C>T,"...nts from childhood and was compound heterozygous (c.22C>T/c.967_979del13) for two AIRE mutations, bu...",156,826,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
c.14590T>C,... analysis disclosed a novel mutation in exon 101 (c.14590T>C) and confirmed a previously reported mu...,8,360,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
c.14590T>C,... analysis disclosed a novel mutation in exon 101 (c.14590T>C) and confirmed a previously reported mu...,8,360,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
c.14590T>C,... analysis revealed a novel heterozygous mutation [c.14590T>C (p.Tyr4864His)] in exon 101 (Fig. 1B). ...,26,424,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
c.14590T>C,... analysis revealed a novel heterozygous mutation [c.14590T>C (p.Tyr4864His)] in exon 101 (Fig. 1B). ...,26,424,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
c.14590T>C,... analysis revealed a novel heterozygous mutation [c.14590T>C (p.Tyr4864His)] in exon 101 (Fig. 1B). ...,26,424,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
c.1975T>C,"154	55	OC	Endometrioid	IA	G1	FGFR2 p.K659E, c.1975T>C	FGFR2 p.K659E, c.1975T>C (1)",38,45,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.3140A>G,"155	45	OC	Serous	IC	G1	PIK3CA p.H1047R, c.3140A>G	PIK3CA p.H1047R, c.3140A>G (3)",39,41,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.743G>A,"152	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,39,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.743G>A,"152	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,39,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.743G>A,"...erous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,62,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.646G>A,"...rous	IIIB	G3	TP53 p.V216M, c.646G>A	TP53 p.V216M, c.646G>A (1)",43,63,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.646G>A,"...rous	IIIB	G3	TP53 p.V216M, c.646G>A	TP53 p.V216M, c.646G>A (1)",43,63,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.404G>A,"143	52	OC	Serous	IIIC	G3	TP53 p.C135Y, c.404G>A	TP53 p.L194R, c.581T>G (3)",45,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.581T>G,"...rous	IIIC	G3	TP53 p.C135Y, c.404G>A	TP53 p.L194R, c.581T>G (3)",45,63,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.581T>G,"...rous	IIIC	G3	TP53 p.C135Y, c.404G>A	TP53 p.L194R, c.581T>G (3)",45,63,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.734G>T,"158	49	OC	Serous	IIIC	G3	TP53 p.G245V, c.734G>T	TP53 p.G245V, c.734G>T (3)",46,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.734G>T,"...rous	IIIC	G3	TP53 p.G245V, c.734G>T	TP53 p.G245V, c.734G>T (3)",46,63,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.771G>T,"...IIC	G2	PPP2R1A p.W257C, c.771G>T	PPP2R1A p.W257C, c.771G>T (1)",47,69,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.711G>C,"132	64	OC	Serous	IIIC	G2	NA	TP53 p.M237I, c.711G>C (1)",48,43,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.711G>C,"132	64	OC	Serous	IIIC	G2	NA	TP53 p.M237I, c.711G>C (1)",48,43,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.578A>C,"...rous	IIIC	G3	TP53 p.H193P, c.578A>C	TP53 p.H193P, c.578A>C (1)",49,63,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.34G>T,"...erous	IIIC	G3	TP53 p.G245S, c.733G>A	KRAS p.G12C, c.34G>T (1)",50,62,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.34G>T,"...erous	IIIC	G3	TP53 p.G245S, c.733G>A	KRAS p.G12C, c.34G>T (1)",50,62,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.818G>A,"...rous	IIIC	G3	TP53 p.R273H, c.818G>A	TP53 p.R273H, c.818G>A (1)",52,63,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.536A>G,"137	61	OC	Serous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.536A>G,"137	61	OC	Serous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.536A>G,"...rous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,63,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.182A>G,"...ant mixed Müllerian tumor	IIIC	G3	NA	NRAS p.Q61R, c.182A>G (1)",55,67,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.182A>G,"...ant mixed Müllerian tumor	IIIC	G3	NA	NRAS p.Q61R, c.182A>G (1)",55,67,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.3074C>A,"...d Müllerian tumor	IIIA1(i)	G3	NA	PIK3CA p.T1025N, c.3074C>A (1)",56,75,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.3074C>A,"...d Müllerian tumor	IIIA1(i)	G3	NA	PIK3CA p.T1025N, c.3074C>A (1)",56,75,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.35G>A,"147	60	OC	Endometrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,45,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.35G>A,"...etrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,66,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.35G>A,"...etrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,66,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.785G>T,"172	55	OC	Serous	IV	G3	NA	TP53 p.G262V, c.785G>T (1)",61,41,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.49G>A,"...	Serous low malignant potential			NA	AKT1 p.E17K, c.49G>A (1)",62,64,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.49G>A,"...	Serous low malignant potential			NA	AKT1 p.E17K, c.49G>A (1)",62,64,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.844C>T,"...ring carcinoma, spread in ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,73,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.844C>T,"...ring carcinoma, spread in ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,73,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.844C>T,"...in ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,96,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.844C>T,"...in ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,96,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.388C>T,"...	EC	EC	IA	G2	PTEN p.R130*, c.388C>T	PTEN p.R130*, c.388C>T (1)",65,57,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.388C>T,"...	EC	EC	IA	G2	PTEN p.R130*, c.388C>T	PTEN p.R130*, c.388C>T (1)",65,57,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.388C>T,"...	EC	EC	IA	G2	PTEN p.R130*, c.388C>T	PTEN p.R130*, c.388C>T (1)",65,57,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.3139C>T,"200	70	EC	EC	IA	G2	PIK3CA p.H1047Y, c.3139C>T	PIK3CA p.H1047Y, c.3139C>T (1)",66,37,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.4405C>T,"201	70	EC	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,34,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.4405C>T,"201	70	EC	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,34,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.4405C>T,"201	70	EC	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,34,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.4405C>T,"...EC	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,58,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.4405C>T,"...EC	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,58,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.34G>T,"177	31	B	Secondary infertility			NA	KRAS p.G12C, c.34G>T (1)",72,50,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.34G>T,"...	Uterus myomatosus, ovarian cyst			—	KRAS p.G12C, c.34G>T (1)",73,59,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.34G>T,"...	Uterus myomatosus, ovarian cyst			—	KRAS p.G12C, c.34G>T (1)",73,59,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.35G>T,"184	78	B	Ovarian cyst			—	KRAS p.G12V, c.35G>T (1)",75,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.725G>T,"...east cancer, uterine leiomyoma			NA	TP53 p.C242F, c.725G>T (1)	Germline mutation",78,64,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.715A>G,"...noma, squamous cell carcinoma)			NA	TP53 p.N239D, c.715A>G (1)	Two or more malignant tumors",79,125,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.715A>G,"...noma, squamous cell carcinoma)			NA	TP53 p.N239D, c.715A>G (1)	Two or more malignant tumors",79,125,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.920-1G>A,"129	82	OC	Serous	IIIC	G2	TP53 c.920-1G>A, g.7576927C>T (splice site)	—",80,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.712T>C,"163	67	OC	Serous	IIIC	G3	TP53 p.C238R, c.712T>C	—",82,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.1024C>T,"174	69	OC	Serous	IV	G3	TP53 p.R342*, c.1024C>T	—",85,38,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.310C>T,"142*	58	OC	Serous	IIIC	G2	TP53 p.Q104*, c.310C>T	—	Tubal ligation",108,41,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.*237C>T,"...710218), VEGFA+936C>T (rs3025039) [NM_001025366.1:c.*237C>T], APEX1 Asp148Glu (T>G, rs1130409) [NM_0...",31,283,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
c.1744C>T,"...], HIF1A Pro582Ser (C>T, rs11549465) [NM_001530.2:c.1744C>T], and HIF1A Ala588Thr (G>A, rs11549467) ...",31,399,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
c.146C>G,...Doody MM    The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer Hum Mutat ...,287,121,J_Exp_Clin_Cancer_Res_2016_Sep_6_35(1)_135.txt
c.244C>T,"...strains except the BN strain (Table I). Thus, the c.244C>T SNP in exon 1 of Vav1 is the only SNP tha...",29,1675,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
c.244C>T,...1996). The mutation in human VAV1 at the position c.244C>T (R63W) of the sequence coding for the R63...,96,406,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
c.244C>T,...1996). The mutation in human VAV1 at the position c.244C>T (R63W) of the sequence coding for the R63...,96,406,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
c.3646T>C,ATM	c.3646T>C	p.Y1216H	12	Tolerated	Damaging (probably...,32,5,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.3646T>C,ATM	c.3646T>C	p.Y1216H	12	Tolerated	Damaging (probably...,32,5,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.2546T>C,BRCA2	c.2546T>C	p.V849A	33	Tolerated	Benign,33,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1007A>T,CHEK2	c.1007A>T	p.Q336L	54	Damaging	Benign,35,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1618A>G,MSH2	c.1618A>G	p.S540G	20	Tolerated	Benign,39,6,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.400T>G,TP53	c.400T>G	p.F134V	47	Damaging	Damaging (probably),45,6,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.817C>T,TP53	c.817C>T	p.R273C	67	Damaging	Damaging (probably),46,6,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.817C>T,TP53	c.817C>T	p.R273C	67	Damaging	Damaging (probably),46,6,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.847A>G,XRCC5	c.847A>G	p.T283A	29	Damaging	Damaging (probably),48,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.319+2T>A,"...hift insertion (p.D293X), a splice-site mutation (c.319+2T>A), and a missense mutation (p.I364T) loc...",61,503,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.319+2T>A,"...hift insertion (p.D293X), a splice-site mutation (c.319+2T>A), and a missense mutation (p.I364T) loc...",61,503,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.319+2T>A,"...hift insertion (p.D293X), a splice-site mutation (c.319+2T>A), and a missense mutation (p.I364T) loc...",61,503,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1091T>C,c.1091T>C	p.I364T	Novel	1/171	ND	Swedish	0	0	Damag...,69,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1091T>C,c.1091T>C	p.I364T	Novel	1/171	ND	Swedish	0	0	Damag...,69,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.444+1G>A,c.444+1G>A	-	Reported	1/171	Germline	Swedish	0	0	-...,72,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1312G>T,c.1312G>T	p.D438Y	rs200050883	2/164	ND	Swedish	0	0...,73,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1312G>T,c.1312G>T	p.D438Y	rs200050883	2/164	ND	Swedish	0	0...,73,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1312G>T,c.1312G>T	p.D438Y	rs200050883	2/164	ND	Swedish	0	0...,73,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1582G>A,c.1582G>A	p.E528K	rs138040612	1/64	Germline	Chines...,74,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.470T>C,c.470T>C	p.I157T	rs17879961	3/171	Germline (1)	Swe...,75,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.538C>T,c.538C>T	p.R180C	rs77130927	1/171	ND	Swedish	0.006...,76,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1111C>T,c.1111C>T	p.H371Y	Reported	2/64	Somatic/germline	C...,78,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1897A>T,PARP1	c.1897A>T	p.K633X	Sanger	Novel	Somatic	Chinese	0	-...,86,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.2789A>G,c.2789A>G	p.Y930C	Sanger	rs189410139	ND	Chinese	0....,90,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1316C>T,MSH2	c.1316C>T	p.P439L	Sanger	Novel	ND	Chinese	0	Damagi...,92,6,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1619A>G,c.1619A>G	p.S540G	Selector & Sanger	Novel	Somatic	...,93,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1619A>G,c.1619A>G	p.S540G	Selector & Sanger	Novel	Somatic	...,93,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1619A>G,c.1619A>G	p.S540G	Selector & Sanger	Novel	Somatic	...,93,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.26C>G,DDB1	c.26C>G	p.A9G	Selector	Novel	Somatic	Chinese	0	Dam...,96,6,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.365A>G,c.365A>G	p.K122R	454 amplicon	Novel	ND	Chinese	0	D...,102,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.2221G>T,c.2221G>T	p.V741I	454 amplicon	rs28756990	ND	Swedi...,103,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.2837C>T,c.2837C>T	p.S946F	Selector	rs201441389	Germline	Ch...,104,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.2964C>G,c.2964C>G	p.I988M	Selector	Novel	Germline	Chinese	...,105,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.2964C>G,c.2964C>G	p.I988M	Selector	Novel	Germline	Chinese	...,105,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.3331C>T,c.3331C>T	p.L1111F	Selector	Novel	Germline	Chinese...,106,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1046C>A,c.1046C>A	p.S349Y	454 amplicon	Novel	Germline	Chin...,108,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1046C>A,c.1046C>A	p.S349Y	454 amplicon	Novel	Germline	Chin...,108,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1522A>G,c.1522A>G	p.I508V	454 amplicon	rs2287558	ND	Swedis...,109,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.524G>A,"...t was found to carry a homozygous point mutation (c.524G>A) in exon 6 of the AK2 gene, leading to an...",57,488,J_Exp_Med_2015_Jul_27_212(8)_1185-1202.txt
c.524G>A,"...t was found to carry a homozygous point mutation (c.524G>A) in exon 6 of the AK2 gene, leading to an...",57,488,J_Exp_Med_2015_Jul_27_212(8)_1185-1202.txt
c.524G>A,...sts were collected from a patient with homozygous c.524G>A mutation in the human AK2 gene (Henderson...,135,72,J_Exp_Med_2015_Jul_27_212(8)_1185-1202.txt
c.524G>A,...sts were collected from a patient with homozygous c.524G>A mutation in the human AK2 gene (Henderson...,135,72,J_Exp_Med_2015_Jul_27_212(8)_1185-1202.txt
c.1791+2T>G,"...-12Rβ1 deficiency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C1207T; P4, p>R1...",96,262,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
c.127C>T,"...letions and frameshift MPL mutations, such as MPL c.127C>T and c.378delT, may be responsible for thi...",43,174,J_Hematol_Oncol_2013_Jan_25_6_11.txt
c.127C>T,"...letions and frameshift MPL mutations, such as MPL c.127C>T and c.378delT, may be responsible for thi...",43,174,J_Hematol_Oncol_2013_Jan_25_6_11.txt
c.742C>T,The mutation c.742C>T in the HOXD13 gene generates a new restri...,29,14,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
c.742C>T,The mutation c.742C>T in the HOXD13 gene generates a new restri...,29,14,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
c.742C>T,"...haplotype A, carry a homozygous nonsense mutation c.742C>T (p.Q248X) in exon 1 of the HOXD13 gene (F...",42,334,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
c.742C>T,"...haplotype A, carry a homozygous nonsense mutation c.742C>T (p.Q248X) in exon 1 of the HOXD13 gene (F...",42,334,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
c.742C>T,"...haplotype A, carry a homozygous nonsense mutation c.742C>T (p.Q248X) in exon 1 of the HOXD13 gene (F...",42,334,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
c.742C>T,...are heterozygous for haplotype A. b) The mutation c.742C>T in the HOXD13 gene generates a restrictio...,75,247,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
c.742C>T,...are heterozygous for haplotype A. b) The mutation c.742C>T in the HOXD13 gene generates a restrictio...,75,247,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
c.742C>T,...are heterozygous for haplotype A. b) The mutation c.742C>T in the HOXD13 gene generates a restrictio...,75,247,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
c.416-1G>A,"...s GCTGG). Seven splice site mutations were found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c....",32,465,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
c.600+1G>T,"...ven splice site mutations were found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c...",32,477,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
c.601-1G>A,"...ite mutations were found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-9A>G a...",32,489,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
c.601-1G>A,"...ite mutations were found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-9A>G a...",32,489,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
c.601-1G>A,"...ite mutations were found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-9A>G a...",32,489,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
c.919-2A>G,"...s were found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-9A>G and c.1707+5G...",32,501,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
c.1002-9A>G,"... c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-9A>G and c.1707+5G>A)",32,526,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
c.919-2A>G,"...723R that accounted for 36.0%, and the second was c.919-2A>G found in 7.0%, followed by c.1707+5G>A ...",38,85,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
c.919-2A>G,"...723R that accounted for 36.0%, and the second was c.919-2A>G found in 7.0%, followed by c.1707+5G>A ...",38,85,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
c.1707+5G>A,"... second was c.919-2A>G found in 7.0%, followed by c.1707+5G>A (4.0%). Frequency of the other 36 muta...",38,123,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
c.919-2A>G,"... in the Japanese and Korean populations,8 whereas c.919-2A>G is most common in the Chinese.",56,405,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
c.832-53C>T,...r site in the exon 9-flanking region in intron 8 (c.832-53C>T),33,397,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
c.7693C>T,5	EX53	c.7693C>T	p.Gln2565*	nonsence,89,8,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
c.10011C>G,7	EX69	c.10011C>G	p.Cys3337Trp	missense,91,8,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
c.10011C>G,7	EX69	c.10011C>G	p.Cys3337Trp	missense,91,8,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
c.8218-2A>G,20	int54	c.8218-2A>G	 	Splice donor variant,104,10,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
c.8218-2A>G,20	int54	c.8218-2A>G	 	Splice donor variant,104,10,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
c.2612A>C,30	EX20	c.2612A>C	p.Lys871Thr	Missense,114,9,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
c.2612A>C,30	EX20	c.2612A>C	p.Lys871Thr	Missense,114,9,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
c.109G>T,P1	+	c.109G>T	6.72	Casale et al. 1998,35,6,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.144G>T,P4	+	c.144G>T/c.504_5delCT	5.61	Menao et al. 2009,39,6,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.575T>C,P6	+	c.575T>C	6.17	Menao et al. 2009,41,6,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.109G>T,P7	+	c.109G>T	5.39	Menao et al. 2009,42,6,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.109G>T,P9	+	c.109G>T/c.825C>G	5.80a	-----,44,6,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.825C>G,P9	+	c.109G>T/c.825C>G	5.80a	-----,44,15,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.109G>T,P10	+	c.109G>T	2.13a	Menao et al. 2009,46,7,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.35A>G,"Recently, a homozygous missense mutation c.35A>G (p.Tyr12Cys) has been described in exon 2 ...",121,42,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
c.337A>T,"...156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T (p.Ile113Phe) (Tomatsu et al 2005a). Howe...",164,778,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
c.337A>T,"...156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T (p.Ile113Phe) (Tomatsu et al 2005a). Howe...",164,778,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
c.599G>A,"1a	72/F	47/57	20	2	rs114688446	c.599G>A, p.S200N	A: 0.8	Benign	Tolerated	Neutral	...",42,32,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
c.683T>G,"2	75/M	70/70	2	1	rs142246283	c.683T>G, p.L228R	no data	Probably damaging	Tolera...",45,30,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
c.2044C>T,"3	46/F	21/21	2	1	rs117918077	c.2044C>T, p.R682W	T: 1.2	Probably damaging	Damagi...",46,30,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
c.2044C>T,"3	46/F	21/21	2	1	rs117918077	c.2044C>T, p.R682W	T: 1.2	Probably damaging	Damagi...",46,30,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
c.2406C>A,"4	35/F	32/32	1	1	no data	c.2406C>A, p.S802R	no data	Benign	Damaging	Patholo...",47,26,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
c.1699C>T,"...acceptor/donor site mutations. Of these, c.64G>T, c.1699C>T, c.466_467 insAC, c.1174-1G>A, and c.176...",4,1040,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1768+5G>A,"...4G>T, c.1699C>T, c.466_467insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations identified in thi...",34,181,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1363G>T,Inspection of the mutations revealed that c.1363G>T (p. Glu455X) and c.1699C>T (p.Arg567X) w...,36,43,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1363G>T,Inspection of the mutations revealed that c.1363G>T (p. Glu455X) and c.1699C>T (p.Arg567X) w...,36,43,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1601C>T,"...C>T (p.Arg567X) were nonsense mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) ...",36,126,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.64G>T,"...e mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) were missense mutations. One...",36,154,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.64G>T,"...e mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) were missense mutations. One...",36,154,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.64G>T,"...e mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) were missense mutations. One...",36,154,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.64G>T,"...e mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) were missense mutations. One...",36,154,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1174-1G>A,"...am stop codon at amino acid 222. Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A...",36,345,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1174-1G>A,"...am stop codon at amino acid 222. Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A...",36,345,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1768+5G>A,"...d 222. Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+...",36,371,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1965+1G>A,"...1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), occur at splicing accept...",36,402,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1174-1G>A,...ted splicing mutation analysis predicted that the c.1174-1G>A variation decreases the binding energy...,36,773,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1174-1G>A,"...ate novel mutations, c.64G>T (A), c.466insAC (B), c.1174-1G>A (C), c.1699C>T (D), and c.1768+5G>A (E...",57,92,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1174-1G>A,"...ate novel mutations, c.64G>T (A), c.466insAC (B), c.1174-1G>A (C), c.1699C>T (D), and c.1768+5G>A (E...",57,92,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1699C>T,"...ns, c.64G>T (A), c.466insAC (B), c.1174-1G>A (C), c.1699C>T (D), and c.1768+5G>A (E), in the PHEX ge...",57,109,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1768+5G>A,"...466insAC (B), c.1174-1G>A (C), c.1699C>T (D), and c.1768+5G>A (E), in the PHEX gene in patients with...",57,128,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1768+5G>A,"...466insAC (B), c.1174-1G>A (C), c.1699C>T (D), and c.1768+5G>A (E), in the PHEX gene in patients with...",57,128,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.679C>T,"...t. One was a C to T transition at nucleotide 679 (c.679C>T) in exon 7, resulting in a Pro to Ser sub...",25,104,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
c.679C>T,...ing of the DHCR7 gene. A novel missense mutation (c.679C>T; Pro227Ser) was identified in the patient...,39,76,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
c.6443T>G,...a heterogenetic mutant allele in the NOTCH2 gene (c.6443T>G) (Fig. 6) leading to an amino acid subst...,11,2517,J_Korean_Med_Sci_2013_Nov_31_28(11)_1682-1686.txt
c.6443T>G,"...is of DNA sequencing. DNA sequencing covering the c.6443T>G mutation of (A) the patient, (B) his mot...",32,64,J_Korean_Med_Sci_2013_Nov_31_28(11)_1682-1686.txt
c.1978A>G,...eport the first germline missense mutation in BHD c.1978A>G (K508R) in a patient who presented with ...,13,300,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1670C>G,"...>G [K508R]) and two nonsense (c.1065-6delGCinsTA, c.1670C>G) (table 1, fig 1). Splice site and misse...",46,847,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1670C>G,268		11	c.1670C>G	Y405X	Nonsense	1	1	DF	1	1	0,72,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1755G>C,290*		11	c.1755G>C	E434Q	Splice site	1	1		1	0	0,94,10,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1755G>A,291*		11	c.1755G>A	E434K	Splice site	2	1	PFF	1	2	1 (n = 4),95,10,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,293		12	c.1844C>G	Y463X	Nonsense	2	2	AF	0	2	1 (n = 2),97,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,293		12	c.1844C>G	Y463X	Nonsense	2	2	AF	0	2	1 (n = 2),97,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,295		12	c.1844C>G	Y463X	Nonsense	1	1	AF	1	1	1 (n = 4),99,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,295		12	c.1844C>G	Y463X	Nonsense	1	1	AF	1	1	1 (n = 4),99,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,295		12	c.1844C>G	Y463X	Nonsense	1	1	AF	1	1	1 (n = 4),99,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,...th mutations in exon 12 shared a common mutation (c.1844C>G). Four families had a BHD mutation in ex...,110,542,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1755G>C,"... frequent site of mutations (c.1733insC/1733delC, c.1755G>C) present in 125 individuals from 40 unre...",180,721,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1207C>T,"...ll five pathogenic variants (MYH7 c.1436A>C, MYH7 c.1207C>T, MYBPC3 c.2373_2374dup, MYBPC3 c.676_701...",103,442,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.415G>T,"...2). Two variants, the PLN c.40_42del and the MYH7 c.415G>T, were both observed twice in unrelated pa...",113,321,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.661G>A,... patient having two variants (MYH7 c.415G>T+LAMP2 c.661G>A). All the other variants were present sol...,113,437,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.877C>T,"...variants of unknown clinical significance (TNNT2, c.877C>T,2",151,656,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.877C>T,"...variants of unknown clinical significance (TNNT2, c.877C>T,2",151,656,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1543G>A,...sed before. These variants are VCL: NM_014000.2:  c.1543G>A (amino acid change and loss of splice si...,155,239,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.566C>T,"...ange and loss of splice site), LDB3: NM_007078.2: c.566C>T.  We classified them as VUS2 (see table 3...",155,313,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.566C>T,"...ange and loss of splice site), LDB3: NM_007078.2: c.566C>T.  We classified them as VUS2 (see table 3...",155,313,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.566C>T,"...ange and loss of splice site), LDB3: NM_007078.2: c.566C>T.  We classified them as VUS2 (see table 3...",155,313,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1231G>A,"...ncing—that is, MYH7: NM_000257.2: c.1178C>T,26–28 c.1231G>A,29–32 c.2002C>A, c.5135G>A, c.1987C>T, c...",183,278,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.2002C>A,"...YH7: NM_000257.2: c.1178C>T,26–28 c.1231G>A,29–32 c.2002C>A, c.5135G>A, c.1987C>T, c.121G>A and MYBP...",183,294,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.2002C>A,"...YH7: NM_000257.2: c.1178C>T,26–28 c.1231G>A,29–32 c.2002C>A, c.5135G>A, c.1987C>T, c.121G>A and MYBP...",183,294,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.2827C>T,"...G>A, c.1987C>T, c.121G>A and MYBPC3: NM_000256.3: c.2827C>T,33 c.3004C>T (twice), c.2864_2865del, MY...",183,361,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.2827C>T,"...G>A, c.1987C>T, c.121G>A and MYBPC3: NM_000256.3: c.2827C>T,33 c.3004C>T (twice), c.2864_2865del, MY...",183,361,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.3004C>T,"...T, c.121G>A and MYBPC3: NM_000256.3: c.2827C>T,33 c.3004C>T (twice), c.2864_2865del, MYL2: NM_000432...",183,374,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.618A>G,"... NM_000432.3: c.37G>A34–37 and TPM1: NM_000366.5: c.618A>G, but also in genes that are part of the a...",183,464,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.618A>G,"... NM_000432.3: c.37G>A34–37 and TPM1: NM_000366.5: c.618A>G, but also in genes that are part of the a...",183,464,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.935A>C,DES: NM_001927.3: c.935A>C (table 4). Ten patients had a single vari...,189,19,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.121G>A,"...ne patient had three variants (MYH7: NM_000257.2: c.121G>A, MYBPC3: NM_000256.3: c.3004C>T, and DES:...",189,319,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1093-24C>T,"... of particular variants (eg, MYBPC3: NM_000256.3: c.1093-24C>T). A balanced representation of all ta...",255,808,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.103A>C,"...tic, hypomature	MMP20	NM_004771.3	c.[954-2A>T](;)[c.103A>C]	p.[0?](;)[R35R]	?	25 and novel	S41",153,76,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
c.943T>C,2	c.943T>C (p.Cys315Arg)	Pathogeni,100,3,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.649T>G,7	c.649T>G (p.Cys217Gly)	Pathogeni,110,3,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.649T>C,8	c.649T>C (p.Cys217Arg)	Pathogeni,112,3,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.649T>C,8	c.649T>C (p.Cys217Arg)	Pathogeni,112,3,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.649T>C,8	c.649T>C (p.Cys217Arg)	Pathogeni,112,3,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.443G>A,9	c.443G>A (p.Cys148Tyr)	Pathogeni,114,3,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.443G>A,9	c.443G>A (p.Cys148Tyr)	Pathogeni,114,3,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.376T>C,11	c.376T>C (p.Cys126Arg)	Pathogeni,118,4,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.230G>A,13	c.230G>A (p.Cys77Tyr)	Pathogeni,122,4,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.-1746T>C,14	c.-1746T>C	associatio,124,4,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.672+1G>T,"... somatic mutation database, with the exception of c.672+1G>T, c.783‐1G>A and R333C. There is no appa...",161,197,J_Pathol_Clin_Res_2015_Mar_30_1(3)_125-133.txt
c.286+2T>G,c.286+2T>G,160,1,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.175C>T,c.175C>T; p.Arg59X	0.56	0.04	0.5	49	1	2	0,167,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.470G>A,c.470G>A;p.Cys157Tyr	0.92,172,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.470G>A,c.470G>A;p.Cys157Tyr	0.92,172,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.470G>A,c.470G>A;p.Cys157Tyr	1.31	0.27	0.58	62	2	1	2,176,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.470G>A,c.470G>A;p.Cys157Tyr	1.31	0.27	0.58	62	2	1	2,176,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.3643C>T,c.3643C>T p.Arg1215X	0.85	0.31	0.42	73	2	2	1,187,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.3643C>T,c.3643C>T p.Arg1215X	0.85	0.31	0.42	73	2	2	1,187,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.3643C>T,c.3643C>T p.Arg1215X	0.85	0.31	0.42	73	2	2	1,187,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.1112A>G,c.1112A>G p.Asp371Gly	0.91	0.3	0.67	77	1	1	0,192,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.1112A>G,c.1112A>G p.Asp371Gly	0.91	0.3	0.67	77	1	1	0,192,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.184G>A,"...f the following SNPs CFH −331C>T (rs3753394), CFH c.184G>A; p.Val62Ile (rs800292), CFH c.1204T>C; p....",220,130,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.1204T>C,"...753394), CFH c.184G>A; p.Val62Ile (rs800292), CFH c.1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G;...",220,167,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.1204T>C,"...753394), CFH c.184G>A; p.Val62Ile (rs800292), CFH c.1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G;...",220,167,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.1204T>C,"...753394), CFH c.184G>A; p.Val62Ile (rs800292), CFH c.1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G;...",220,167,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.1204T>C,"...753394), CFH c.184G>A; p.Val62Ile (rs800292), CFH c.1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G;...",220,167,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.2016A>G,"...292), CFH c.1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G; p.Gln672Gln (rs3753396), CFH IVS15 −543...",220,207,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.2808G>T,"...96), CFH IVS15 −543G>A intron 15 (rs1410996), CFH c.2808G>T; p.Glu936Asp (rs1065489), CD46 −652A>G (...",220,288,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.2808G>T,"...96), CFH IVS15 −543G>A intron 15 (rs1410996), CFH c.2808G>T; p.Glu936Asp (rs1065489), CD46 −652A>G (...",220,288,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.286+2T>C,"... 1) showed a compound heterozygote CD46 mutation (c.286+2T>C, c.286+2T>G), which resulted in complet...",246,96,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.286+2T>C,"... 1) showed a compound heterozygote CD46 mutation (c.286+2T>C, c.286+2T>G), which resulted in complet...",246,96,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.1979C>T,"...l homozygous mutation in TMC1 located in exon 20, c.1979C>T, p.P660L in a three-generation, 14-membe...",29,86,J_Transl_Med_2016_Jan_28_14_29.txt
c.1979C>T,"...y Sanger sequencing and found a missense variant, c.1979C>T, p.P660L, in exon 20 of TMC1 [NM_138691,...",66,117,J_Transl_Med_2016_Jan_28_14_29.txt
c.1979C>T,...ily SH-02. a DNA sequences of homozygous missense c.1979C>T mutations and the wild-type control. b T...,66,804,J_Transl_Med_2016_Jan_28_14_29.txt
c.1979C>T,"...tified a novel TMC1 missense mutation in exon 20, c.1979C>T, p.P660L",81,1019,J_Transl_Med_2016_Jan_28_14_29.txt
c.1979C>T,"...tified a novel TMC1 missense mutation in exon 20, c.1979C>T, p.P660L",81,1019,J_Transl_Med_2016_Jan_28_14_29.txt
c.1979C>T,"...TM6 appears to confer channel function [18]. TMC1 c.1979C>T, p.P660L is located in a predicted third...",91,728,J_Transl_Med_2016_Jan_28_14_29.txt
c.556C>G,"...ocated on chromosome 11p15.1 and encoding Kir6.2, c.556C>G (p.His186Asp), was found (Fig. 1). Geneti...",17,226,Korean_J_Pediatr_2015_Aug_21_58(8)_309-312.txt
c.504T>C,...-Tzeli S  Traeger-Synodinos J  Giannatou E    The c.504T>C (p.Asn168Asn) polymorphism in the ABCB4 g...,176,61,Med_Sci_Monit_2011_May_1_17(5)_CR265-CR271.txt
c.504T>C,...-Tzeli S  Traeger-Synodinos J  Giannatou E    The c.504T>C (p.Asn168Asn) polymorphism in the ABCB4 g...,176,61,Med_Sci_Monit_2011_May_1_17(5)_CR265-CR271.txt
c.677C>T,...netetrahydrofolate reductase polymorphism (MTHFR  c.677C>T) and elevated plasma homocysteine levels ...,154,105,Med_Sci_Monit_2016_Jan_12_22_127-133.txt
c.677C>T,...netetrahydrofolate reductase polymorphism (MTHFR  c.677C>T) and elevated plasma homocysteine levels ...,154,105,Med_Sci_Monit_2016_Jan_12_22_127-133.txt
c.265T>C,...analysis showed that the proband has a homozygote c.265T>C (p.C89R) HJV mutation + a heterozygote c....,43,294,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.265T>C,...analysis showed that the proband has a homozygote c.265T>C (p.C89R) HJV mutation + a heterozygote c....,43,294,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.884T>C,...e c.265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p.V295A) mutation of HFE. The affected p...,43,342,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.884T>C,...e c.265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p.V295A) mutation of HFE. The affected p...,43,342,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.265T>C,...cted proband’s sister presented with the same HJV c.265T>C (p.C89R) homozygote mutation. In addition...,43,436,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.265T>C,...cted proband’s sister presented with the same HJV c.265T>C (p.C89R) homozygote mutation. In addition...,43,436,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.98-6C>G,"...omozygote mutation. In addition, we found the HJV c.98-6C>G polymorphic variant in both the sister a...",43,505,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.884T>C,...e c.265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p.V295A) mutation for HFE. The latter mu...,317,160,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.884T>C,...e c.265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p.V295A) mutation for HFE. The latter mu...,317,160,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.884T>C,...I-1 and III- 5 were also heterozygous for the HFE c.884T>C (p.V295A) mutation. Both parents (II-10 a...,317,568,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.884T>C,...I-1 and III- 5 were also heterozygous for the HFE c.884T>C (p.V295A) mutation. Both parents (II-10 a...,317,568,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.265T>C,The HJV c.265T>C (p.C89R) mutation is a novel mutation and...,336,9,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.19G>C,...rence of the G/C genotype and the C allele of the c.19G>C polymorphism of the HMOX1 gene increased t...,71,1212,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
c.19G>C,...rence of the G/C genotype and the C allele of the c.19G>C polymorphism of the HMOX1 gene increased t...,71,1212,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
c.1987C>T,...SNP (NCBI accession number rs 337183461) and LEPR c.1987C>T SNP (db SNP accession number ss 26280382...,45,779,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
c.1987C>T,...SNP (NCBI accession number rs 337183461) and LEPR c.1987C>T SNP (db SNP accession number ss 26280382...,45,779,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
c.4933C>T,"...rated iPSCs from a Dravet syndrome patient with a c.4933C>T substitution in SCN1A, which is predicte...",7,58,Mol_Brain_2013_May_2_6_19.txt
c.4933C>T,"...rated iPSCs from a Dravet syndrome patient with a c.4933C>T substitution in SCN1A, which is predicte...",7,58,Mol_Brain_2013_May_2_6_19.txt
c.4933C>T,"...ted genomic DNA revealed an SCN1A point mutation, c.4933C>T [GenBank: NM_001165963.1] (Figure 1A) as...",23,745,Mol_Brain_2013_May_2_6_19.txt
c.1723G>T,"...tient and a nonsense mutation in another patient (c.1723G>T, p.Glu575*). None of these mutations wer...",12,115,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
c.1723G>T,"...tient and a nonsense mutation in another patient (c.1723G>T, p.Glu575*). None of these mutations wer...",12,115,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
c.733G>A,"... identified one single nucleotide polymorphismus (c.733G>A, p.Gly245Arg) homozygous in two and heter...",12,266,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
c.733G>A,"... identified one single nucleotide polymorphismus (c.733G>A, p.Gly245Arg) homozygous in two and heter...",12,266,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
c.733G>A,"... identified one single nucleotide polymorphismus (c.733G>A, p.Gly245Arg) homozygous in two and heter...",12,266,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
c.733G>A,"... identified one single nucleotide polymorphismus (c.733G>A, p.Gly245Arg) homozygous in two and heter...",12,266,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
c.5835T>G,"... novel MYO15A mutations, c.3871C>T (p.L1291F) and c.5835T>G (p.Y1945X) in an affected individual car...",11,608,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,"...ngle gene, MYO15A, remained (Table 1). These were c.3871C>T (p.L 1291F) in exon 6 and c.5835T>G (p.Y...",47,645,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,...). These were c.3871C>T (p.L 1291F) in exon 6 and c.5835T>G (p.Y1945*) in exon 24 (Fig. 1C). The mot...,47,681,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,...). These were c.3871C>T (p.L 1291F) in exon 6 and c.5835T>G (p.Y1945*) in exon 24 (Fig. 1C). The mot...,47,681,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,...). These were c.3871C>T (p.L 1291F) in exon 6 and c.5835T>G (p.Y1945*) in exon 24 (Fig. 1C). The mot...,47,681,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,...). These were c.3871C>T (p.L 1291F) in exon 6 and c.5835T>G (p.Y1945*) in exon 24 (Fig. 1C). The mot...,47,681,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,...her of SB156-272 (SB156-328) was heterozygous for c.3871C>T (p.L1291F) and the father (SB156-327) wa...,47,781,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,...hen-2 analyses consistently identified the MYO15A c.3871C>T (p.L1291F) SNP as “damaging.” Furthermor...,47,1076,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,...hen-2 analyses consistently identified the MYO15A c.3871C>T (p.L1291F) SNP as “damaging.” Furthermor...,47,1076,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,... at residue 1291 of myosin XVA. The c.3871C>T and c.5835T>G mutations resided in the myosin motor an...,47,1379,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,"...arily in the motor domain, such as the p. L1291F (c.3871C>T) mutation identified in this study. The ...",62,160,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,"...arily in the motor domain, such as the p. L1291F (c.3871C>T) mutation identified in this study. The ...",62,160,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,"...mutation found was a nonsense mutation: p.Y1945* (c.5835T>G). It resides in the IQ2 domain, which is...",64,62,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,"...mutation found was a nonsense mutation: p.Y1945* (c.5835T>G). It resides in the IQ2 domain, which is...",64,62,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,...eady state response (ASSR) and segregation of the c.3871C>T and c.5835T>G variants of MYO15A in fami...,79,80,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,...ponse (ASSR) and segregation of the c.3871C>T and c.5835T>G variants of MYO15A in family SB156. (A) ...,79,94,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,... sequencing traces for the c.3871C>T (p.L1291F) + c.5835T>G (p.Y1945*) compound heterozygote (SB156-...,79,502,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,...(SB156-327). (E) Sanger sequencing traces for the c.3871C>T carrier (SB156-328). (F) Conservation of...,79,663,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,...ebrafish. (G) The sequence variants c.3871C>T and c.5835T>G reside in exon 6 (motor domain) and exon...,79,882,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,...ebrafish. (G) The sequence variants c.3871C>T and c.5835T>G reside in exon 6 (motor domain) and exon...,79,882,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4176C>A,c.4176C>A	p.Tyr1392*	Motor	Homozygous	Severe to pr...,105,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4176C>A,c.4176C>A	p.Tyr1392*	Motor	Homozygous	Severe to pr...,105,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4240G>A,c.4240G>A	p.Glu1414Lys		Homozygous	Profound	Browns...,107,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4240G>A,c.4240G>A	p.Glu1414Lys		Homozygous	Profound	Browns...,107,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4240G>A,c.4240G>A	p.Glu1414Lys		Homozygous	Profound	Browns...,107,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4351G>A,c.4351G>A	p.Asp1451Asn	Motor	Homozygous	Severe to ...,109,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4441T>C,c.4441T>C	p.Ser1481Pro	Motor	Homozygous	Severe to ...,110,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4669A>G,c.4669A>G	p.Lys1557Glu	Motor	Homozygous	Severe to ...,111,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4669A>G,c.4669A>G	p.Lys1557Glu	Motor	Homozygous	Severe to ...,111,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4998C>A,c.4998C>A	p.Cys1666*	Motor	Homozygous	Severe to pr...,112,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4998C>A,c.4998C>A	p.Cys1666*	Motor	Homozygous	Severe to pr...,112,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5189T>C,c.5189T>C	p.Leu1730Pro	Motor	Homozygous	Severe to ...,114,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,c.5835T>G	p.Tyr1945*	IQ 2	Heterozygous	Profound	Th...,117,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5913G>A,c.5913G>A			Heterozygous	Severe to profound	Gao et...,118,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6217C>T,c.6217C>T	p.Pro2073Ser	MyTH4 1	Homozygous	Severe t...,120,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6340G>A,c.6340G>A	p.Val2114Met	MyTH4 1	Heterozygous	Severe...,122,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6371G>A,c.6371G>A	p.Arg2124Gln	MyTH4 1	Homozygous	Severe t...,123,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6371G>A,c.6371G>A	p.Arg2124Gln	MyTH4 1	Homozygous	Severe t...,123,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6614C>T,c.6614C>T	p.Thr2205Ile	MyTH4 1	Hemizygous	*Residua...,125,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6796G>A,c.6796G>A	p.Val2266Met		Homozygous	Severe to profo...,127,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6956+9C>G,c.6956+9C>G			Heterozygous	Severe to profound	Yang...,128,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6956+9C>G,c.6956+9C>G			Heterozygous	Severe to profound	Yang...,128,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.7395+3G>C,c.7395+3G>C			Homozygous	Severe to profound	Belgui...,130,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.8324G>A,c.8324G>A	p.Arg2775His		Heterozygous	Severe to pro...,133,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.8375T>C,c.8375T>C	p.Val2792Ala		Heterozygous	Severe to pro...,134,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.8767C>T,c.8767C>T	p.Arg2923*	SH3	Heterozygous	Severe to pr...,135,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.10474C>T,c.10474C>T	p.Gln3492*	FERM	Homozygous	Severe to pr...,143,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.381G>A,"... (D85V, R175W & N372Y) are missense, 3 (c.366G>A, c.381G>A & c.384C>T) are in 5’UTR, 1 synonymous ch...",12,371,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.381G>A,"... (D85V, R175W & N372Y) are missense, 3 (c.366G>A, c.381G>A & c.384C>T) are in 5’UTR, 1 synonymous ch...",12,371,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.384C>T,"...5W & N372Y) are missense, 3 (c.366G>A, c.381G>A & c.384C>T) are in 5’UTR, 1 synonymous change (c.682...",12,382,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.384C>T,"...5W & N372Y) are missense, 3 (c.366G>A, c.381G>A & c.384C>T) are in 5’UTR, 1 synonymous change (c.682...",12,382,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.682G>T,"...>A & c.384C>T) are in 5’UTR, 1 synonymous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.128...",12,427,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.682G>T,"...>A & c.384C>T) are in 5’UTR, 1 synonymous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.128...",12,427,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.682G>T,"...>A & c.384C>T) are in 5’UTR, 1 synonymous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.128...",12,427,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.947-20G>C,"...e in 5’UTR, 1 synonymous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.1289+68G>A) are intr...",12,444,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.1140+14G>A,"... synonymous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.1289+68G>A) are intronic variants...",12,457,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.662C>T,...5dupGGATTCCG; p.Val19fs*24) and a point mutation (c.662C>T; p.Pro221Leu). The consanguineous parents...,3,1455,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
c.1312+5G>A,...s splicing mutation was found in APC (NM_000038.4:c.1312+5G>A) and six heterozygous in GNAQ (NM_0020...,5,1023,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1312+5G>A,...s splicing mutation was found in APC (NM_000038.4:c.1312+5G>A) and six heterozygous in GNAQ (NM_0020...,5,1023,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.735+1C>T,"...2+5G>A) and six heterozygous in GNAQ (NM_002072.2:c.735+1C>T), ABCC3 (NM_003786.3:c.1783-1G>A), KLHD...",5,1078,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1783-1G>A,"...GNAQ (NM_002072.2:c.735+1C>T), ABCC3 (NM_003786.3:c.1783-1G>A), KLHDC1 (NM_172193.1:c.568-2A>G), HOO...",5,1110,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,"...C3 (NM_003786.3:c.1783-1G>A), KLHDC1 (NM_172193.1:c.568-2A>G), HOOK1 (NM_015888.4:c.1662-1G>A), SMAD...",5,1144,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,"...C3 (NM_003786.3:c.1783-1G>A), KLHDC1 (NM_172193.1:c.568-2A>G), HOOK1 (NM_015888.4:c.1662-1G>A), SMAD...",5,1144,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1662-1G>A,"...HDC1 (NM_172193.1:c.568-2A>G), HOOK1 (NM_015888.4:c.1662-1G>A), SMAD9 (NM_001127217.2:c.1004-1C>T), ...",5,1176,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1662-1G>A,"...HDC1 (NM_172193.1:c.568-2A>G), HOOK1 (NM_015888.4:c.1662-1G>A), SMAD9 (NM_001127217.2:c.1004-1C>T), ...",5,1176,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1004-1C>T,"... (NM_015888.4:c.1662-1G>A), SMAD9 (NM_001127217.2:c.1004-1C>T), and DNAH9 (NM_001372.3:c.10242+5G>A)...",5,1212,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1312+5G>A,"...site in the intron between exon 10 and 11 of APC (c.1312+5G>A, OMIM# 611731, NM_000038, NCBI36.1 nom...",64,535,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.735+1C>T,"GNAQ	Ph+001	9,79599197,79599198,1,C/T	c.735+1C>T	23 (65)	8 (0)	35% (0%)	Donor lost",71,39,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1783-1G>A,"ABCC3	Ph+004	17,46100788,46100789,1,G/A	c.1783-1G>A	59 (36)	30 (0)	51% (1%)	Acceptor lost",72,41,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1783-1G>A,"ABCC3	Ph+004	17,46100788,46100789,1,G/A	c.1783-1G>A	59 (36)	30 (0)	51% (1%)	Acceptor lost",72,41,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,"KLHDC1	Ph+005	14,49265391,49265392,1,A/G	c.568-2A>G	93 (14)	48 (1)	52% (7%)	Acceptor lost",73,42,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,"KLHDC1	Ph+005	14,49265391,49265392,1,A/G	c.568-2A>G	93 (14)	48 (1)	52% (7%)	Acceptor lost",73,42,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.10242+5G>A,"DNAH9	Ph-007	17,11715832,11715833,1,G/A	c.10242+5G>A	37 (43)	19 (0)	51% (0%)	Donor lost",76,41,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1783-1G>A,ABCC3	Ph+004	c.1783-1G>A	1	0.91/–	0.390/–	5155	859	6.109	58% wt...,85,14,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1004-1C>T,SMAD9	Ph-005	c.1004-1C>T	1	0.98/–	0.988/–	5558	42	0.379	Low exp...,87,14,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.10242+5G>A,DNAH9	Ph-007	c.10242+5G>A	0.999	0.95/–	0.949/–	14087	0	0	Not ex...,89,14,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1783-1G>A,...3 and 14 of ABCC3 (OMIM#604323) gene (NM_003786.3:c.1783-1G>A); it was present with a frequency of 5...,100,171,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,"...ion in the KLHDC1 (OMIM#611281) gene (NM_172193.1:c.568-2A>G), near the 3’ acceptor splice site at p...",102,86,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1004-1C>T,"...6 of the SMAD9 (OMIM#603295) gene (NM_001127217.2:c.1004-1C>T), causing a loss of acceptor site. Des...",106,178,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1312+2T>C,"...he transversion (c.1312+4T>G) and the transition (c.1312+2T>C) affected, respectively, position +4 (...",119,646,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1312+2T>C,"...he transversion (c.1312+4T>G) and the transition (c.1312+2T>C) affected, respectively, position +4 (...",119,646,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1662-1G>A,...f intron retention in HOOK1 caused by NM_015888.4:c.1662-1G>A mutation was functionally validated by...,129,65,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1662-1G>A,...f intron retention in HOOK1 caused by NM_015888.4:c.1662-1G>A mutation was functionally validated by...,129,65,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1662-1G>A,...f intron retention in HOOK1 caused by NM_015888.4:c.1662-1G>A mutation was functionally validated by...,129,65,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1783-1G>A,Figure S3. (A) ABCC3 (NM_003786.3:c.1783-1G>A) splicing mutation near the 3’ accepto...,150,35,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1783-1G>A,Figure S3. (A) ABCC3 (NM_003786.3:c.1783-1G>A) splicing mutation near the 3’ accepto...,150,35,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1783-1G>A,Figure S3. (A) ABCC3 (NM_003786.3:c.1783-1G>A) splicing mutation near the 3’ accepto...,150,35,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1783-1G>A,Figure S3. (A) ABCC3 (NM_003786.3:c.1783-1G>A) splicing mutation near the 3’ accepto...,150,35,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,... DNAH9 somatic mutations. (A) KLHDC1 (NM_172193.1:c.568-2A>G) splicing mutation near the 3’ acceptor...,153,61,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.10242+5G>A,"...ow, the Sanger validation. (C) DNAH9 (NM_001372.3:c.10242+5G>A) splicing mutation near the 5’ donor ...",153,449,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1662-1G>A,Figure S5. (A) HOOK1 (NM_015888.4:c.1662-1G>A) splicing mutation near the 3’ accepto...,155,35,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.313G>C,...tGene2/) for mutations affecting splice sites and c.313G>C,16,1748,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.313G>C,...tGene2/) for mutations affecting splice sites and c.313G>C,16,1748,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2025+1G>A,"...ding sequence of CCM1 lacking human exon 18 (CCM1:c.2025+1G>A, CCM1:p.N607_K675del) was similarly fu...",22,261,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.729+5G>A,IVS9	c.729+5G>A	p.Q201Rfs*23	f	Novel	44,39,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.845+1G>A,IVS10	c.845+1G>A	p.?	i	Novel	36,42,7,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.845+1G>T,IVS10	c.845+1G>T	p.?	f	Novel	77,43,7,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2025+1G>A,IVS18	c.2025+1G>A	p.N607_K675del3	f	Denier et al. (2004)...,63,7,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2026-12A>G,IVS18	c.2026-12A>G	p.A676_Q714del3	f	Laberge-le Couteulx...,64,7,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.558-2A>C,IVS9	c.558-2A>C	p.?	i	Novel	3,80,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2025+1G>A,...o turned out to be a heterozygous carrier of CCM1:c.2025+1G>A (Fig. 2B and C),103,541,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2025+1G>A,CCM1:c.2025+1G>A affects a canonical splice site and is...,107,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2026-12A>G,...ses have shown that the splice site mutation CCM1:c.2026-12A>G results in the deletion of entire exo...,107,678,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.598C>T,...tation carriers: c.317delA (unpublished data) and c.598C>T (Schröder et al. 2014),125,1090,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2219G>C,"...ations in this study, with two mutations in MFN2 (c.2219G>C, p.W740S; c.227T>C; p.L76P) comprising 8...",82,1049,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
c.305A>G,"...]), FIG4 (c.122T>C; p.Ile41Thr [4.3%]), and GJB1 (c.305A>G; p.Glu102Gly [2.5%]) (Table S6). The dist...",82,1222,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
c.3279G>A,"...ovel unreported missense point mutation (exon 14, c.3279G>A, p.Met1093Ile) (Fig. 1)",31,178,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
c.3279G>A,"...ovel unreported missense point mutation (exon 14, c.3279G>A, p.Met1093Ile) (Fig. 1)",31,178,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
c.3279G>A,"...ovel unreported missense point mutation (exon 14, c.3279G>A, p.Met1093Ile) (Fig. 1)",31,178,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
c.3279G>A,...c.1505T>A (p.Val502Asp). (B) Exon 14: NM_000132.3 c.3279G>A (p.Met1093Ile),51,133,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
c.574C>T,"...f RS1 gene revealed five mutations in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C...",15,70,Mol_Vis_2007_Apr_19_13_611-617.txt
c.583A>G,"... revealed five mutations in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respec...",15,80,Mol_Vis_2007_Apr_19_13_611-617.txt
c.583A>G,"... revealed five mutations in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respec...",15,80,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,"...ions in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respectively, among them f...",15,100,Mol_Vis_2007_Apr_19_13_611-617.txt
c.637C>T,"... like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respectively, among them four missense m...",15,114,Mol_Vis_2007_Apr_19_13_611-617.txt
c.608C>T,"...c variations were identified: c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T. Two of these, c....",58,220,Mol_Vis_2007_Apr_19_13_611-617.txt
c.637C>T,"...fied: c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T. Two of these, c.583A>G and c.617G>A, are...",58,244,Mol_Vis_2007_Apr_19_13_611-617.txt
c.583A>G,"..., c.608C>T, c.617G>A, and c.637C>T. Two of these, c.583A>G and c.617G>A, are novel. Similar to previ...",58,268,Mol_Vis_2007_Apr_19_13_611-617.txt
c.574C>T,Patient 1 with c.574C>T mutatio,80,16,Mol_Vis_2007_Apr_19_13_611-617.txt
c.574C>T,A c.574C>T mutation was found in a 10-year-old male....,81,3,Mol_Vis_2007_Apr_19_13_611-617.txt
c.608C>T,Patient 3 with c.608C>T mutatio,86,16,Mol_Vis_2007_Apr_19_13_611-617.txt
c.608C>T,A c.608C>T mutation was observed in a 20-year-old ma...,87,3,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,Patient 4 with c.617G>A novel nonsense variatio,89,16,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,A c.617G>A nonsense mutation was found in a 10-year-...,90,3,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,...on analysis of RS1 and sequencing result showed a c.617G>A transition that resulted in a nonsense mu...,94,264,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,"...mily pedigree of patient 4, who exhibited a novel c.617G>A mutation. The arrow indicates proband. Th...",96,133,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,"...mily pedigree of patient 4, who exhibited a novel c.617G>A mutation. The arrow indicates proband. Th...",96,133,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,... B: This sequence chromatogram compares the novel c.617G>A nonsense mutation with the sequence deriv...,96,336,Mol_Vis_2007_Apr_19_13_611-617.txt
c.637C>T,Patient 5 with c.637C>T transitio,98,16,Mol_Vis_2007_Apr_19_13_611-617.txt
c.637C>T,Patient 5 with c.637C>T transitio,98,16,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,"... be sporadic cases, and one novel genetic variant c.617G>A was identified in a family",107,916,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,"... be sporadic cases, and one novel genetic variant c.617G>A was identified in a family",107,916,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,A c.617G>A novel nonsense mutation was identifiedin ...,109,3,Mol_Vis_2007_Apr_19_13_611-617.txt
c.583A>G,"Patient 2 was found to have a c.583A>G novel genetic variation, leading to the r...",111,31,Mol_Vis_2007_Apr_19_13_611-617.txt
c.99+1G>A,Intron 2	c.99+1G>A	Aberrant splicing	LCA/Early onset RP	Fou...,45,10,Mol_Vis_2008_Apr_21_14_675-682.txt
c.99+1G>A,Intron 2	c.99+1G>A	Aberrant splicing	LCA/Early onset RP	Fou...,45,10,Mol_Vis_2008_Apr_21_14_675-682.txt
c.718+2T>C,Intron 7	c.718+2T>C	Aberrant splicing	Juvenile RP		 [16],48,10,Mol_Vis_2008_Apr_21_14_675-682.txt
c.999+5G>C,Intron 10	c.999+5G>C	Aberrant splicing	Juvenile RP		 [16],50,11,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1102G>T,Exon 11	c.1102G>T	p.G368W	LCA		 [2],51,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1102G>T,Exon 11	c.1102G>T	p.G368W	LCA		 [2],51,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1204G>T,Exon 12	c.1204G>T	p.E402X	LCA	Found in compound heterozygo...,54,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.99+1G>A,...p.E402X	LCA	Found in compound heterozygosity with c.99+1G>A	 [2],54,69,Mol_Vis_2008_Apr_21_14_675-682.txt
c.99+1G>A,...ly onset RP	Found in compound heterozygosity with c.99+1G>A	 [11],57,81,Mol_Vis_2008_Apr_21_14_675-682.txt
c.99+1G>A,...ly onset RP	Found in compound heterozygosity with c.99+1G>A	 [11],57,81,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1381C>G,Exon 14	c.1381C>G	p.L461V	Juvenile RP		 [16],58,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1444C>T,Exon 14	c.1444C>T	p.R482W	Early onset RP	Found in compound...,60,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1444C>T,Exon 14	c.1444C>T	p.R482W	Early onset RP	Found in compound...,60,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1444C>T,Exon 14	c.1444C>T	p.R482W	Early onset RP	Found in compound...,60,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1502G>A,Exon 14	c.1502G>A	p.K489R	RP		 [18],61,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1502G>A,Exon 14	c.1502G>A	p.K489R	RP		 [18],61,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1502G>A,Exon 14	c.1502G>A	p.K489R	RP		 [18],61,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1502G>A,Exon 14	c.1502G>A	p.K489R	RP		 [18],61,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1496-6C>A,"Intron 14	c.1496-6C>A, (IVS14-6C>A)	Aberrant splicing	RP		 [...",65,11,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1495+1G>A,...1495+3insT mutation or from a normal control. The c.1495+1G>A mutation was generated by site-directe...,74,286,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1495+1G>A,...splice-site of intron 14: c.1495+2_1495+3insT and c.1495+1G>A. Also shown are the locations of prime...,99,415,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1495+1G>A,"...ations of TULP1 which have been reported to date, c.1495+1G>A (IVS14+1G>A) and c.1496–6C>A (IVS14–6C...",102,722,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1495+1G>A,"...ations of TULP1 which have been reported to date, c.1495+1G>A (IVS14+1G>A) and c.1496–6C>A (IVS14–6C...",102,722,Mol_Vis_2008_Apr_21_14_675-682.txt
c.575C>T,"...ilies: six known and one novel missense mutation (c.575C>T, p.Pro192Leu), one insertion mutation (c....",15,1478,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.78+1G>C,"...and one frameshift, causing splice site mutation (c.78+1G>C) were detected. These mutations were abs...",15,1610,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.78+1G>C,"...and one frameshift, causing splice site mutation (c.78+1G>C) were detected. These mutations were abs...",15,1610,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.214G>A,c.214G>A	missense	p.Glu72Lys	exon 4	5	5	2	17.86,89,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.421C>T,c.421C>T	missense	p.Arg141Cys	exon 5	6	6+1	3	21.42...,91,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.422G>A,c.422G>A	missense	p.Arg141His	exon 5	5	4	1	16.07,92,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.422G>A,c.422G>A	missense	p.Arg141His	exon 5	5	4	1	16.07,92,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.422G>A,c.422G>A	missense	p.Arg141His	exon 5	5	4	1	16.07,92,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.574C>T,c.574C>T	missense	p.Pro192Ser	exon 6	3	2	2	8.93,93,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.574C>T,c.574C>T	missense	p.Pro192Ser	exon 6	3	2	2	8.93,93,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.575C>T,c.575C>T *	missense	p.Pro192Leu	exon 6	-	1	1	1.79,94,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.625C>T,c.625C>T	missense	p.Arg209Cys	exon 6	3	1	1	7.14,96,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.625C>T,c.625C>T	missense	p.Arg209Cys	exon 6	3	1	1	7.14,96,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.574C>T,"...ily 4, who had two different mutations (c.421C>T, c.574C>T) in the RS1 gene, which resulted in appar...",98,510,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.421C>T,"...4, two different mutations were found: a de novo (c.421C>T, Arg141Cys) mutation and a maternal inher...",121,1196,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.574C>T,"...Arg141Cys) mutation and a maternal inherited one (c.574C>T, Pro192Ser). The pathogenic effects of th...",121,1256,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.574C>T,"...r with the already known disease-causing variant (c.574C>T, inherited from his mother), illustrates ...",147,240,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.574C>T,"...r with the already known disease-causing variant (c.574C>T, inherited from his mother), illustrates ...",147,240,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.2197C>T,...1 protein. A novel heterozygous nonsense mutation c.2197C>T(p.R733X)was detected in family F2,17,491,Mol_Vis_2008_Dec_29_14_2451-2457.txt
c.2197C>T,...5–2A>G and a novel heterozygous nonsense mutation c.2197C>T (p.R733X). The 2 novel mutations cosegre...,120,220,Mol_Vis_2008_Dec_29_14_2451-2457.txt
c.2197C>T,The novel nonsense mutation c.2197C>T (p.R733X) detected in family F2 presumab...,126,29,Mol_Vis_2008_Dec_29_14_2451-2457.txt
c.2109C>T,"...Using pyrosequencing of an RT–PCR amplified cSNP (c.2109C>T) in OPA1, they found that mutant transcr...",126,938,Mol_Vis_2008_Dec_29_14_2451-2457.txt
c.448G>A,"...t sequencing of RHO resulted in identification of c.448G>A, a previously reported mutation in exon 2...",141,56,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,"...t sequencing of RHO resulted in identification of c.448G>A, a previously reported mutation in exon 2...",141,56,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,To determine the frequency of the c.448G>A mutation in the general Pakistani populat...,145,35,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,Founder effect analysis of the c.448G>A mutation in the two Pakistani families (R...,158,32,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,This c.448G>A mutation has previously been reported to ...,167,6,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.603T>A,"...ill be performed. Accordingly, five SNPs in OPTN (c.603T>A [M98K], c.1944G>A [R545Q], IVS5+38T>G, IV...",40,270,Mol_Vis_2009_Jan_16_15_89-98.txt
c.603T>A,"...ill be performed. Accordingly, five SNPs in OPTN (c.603T>A [M98K], c.1944G>A [R545Q], IVS5+38T>G, IV...",40,270,Mol_Vis_2009_Jan_16_15_89-98.txt
c.526C>T,...219T>G) and the ε2/ε3/ε4 polymorphisms in exon 4 (c.526C>T for ε2 and c.388T>C for ε4) were investig...,40,1041,Mol_Vis_2009_Jan_16_15_89-98.txt
c.526C>T,...219T>G) and the ε2/ε3/ε4 polymorphisms in exon 4 (c.526C>T for ε2 and c.388T>C for ε4) were investig...,40,1041,Mol_Vis_2009_Jan_16_15_89-98.txt
c.388T>C,...3/ε4 polymorphisms in exon 4 (c.526C>T for ε2 and c.388T>C for ε4) were investigated by the TaqMan g...,40,1061,Mol_Vis_2009_Jan_16_15_89-98.txt
c.227G>A,"...k, spanning from the promoter (−83G>A) to exon 1 (c.227G>A). Within this block, polymorphisms −83G>A...",126,93,Mol_Vis_2009_Jan_16_15_89-98.txt
c.227G>A,"...k, spanning from the promoter (−83G>A) to exon 1 (c.227G>A). Within this block, polymorphisms −83G>A...",126,93,Mol_Vis_2009_Jan_16_15_89-98.txt
c.34C>T,"...d subjects. A heterozygous missense substitution, c.34C>T, in CRYAA, which is responsible for the R1...",15,205,Mol_Vis_2009_Jun_4_15_1127-1138.txt
c.34C>T,"...d subjects. A heterozygous missense substitution, c.34C>T, in CRYAA, which is responsible for the R1...",15,205,Mol_Vis_2009_Jun_4_15_1127-1138.txt
c.34C>T,...ygous C>T transition at the 34th coding position (c.34C>T) in exon 1 of CRYAA (NM_000394) was identi...,290,434,Mol_Vis_2009_Jun_4_15_1127-1138.txt
c.34C>T,...ygous C>T transition at the 34th coding position (c.34C>T) in exon 1 of CRYAA (NM_000394) was identi...,290,434,Mol_Vis_2009_Jun_4_15_1127-1138.txt
c.34C>T,...ygous C>T transition at the 34th coding position (c.34C>T) in exon 1 of CRYAA (NM_000394) was identi...,290,434,Mol_Vis_2009_Jun_4_15_1127-1138.txt
c.34C>T,...ygous C>T transition at the 34th coding position (c.34C>T) in exon 1 of CRYAA (NM_000394) was identi...,290,434,Mol_Vis_2009_Jun_4_15_1127-1138.txt
c.34C>T,"...results showed a substitution of C to T in CRYAA (c.34C>T), which led to a R12C amino acid change. I...",292,103,Mol_Vis_2009_Jun_4_15_1127-1138.txt
c.34C>T,"...results showed a substitution of C to T in CRYAA (c.34C>T), which led to a R12C amino acid change. I...",292,103,Mol_Vis_2009_Jun_4_15_1127-1138.txt
c.34C>T,"... study, we first reported a heterozygous mutation c.34C>T in exon 1 of CRYAA in a Chinese family aff...",313,58,Mol_Vis_2009_Jun_4_15_1127-1138.txt
c.413C>G,A de novo heterozygous c.413C>G p.S138X stop mutation was identified in a...,31,24,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.674A>G,c.674A>G	p.Asn225Ser	CPHD	[22],53,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.93C>G,c.93C>G	p.Tyr31X	Microphthalmia	[20],56,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.93C>G,c.93C>G	p.Tyr31X	Microphthalmia	[20],56,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.265C>G,c.265C>G	p.Arg89Gly	bilateral microphthalmia	[11],65,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.265C>G,c.265C>G	p.Arg89Gly	bilateral microphthalmia	[11],65,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.265C>G,c.265C>G	p.Arg89Gly	bilateral microphthalmia	[11],65,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.265C>G,c.265C>G	p.Arg89Gly	bilateral microphthalmia	[11],65,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.537T>A,"c.537T>A	p.Tyr179X	bilateral mild microphthalmia, ...",68,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.537T>A,"c.537T>A	p.Tyr179X	bilateral mild microphthalmia, ...",68,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.397C>A,c.397C>A	p.Pro133Thr	bilateral microphthalmia	[11]...,71,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.400C>G,c.400C>G	p.Pro134Ala	anophthalmia OS/ OD normal	[1...,72,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.400C>G,c.400C>G	p.Pro134Ala	anophthalmia OS/ OD normal	[1...,72,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.718C>T,...7fs17] and c.475delC [p.R159fs47]) and one known (c.718C>T [p.R240X]) PAX6 mutations in the affected...,13,420,Mol_Vis_2009_Oct_17_15_2074-2083.txt
c.718C>T,...7fs17] and c.475delC [p.R159fs47]) and one known (c.718C>T [p.R240X]) PAX6 mutations in the affected...,13,420,Mol_Vis_2009_Oct_17_15_2074-2083.txt
c.718C>T,"...abase [17]. In Family 3, the previously described c.718C>T (p.R240X) nonsense mutation in exon 9 [2,...",86,789,Mol_Vis_2009_Oct_17_15_2074-2083.txt
c.529C>T,"...r recurrent mutation in SOX2; one other mutation, c.529C>T, has been noted in three unrelated famili...",56,1699,Mol_Vis_2010_Apr_28_16_768-773.txt
c.529C>T,"...r recurrent mutation in SOX2; one other mutation, c.529C>T, has been noted in three unrelated famili...",56,1699,Mol_Vis_2010_Apr_28_16_768-773.txt
c.453G>A,... conserved with only one synonymous polymorphism (c.453G>A) observed in our patient group (also seen...,70,720,Mol_Vis_2010_Apr_28_16_768-773.txt
c.846T>C, 	c.846T>C	p.Asp282Asp	rs28455091	Y (hetero) Score=2...,84,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.553T>C, 	c.553T>C	p.Cys185Arg	rs3748493	N*	N*	Y (hetero)	Y ...,89,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1199T>G,CSRP2BP (NM_020536)	c.1199T>G	p.Val400Gly	rs1205193	Y (homo) Score=23	...,95,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1199T>G,CSRP2BP (NM_020536)	c.1199T>G	p.Val400Gly	rs1205193	Y (homo) Score=23	...,95,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1437C>T, 	c.1437C>T	p.Pro479Pro	rs1205194	N	N	N	N,96,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1499C>T, 	c.1499C>T	p.Ala500Val	rs41276418	Y (hetero) Score=...,97,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1499C>T, 	c.1499C>T	p.Ala500Val	rs41276418	Y (hetero) Score=...,97,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1499C>T, 	c.1499C>T	p.Ala500Val	rs41276418	Y (hetero) Score=...,97,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.89T>C,MGC44328 (NM_001004344)	c.89T>C	p.Leu30Pro	rs1883938	Y (homo) Score=27	Y (...,101,25,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.89T>C,MGC44328 (NM_001004344)	c.89T>C	p.Leu30Pro	rs1883938	Y (homo) Score=27	Y (...,101,25,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1410G>C, 	c.1410G>C	p.Leu470Leu	rs6075337	Y (homo) Score=26	...,104,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1410G>C, 	c.1410G>C	p.Leu470Leu	rs6075337	Y (homo) Score=26	...,104,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1410G>C, 	c.1410G>C	p.Leu470Leu	rs6075337	Y (homo) Score=26	...,104,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1410G>C, 	c.1410G>C	p.Leu470Leu	rs6075337	Y (homo) Score=26	...,104,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1410G>C, 	c.1410G>C	p.Leu470Leu	rs6075337	Y (homo) Score=26	...,104,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.840A>G,POLR3F (NM_006466)	c.840A>G	p.Thr280Thr	rs1055171	Y (homo) Score=26	Y...,106,20,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.840A>G,POLR3F (NM_006466)	c.840A>G	p.Thr280Thr	rs1055171	Y (homo) Score=26	Y...,106,20,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.136C>G,RPS19P1 (NG_001295)	c.136C>G	p.Pro46Ala	rs2009092	Y (hetero) Score=12	...,109,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.167G>A, 	c.167G>A	p.Arg56Gln	-	N*	N*	Y (hetero)	N,110,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.490G>A,SEC23B (NM_032985)	c.490G>A	p.Val164Met	rs36023150	N	N	N	N,111,20,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.490G>A,SEC23B (NM_032985)	c.490G>A	p.Val164Met	rs36023150	N	N	N	N,111,20,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1467C>G, 	c.1467C>G	p.His489Gln	rs2273526	N	Y (hetero) Score...,114,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.48A>G,LOC388789 (XM_939954)	c.48A>G	p.Arg16Arg	rs12624935	N*	N*	N	Y (hetero),115,23,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.48A>G,LOC388789 (XM_939954)	c.48A>G	p.Arg16Arg	rs12624935	N*	N*	N	Y (hetero),115,23,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.447A>C,DUXAP7 (NG_004846)	c.447A>C	p.Gln149His	rs6132094	N*	N*	Y (hetero)	Y ...,117,20,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.665C>T, 	c.665C>T	p.Thr222Ile	rs6081270	N*	N*	Y (hetero)	Y ...,119,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.716T>A, 	c.716T>A	p.Ile239Lys	-	N*	N*	Y (hetero)	Y (hetero)...,120,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.943G>C, 	c.943G>C	p.Val315Leu	rs6132093	N*	N*	Y (hetero)	Y ...,126,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1124T>C, 	c.1124T>C	p.Val375Ala	rs6081268	N*	N*	Y (hetero)	Y...,127,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1156C>T, 	c.1156C>T	p.Pro386Ser	rs6075382	N*	N*	Y (hetero)	Y...,128,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1156C>T, 	c.1156C>T	p.Pro386Ser	rs6075382	N*	N*	Y (hetero)	Y...,128,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.543G>T,c.543G>T	p.Gly181Gly	rs7262320	Y (hetero) Score=26...,132,2,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.138C>G,LOC100128496 (XM_001725705)	c.138C>G	p.Leu46Leu	rs56743271	Y (hetero) Score=19...,136,29,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.163G>A,c.163G>A	p.Val55Ile	rs1569767	N	Y (hetero) Score=1...,140,2,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.369G>A,c.369G>A	p.Ala123Ala	rs3790261	Y (Hetero) Score=26...,141,2,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.843C>T,...wn genes. Two variants (c. 846T>C in C20orf72 and c.843C>T in PTMAP3) that were identified by Sanger...,168,1694,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1876A>G,"...n hotspot mutations, c. 531C>T (p. Arg124Cys) and c.1876A>G (p.His572Arg), were revealed in Family 2...",13,169,Mol_Vis_2010_Feb_15_16_224-230.txt
c.1876A>G,"...g514Pro and Phe515Leu), c. 531C>T (p. Arg124Cys), c.1876A>G (p.His572Arg) in TGFBI were responsible ...",16,99,Mol_Vis_2010_Feb_15_16_224-230.txt
c.1702G>C,"...g the TGFBI locus markers D5S816, D5S393, and the c.1702G>C and c.1706T>A variants in Family 1",32,782,Mol_Vis_2010_Feb_15_16_224-230.txt
c.1702G>C,"...g the TGFBI locus markers D5S816, D5S393, and the c.1702G>C and c.1706T>A variants in Family 1",32,782,Mol_Vis_2010_Feb_15_16_224-230.txt
c.1876A>G,"...ted (Figure 7). A recently reported mutation [8], c.1876A>G (p.His572Arg), in exon 13 was identified...",61,510,Mol_Vis_2010_Feb_15_16_224-230.txt
c.1876A>G,"... Sequencing results of the heterozygote mutations c.1876A>G (p.His572Arg) of TGFBI in Family 3, and ...",67,59,Mol_Vis_2010_Feb_15_16_224-230.txt
c.2116G>C,Exon 4	c.2116G>C *	p.G706R	 [26]	20121	1/190,55,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.2953A>T,Exon 4	c.2953A>T	p.N985Y	rs2293869	20149	27/190,57,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.6542C>T,Exon 4 (3′UTR)	c.6542C>T	/	 [26]	20149	2/190,66,16,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.6542C>T,"... variants, three of which (p.G706R, p.Q1008Q, and c.6542C>T) occurred in both the case and control s...",69,80,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.4108A>G,Exon 4	c.4108A>G	p.K1370E	sRP	F	61	0/552	Potentially dama...,77,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.4108A>G,Exon 4	c.4108A>G	p.K1370E	sRP	F	61	0/552	Potentially dama...,77,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.4955G>T,Exon 4	c.4955G>T	p.R1652L	sRP	F	50	0/552	Possibly damagin...,78,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.4955G>T,Exon 4	c.4955G>T	p.R1652L	sRP	F	50	0/552	Possibly damagin...,78,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.2005G>A,p.A669T	c.2005G>A	Pakistan	ARRP	[18],107,9,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.2951A>G,p.D984G	c.2951A>G	Chinese	ADRP	[21],108,9,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.4955G>T,p.R1652L	c.4955G>T	Chinese	SRP	Present Study,111,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.4955G>T,p.R1652L	c.4955G>T	Chinese	SRP	Present Study,111,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.319G>A,...ng of the candidate genes detected a heterozygous c.319G>A change in the coding region of the major ...,15,274,Mol_Vis_2010_Mar_25_16_534-539.txt
c.319G>A,...ng of the candidate genes detected a heterozygous c.319G>A change in the coding region of the major ...,15,274,Mol_Vis_2010_Mar_25_16_534-539.txt
c.319G>A,"...aled a heterozygous change, G>A, at position 319 (c.319G>A) in MIP in all of the affected individual...",46,125,Mol_Vis_2010_Mar_25_16_534-539.txt
c.319G>A,... junction-forming interactions of AQP0. The novel c.319G>A transition results in the substitution of...,75,491,Mol_Vis_2010_Mar_25_16_534-539.txt
c.471G>A,"...sequencing of the candidate gene cluster showed a c.471G>A transition in exon 3 of CRYGC, which co-s...",13,143,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.471G>A,...n residue to a stop codon (W157X). The transition c.471G>A was not found in any of the unaffected fa...,81,315,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.471G>A,...m the COOH-terminus of γC-crystallin as result of c.471G>A mutation,90,293,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.13A>C,c.13A>C	T5P	GKM1	Coppock-like	[21],103,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.502C>T,c.502C>T	R168W	GKM4	Lamellar	[23],105,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.502C>T,c.502C>T	R168W	GKM4	Nuclear	[24],106,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.327C>A,c.327C>A	C109X	GKM3	Nuclear	[25],107,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.327C>A,c.327C>A	C109X	GKM3	Nuclear	[25],107,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.385G>T,c.385G>T	G129C	GKM4	Nuclear	[27],109,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.385G>T,c.385G>T	G129C	GKM4	Nuclear	[27],109,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.813C>A,"...the MF1 family, a heterozygous base substitution, c.813C>A, was detected in exon 8. This single base...",93,157,Mol_Vis_2013_Apr_5_19_751-758.txt
c.813C>A,"...the MF1 family, a heterozygous base substitution, c.813C>A, was detected in exon 8. This single base...",93,157,Mol_Vis_2013_Apr_5_19_751-758.txt
c.1910G>A,"...1*). In the MF2 family, a heterozygous variation, c.1910G>A was found in exon 16, resulting in a cys...",93,357,Mol_Vis_2013_Apr_5_19_751-758.txt
c.1910G>A,"...1*). In the MF2 family, a heterozygous variation, c.1910G>A was found in exon 16, resulting in a cys...",93,357,Mol_Vis_2013_Apr_5_19_751-758.txt
c.813C>A,"...decay (NMD), therefore, the heterozygous mutation c.813C>A of FBN1 could cause haploinsufficiency of...",98,1132,Mol_Vis_2013_Apr_5_19_751-758.txt
c.1910G>A,...otype was the consequence of a missense mutation (c.1910G>A) of the FBN1 gene. This mutation is loca...,100,316,Mol_Vis_2013_Apr_5_19_751-758.txt
c.1910G>A,...otype was the consequence of a missense mutation (c.1910G>A) of the FBN1 gene. This mutation is loca...,100,316,Mol_Vis_2013_Apr_5_19_751-758.txt
c.641C>T,PRPH2	6–42672290	c.641C>T,38,18,Mol_Vis_2013_Mar_21_19_654-664.txt
c.313C>A,"... including c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c....",12,104,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.313C>A,"... including c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c....",12,104,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.313C>A,"... including c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c....",12,104,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,"...0 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c.672_701dup30 (p.Ala224_A...",12,128,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,"...0 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c.672_701dup30 (p.Ala224_A...",12,128,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.313C>A,"... including c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p. N105H), and c.430G>T (p.R144W; Figure...",53,166,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.313C>A,"... including c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p. N105H), and c.430G>T (p.R144W; Figure...",53,166,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,"... (p.Ala224_Ala234dup10), c.313C>A (p. N105H), and c.430G>T (p.R144W; Figure 3). These mutations were...",53,191,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,...B: Mutation of c.313C>A (p.N105H). C: Mutation of c.430G>T (p.R144W). The upper panel is the chromat...,55,211,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,...B: Mutation of c.313C>A (p.N105H). C: Mutation of c.430G>T (p.R144W). The upper panel is the chromat...,55,211,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,...B: Mutation of c.313C>A (p.N105H). C: Mutation of c.430G>T (p.R144W). The upper panel is the chromat...,55,211,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,...est that the mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are novel mutations in the FOXL...,67,630,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,"...0 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FOXL2 gene in four Han C...",82,106,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.313C>A,"...BPES type II, while the two missense mutations of c.313C>A and c.430G>T are novel mutations detected...",82,298,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.402C>G,...or-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS ONE 2010 5 e8789 20098707,106,273,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.402C>G,...or-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS ONE 2010 5 e8789 20098707,106,273,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.402C>G,...or-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS ONE 2010 5 e8789 20098707,106,273,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.4325T>C,"... type 2A (USH2A) compound heterozygous mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), lo...",10,71,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.4325T>C,"... type 2A (USH2A) compound heterozygous mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), lo...",10,71,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.15188T>G,...ositions 1:216363636 (c.4325T>C) and 1:215807910 (c.15188T>G). No other pathogenic mutations were fo...,60,854,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.15188T>G,...ositions 1:216363636 (c.4325T>C) and 1:215807910 (c.15188T>G). No other pathogenic mutations were fo...,60,854,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.4325T>C,...d control individuals were screened for the USH2A c.4325T>C and c.15188T>G mutations. Sanger sequenc...,72,215,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.4325T>C,...d control individuals were screened for the USH2A c.4325T>C and c.15188T>G mutations. Sanger sequenc...,72,215,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.4325T>C,...d control individuals were screened for the USH2A c.4325T>C and c.15188T>G mutations. Sanger sequenc...,72,215,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.992A>C,"...s with BCD include c.802_810del17insGC in exon 7, c.992A>C in exon 8, and c.1091–2A>G in an intronic...",22,513,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.992A>C,"...s with BCD include c.802_810del17insGC in exon 7, c.992A>C in exon 8, and c.1091–2A>G in an intronic...",22,513,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.992A>C,"...s with BCD include c.802_810del17insGC in exon 7, c.992A>C in exon 8, and c.1091–2A>G in an intronic...",22,513,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.31C>T,"60	55/M	49	44	RE: —2.75	RE:20/200	c.31C>T, p.Q11X*+ c.31C>T, p.Q11X*",50,35,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.64C>G,1	c.64C>G	p.L22V	1/4	ND	6/184	Reported,67,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.219T>A,2	c.219T>A	p.F73L	0/3	0/200	3/184	Reported,69,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.219T>A,2	c.219T>A	p.F73L	0/3	0/200	3/184	Reported,69,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.732G>A,6	c.732G>A	p.W244X	0/1	ND	1/184	Reported,72,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.992A>C,8	c.992A>C	p.H331P	0/22	ND	22/184	Reported,76,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.1027T>G,8	c.1027T>G	p.Y343D	0/1	0/200	1/184	novel,77,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.31C>T,"...p.Tyr343Asp). In patient 60, a nonsense mutation (c.31C>T) that converts a glutamine (CAG) into a pr...",84,552,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.1027T>G,"... The heterozygous mutant single base-pair change (c.1027T>G,p.Y343D). B: Control (wild type, WT). C:...",88,127,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,"...WT). G: DNA-MT of the heterozygous splice change (c.413+2T>G). H: Control (WT). I: cDNA sequence, fr...",88,338,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,...). J: The cDNA of the heterozygous splice change (c.413+2T>G). The deletion is indicated with an arr...,88,478,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,...). J: The cDNA of the heterozygous splice change (c.413+2T>G). The deletion is indicated with an arr...,88,478,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,"...ing that these four novel mutations, p.Tyr343Asp, c.413+2T>G, c.791delT, and p.Gln11X, segregated wi...",103,182,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,"...the structure and function of CYP4V2, such as the c.413+2T>G mutation that was located in a splice s...",103,405,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.873+1G>T,ADAMTS17	NM_139057.2	c.873+1G>T	-	Disease causin,55,22,Mol_Vis_2014_Jun_12_20_790-796.txt
c.326G>A,CAMK1D	NM_020397.2	c.326G>A (p.R109Q)	Probably damagin,57,20,Mol_Vis_2014_Jun_12_20_790-796.txt
c.847G>A,PYROXD2	NM_032709.2	c.847G>A (p.V283I)	Probably damagin,61,21,Mol_Vis_2014_Jun_12_20_790-796.txt
c.2488G>A,SIPA1L3	NM_015073.1	c.2488G>A (p.E830K)	Possibly damagin,64,21,Mol_Vis_2014_Jun_12_20_790-796.txt
c.326G>A,...nts of unknown significance in three other genes [c.326G>A (p.R109Q) in CAMK1D located on chromosome...,70,85,Mol_Vis_2014_Jun_12_20_790-796.txt
c.847G>A,"... (p.R109Q) in CAMK1D located on chromosome 10p13, c.847G>A (p.V283I) in PYROXD2 located on chromosom...",70,143,Mol_Vis_2014_Jun_12_20_790-796.txt
c.847G>A,"... (p.R109Q) in CAMK1D located on chromosome 10p13, c.847G>A (p.V283I) in PYROXD2 located on chromosom...",70,143,Mol_Vis_2014_Jun_12_20_790-796.txt
c.1721+1G>A,2	c.1721+1G>A	Intron 12	Splice site	Homozygous	Saudi...,90,3,Mol_Vis_2014_Jun_12_20_790-796.txt
c.873+1G>T,6	c.873+1G>T	Intron 5	Splice site	Homozygous	Indian	...,96,3,Mol_Vis_2014_Jun_12_20_790-796.txt
c.1184A>G,...vered that both patients share a novel homozygous c.1184A>G missense mutation in the MKKS/BBS6 gene ...,24,236,Mol_Vis_2016_Jan_24_22_73-81.txt
c.9248G>A,"... (EYS) gene, involving two novel (c.7228+1G>A and c.9248G>A) and three recurrent mutations (c.4957du...",12,252,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"... (EYS) gene, involving two novel (c.7228+1G>A and c.9248G>A) and three recurrent mutations (c.4957du...",12,252,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"... (EYS) gene, involving two novel (c.7228+1G>A and c.9248G>A) and three recurrent mutations (c.4957du...",12,252,Mol_Vis_2016_Jun_16_22_646-657.txt
c.5093T>C,...sative in the four families. The missense variant c.5093T>C was determined to be a variant of unknow...,12,402,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6416G>A,...same allele with the reported pathogenic mutation c.6416G>A. The two novel variants were further con...,12,566,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"...n of its neighboring β-sheet induced by p.G3083D (c.9248G>A), which could alter the tertiary structu...",12,957,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"6: 64,430,679	c.9248G>A	p.G3083D	missense	Het	E43	DA (0.02)	DA (...",70,15,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6557G>A,"ARRP09	RPSP	6: 64,791,763	c.6557G>A	p.G2186E	missense	Het	E32	DA (0.03)	PD (...",72,27,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6557G>A,"ARRP09	RPSP	6: 64,791,763	c.6557G>A	p.G2186E	missense	Het	E32	DA (0.03)	PD (...",72,27,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6557G>A,"ARRP09	RPSP	6: 64,791,763	c.6557G>A	p.G2186E	missense	Het	E32	DA (0.03)	PD (...",72,27,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"...ARRP08-II:2 (Figure 1A,C–E). The missense variant c.9248G>A was novel, while c.5093T>C was determine...",78,143,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"...ARRP08-II:2 (Figure 1A,C–E). The missense variant c.9248G>A was novel, while c.5093T>C was determine...",78,143,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6416G>A,...same allele with the reported pathogenic mutation c.6416G>A. The missense variant c.9248G>A would in...,78,321,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6416G>A,"... properties (Figure 3D,E). The recurrent mutation c.6416G>A would lead to an amino acid change from ...",78,709,Mol_Vis_2016_Jun_16_22_646-657.txt
c.7228+1G>A,...ient ARRP07-II:1. The novel splice-site variation c.7228+1G>A was predicted to abolish the regular s...,80,251,Mol_Vis_2016_Jun_16_22_646-657.txt
c.7228+1G>A,...ient ARRP07-II:1. The novel splice-site variation c.7228+1G>A was predicted to abolish the regular s...,80,251,Mol_Vis_2016_Jun_16_22_646-657.txt
c.7228+1G>A,"...1653Kfs*2 or cause NMD. The two novel variations, c.7228+1G>A and c.9248G>A, were further confirmed ...",80,679,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"...se NMD. The two novel variations, c.7228+1G>A and c.9248G>A, were further confirmed absent in the 10...",80,695,Mol_Vis_2016_Jun_16_22_646-657.txt
c.5093T>C,"...on of its neighboring β-sheet, and a missense VUS c.5093T>C colocalized in the same allele with the ...",118,684,Mol_Vis_2016_Jun_16_22_646-657.txt
c.170C>G,c.170C>G (p.Ser57*)	-	-	Reported [59]	OU:5	108 FR	...,85,1,Mol_Vis_2016_May_16_22_491-502.txt
c.338G>A,Exon 3	c.338G>A (p.Gly113Asp)	Damaging 0	Probably damagin...,86,8,Mol_Vis_2016_May_16_22_491-502.txt
c.338G>A,Exon 3	c.338G>A (p.Gly113Asp)	Damaging 0	Probably damagin...,86,8,Mol_Vis_2016_May_16_22_491-502.txt
c.362G>A,c.362G>A (p.Arg121Gln)	Damagin,87,1,Mol_Vis_2016_May_16_22_491-502.txt
c.376T>C,c.376T>C (p.Cys126Arg)	Damaging 0	Probably damagin...,89,1,Mol_Vis_2016_May_16_22_491-502.txt
c.*522T>C,"...ngs. Further, two novel variations in the 3′ UTR, c.*522T>C and c.*974C>G, were observed in two pati...",92,675,Mol_Vis_2016_May_16_22_491-502.txt
c.*974C>G,"...two novel variations in the 3′ UTR, c.*522T>C and c.*974C>G, were observed in two patients with dise...",92,689,Mol_Vis_2016_May_16_22_491-502.txt
c.*974C>G,"...two novel variations in the 3′ UTR, c.*522T>C and c.*974C>G, were observed in two patients with dise...",92,689,Mol_Vis_2016_May_16_22_491-502.txt
c.*974C>G,"...two novel variations in the 3′ UTR, c.*522T>C and c.*974C>G, were observed in two patients with dise...",92,689,Mol_Vis_2016_May_16_22_491-502.txt
c.1194+2T>C,...s). A heterozygous essential splice-site mutation c.1194+2T>C was detected in both sisters and was i...,21,148,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+2T>C,...s). A heterozygous essential splice-site mutation c.1194+2T>C was detected in both sisters and was i...,21,148,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+2T>C,...s). A heterozygous essential splice-site mutation c.1194+2T>C was detected in both sisters and was i...,21,148,Nat_Commun_2014_Aug_7_5_4398.txt
c.3487A>T,"...DNA and identified a somatic truncating mutation, c.3487A>T; p.R1163X (Fig. 1b). While the phase of ...",25,329,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+2T>C,...lasmids containing wild-type CTR9 sequence or the c.1194+2T>C mutation using a QIAprep Spin MiniPrep...,71,479,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+2T>C,"... CTR9 minigene splicing constructs containing the c.1194+2T>C mutation identified in Fam3727, showin...",91,174,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+3A>C,...epeat domains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations result in an in-...,91,535,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+3A>C,...epeat domains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations result in an in-...,91,535,Nat_Commun_2014_Aug_7_5_4398.txt
c.304A>G,c.304A>G; p.Asn102Asp	 	Benign	Tolerated	No effect...,169,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.762T>C,c.762T>C(p.=)	rs116362368	 	 	No effect	1	 ,170,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.762T>C,c.762T>C(p.=)	rs116362368	 	 	No effect	1	 ,170,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.762T>C,c.762T>C(p.=)	rs116362368	 	 	No effect	1	 ,170,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.921G>A,c.921G>A(p.=)	rs368868162	 	 	No effect	1	 ,171,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.921G>A,c.921G>A(p.=)	rs368868162	 	 	No effect	1	 ,171,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.921G>A,c.921G>A(p.=)	rs368868162	 	 	No effect	1	 ,171,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.1233T>C,c.1233T>C(p.=)	rs143491141	 	 	No effect	1	 ,172,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.1494C>T,c.1494C>T(p.=)	rs7118399	 	 	No effect	Common	Comm...,175,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.1687-3C>T,c.1687-3C>T	rs76650154	 	 	No effect	5	 ,176,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.1800T>C,c.1800T>C(p.=)	rs199500868	 	 	No effect	1	 ,177,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.1800T>C,c.1800T>C(p.=)	rs199500868	 	 	No effect	1	 ,177,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.1873-4A>G,c.1873-4A>G	 	 	 	No effect	 	3,178,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.1873-4A>G,c.1873-4A>G	 	 	 	No effect	 	3,178,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.1873-4A>G,c.1873-4A>G	 	 	 	No effect	 	3,178,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2372+4A>C,c.2372+4A>C	rs199735513	 	 	No effect	1	 ,180,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2372+4A>C,c.2372+4A>C	rs199735513	 	 	No effect	1	 ,180,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2487C>T,c.2487C>T(p.=)	 	 	 	No effect	 	1,182,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2516G>A,c.2516G>A; p.Arg839Gln	 	Benign	Tolerated	No effec...,183,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2516G>A,c.2516G>A; p.Arg839Gln	 	Benign	Tolerated	No effec...,183,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2516G>A,c.2516G>A; p.Arg839Gln	 	Benign	Tolerated	No effec...,183,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2516G>A,c.2516G>A; p.Arg839Gln	 	Benign	Tolerated	No effec...,183,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2610G>A,c.2610G>A(p.=)	 	 	 	No effect	 	1,184,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2953C>T,c.2953C>T; p.Arg985Cys	 	Possibly damaging	Affect ...,187,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2953C>T,c.2953C>T; p.Arg985Cys	 	Possibly damaging	Affect ...,187,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2953C>T,c.2953C>T; p.Arg985Cys	 	Possibly damaging	Affect ...,187,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3149A>G,c.3149A>G; p.Lys1050Arg	rs141131642	Benign	Tolerat...,189,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3154T>C,c.3154T>C; p.Cys1052Arg	rs35696189	Benign	Tolerate...,190,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3154T>C,c.3154T>C; p.Cys1052Arg	rs35696189	Benign	Tolerate...,190,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3195G>A,c.3195G>A(p.=)	rs34200650	 	 	No effect	1	 ,191,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3292G>A,c.3292G>A; p.Gly1098Ser	rs376210239	Benign	Tolerat...,195,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3402G>A,c.3402G>A(p.=)	rs147016884	 	 	No effect	1	1,196,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3551T>C,"...by both individuals, a missense change in SCN11A, c.3551T>C, p.V1184A (chr3:38913144A>G, hg19), was ...",20,1188,Nat_Commun_2015_Dec_8_6_10049.txt
c.993+3A>G,"...terozygous for changes in in-tron 12 (c.993+1G>A, c.993+3A>G) that are predicted to affect splicing ...",20,210,Nat_Commun_2015_Jun_16_6_7092.txt
c.993+3A>G,"...terozygous for changes in in-tron 12 (c.993+1G>A, c.993+3A>G) that are predicted to affect splicing ...",20,210,Nat_Commun_2015_Jun_16_6_7092.txt
c.993+3A>G,"...terozygous for changes in in-tron 12 (c.993+1G>A, c.993+3A>G) that are predicted to affect splicing ...",20,210,Nat_Commun_2015_Jun_16_6_7092.txt
c.993+1G>A,...ed that DYNC2LI1 is markedly reduced in R01-013A (c.993+1G>A; p.Leu117Val) and R07-628A (p.Trp124Ter...,20,1336,Nat_Commun_2015_Jun_16_6_7092.txt
c.993+1G>A,R01-013A	0/1	c.993+1G>A	Intron 12	4.37			16.1		0.00008,148,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.993+1G>A,R01-013A	0/1	c.993+1G>A	Intron 12	4.37			16.1		0.00008,148,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.993+1G>A,R01-013A	0/1	c.993+1G>A	Intron 12	4.37			16.1		0.00008,148,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.993+1G>A,R01-013A	0/1	c.993+1G>A	Intron 12	4.37			16.1		0.00008,148,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.349C>G,R07-628A	0/1	c.349C>,151,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.349C>G,R07-628A	0/1	c.349C>,151,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.372G>A,0/1	c.372G>,153,5,Nat_Commun_2015_Jun_16_6_7092.txt
c.372G>A,0/1	c.372G>,153,5,Nat_Commun_2015_Jun_16_6_7092.txt
c.1000G>T,R03-303A	0/1	c.1000G>,155,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.1000G>T,R03-303A	0/1	c.1000G>,155,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.1000G>T,R03-303A	0/1	c.1000G>,155,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.993+3A>G,0/1	c.993+3A>G	Intron 12	4.37			10.8,157,5,Nat_Commun_2015_Jun_16_6_7092.txt
c.1861A>G,"...). As such, we have shown segregation of the CCNF c.1861A>G mutation in seven ALS patients from fami...",17,1663,Nat_Commun_2016_Apr_15_7_11253.txt
c.2758-2A>G,"...cient to cause JATD. However, a similar genotype (c.2758-2A>G/P209L or C552X/P209L) leads to early-o...",44,784,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
c.2758-2A>G,"...cient to cause JATD. However, a similar genotype (c.2758-2A>G/P209L or C552X/P209L) leads to early-o...",44,784,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
c.2322+3A>G,NPHP	F925-II1	N. European	c.2322+3A>G		0/440	0/356,157,27,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
c.2931G>A,"...plementary Table 1) revealed a nonsense mutation, c.2931G>A (p.Trp977X), also in IGSF1 (Fig. 1c). B-...",42,1215,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
c.2931G>A,c.2931G>A	p.Trp977X	UK	4 wks	+	+	10.52	1.1/1.0 [0....,184,2,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
c.3518G>A,c.3518G>A	p.Trp1173X	NL	14.1 yrs	+	+	16.69	19/17 [...,248,2,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
c.3518G>A,c.3518G>A	p.Trp1173X	NL	14.1 yrs	+	+	16.69	19/17 [...,248,2,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
c.3518G>A,c.3518G>A	p.Trp1173X	NL	14.1 yrs	+	+	16.69	19/17 [...,248,2,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
c.3518G>A,c.3518G>A	p.Trp1173X	NL	14.1 yrs	+	+	16.69	19/17 [...,248,2,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
c.2309G>A,c.2309G>A	p.Ser770Asn	IT	10.6 yrs	+	+	26.54	21.5/2...,257,2,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
c.272T>C,"...kistani families, we found a homozygous mutation (c.272T>C; p.Phe91Ser) of CIB2 (Figs. 1 and 2a; Sup...",24,425,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.272T>C,"...kistani families, we found a homozygous mutation (c.272T>C; p.Phe91Ser) of CIB2 (Figs. 1 and 2a; Sup...",24,425,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.272T>C,"...kistani families, we found a homozygous mutation (c.272T>C; p.Phe91Ser) of CIB2 (Figs. 1 and 2a; Sup...",24,425,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.297C>G,"...while in two DFNB48 families (DEM4025, DEM4225) a c.297C>G (p.Cys99Trp) CIB2 mutation co-segregated ...",24,545,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.272T>C,"...282) at D15SA975 (78.56 Mb). CIB2 mutant alleles [c.272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c...",118,599,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.272T>C,"...282) at D15SA975 (78.56 Mb). CIB2 mutant alleles [c.272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c...",118,599,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.3G>A,"...ed. RPS19 mutations in these two individuals were c.3G>A Met1Ile and c.185G>A Arg62Gln, respectively...",33,1090,Nat_Med_2014_Jul_22_20(7)_748-753.txt
c.3G>A,"...ed. RPS19 mutations in these two individuals were c.3G>A Met1Ile and c.185G>A Arg62Gln, respectively...",33,1090,Nat_Med_2014_Jul_22_20(7)_748-753.txt
c.3G>A,"...ed. RPS19 mutations in these two individuals were c.3G>A Met1Ile and c.185G>A Arg62Gln, respectively...",33,1090,Nat_Med_2014_Jul_22_20(7)_748-753.txt
c.185G>A,"... in these two individuals were c.3G>A Met1Ile and c.185G>A Arg62Gln, respectively",33,1109,Nat_Med_2014_Jul_22_20(7)_748-753.txt
c.185G>A,"... in these two individuals were c.3G>A Met1Ile and c.185G>A Arg62Gln, respectively",33,1109,Nat_Med_2014_Jul_22_20(7)_748-753.txt
c.5615T>C,"...sense mutations - p.R1020K,c.3059G>A and p.L1872P,c.5615T>C. Both cases (PD2126, PD2127) have a PBRM...",29,230,Nature_2011_Jan_27_469(7331)_539-542.txt
c.1448T>C,...atic patients with the L444P/L444P GBA1 genotype (c.1448T>C) who were on ERT were included in this s...,342,119,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
c.1448T>C,...atic patients with the L444P/L444P GBA1 genotype (c.1448T>C) who were on ERT were included in this s...,342,119,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
c.1226A>G,"...BA gene (c.84dupG (84GG), c.115+1G>A (IVS2+1G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>...",342,627,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
c.902C>G,"...ft, and the mutations, c.464G>A (p.Arg155His) and c.902C>G (p.Ser301Cys), affect highly conserved si...",1220,445,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.902C>G,"...ft, and the mutations, c.464G>A (p.Arg155His) and c.902C>G (p.Ser301Cys), affect highly conserved si...",1220,445,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.902C>G,"...ft, and the mutations, c.464G>A (p.Arg155His) and c.902C>G (p.Ser301Cys), affect highly conserved si...",1220,445,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.79G>C,...This can be attributed to the allele carrying the c.79G>C mutation because the c.859C>T mutation has...,1230,139,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.79G>C,...This can be attributed to the allele carrying the c.79G>C mutation because the c.859C>T mutation has...,1230,139,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.79G>C,...This can be attributed to the allele carrying the c.79G>C mutation because the c.859C>T mutation has...,1230,139,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.859C>T,... allele carrying the c.79G>C mutation because the c.859C>T mutation has been shown to yield no prote...,1230,168,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.859C>T,... allele carrying the c.79G>C mutation because the c.859C>T mutation has been shown to yield no prote...,1230,168,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.1205G>A,"...is of TUBA1A gene revealed a missense mutation of c.1205G>A, which was negative in both parents indi...",8,530,Neurol_Sci_2014_Feb_8_35(5)_801-803.txt
c.1205G>A,"...is of TUBA1A gene revealed a missense mutation of c.1205G>A, which was negative in both parents indi...",8,530,Neurol_Sci_2014_Feb_8_35(5)_801-803.txt
c.2082G>A,"...4Val, c.2080A>G, rs61752717), M694I (p.Met694Ile, c.2082G>A, rs28940578), M680I (p.Met680Ile, c.2040...",22,620,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.2082G>A,"...4Val, c.2080A>G, rs61752717), M694I (p.Met694Ile, c.2082G>A, rs28940578), M680I (p.Met680Ile, c.2040...",22,620,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.2040G>C,"...4Ile, c.2082G>A, rs28940578), M680I (p.Met680Ile, c.2040G>C, rs28940580), V726A (p.Val726Ala, c.2177...",22,664,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.2177T>C,"...0Ile, c.2040G>C, rs28940580), V726A (p.Val726Ala, c.2177T>C, rs28940579), R761H (p.Arg761His, c.2282...",22,708,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.2177T>C,"...0Ile, c.2040G>C, rs28940580), V726A (p.Val726Ala, c.2177T>C, rs28940579), R761H (p.Arg761His, c.2282...",22,708,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.2282G>A,"...6Ala, c.2177T>C, rs28940579), R761H (p.Arg761His, c.2282G>A, rs104895097), and K695R (p.Lys695Arg, c...",22,752,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.1105C>T,"...A>G, rs104895094) in exon 10; P369S (p.Pro369Ser, c.1105C>T, rs11466023) in exon 3; and E148Q (p.Glu...",22,857,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.1105C>T,"...A>G, rs104895094) in exon 10; P369S (p.Pro369Ser, c.1105C>T, rs11466023) in exon 3; and E148Q (p.Glu...",22,857,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.442G>C,"...T, rs11466023) in exon 3; and E148Q (p.Glu148Gln, c.442G>C, rs3743930) in exon 2 of the MEFV gene. T...",22,915,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.442G>C,"...T, rs11466023) in exon 3; and E148Q (p.Glu148Gln, c.442G>C, rs3743930) in exon 2 of the MEFV gene. T...",22,915,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.6792C>G,...  Baralle FE   The pathological splicing mutation c.6792C>G in NF1 exon 37 causes a change of tenanc...,123,83,Nucleic_Acids_Res_2013_Nov_21_41(21)_9858-9869.txt
c.80A>G,"...00, Chango and coworkers [18] identified a common c.80A>G polymorphism in the gene coding for RFC-1 ...",14,56,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
c.80A>G,...shows allele and genotype distributions for RFC-1 c.80A>G in the selected studies. Deviations from H...,22,216,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
c.385G>C,"... missense mutation in exon 7 was identified (EYA4:c.385G>C, p.Gly129Arg), which is shown along with ...",93,234,Oncogene_2014_Sep_4_33(36)_4464-4473.txt
c.385G>C,"... missense mutation in exon 7 was identified (EYA4:c.385G>C, p.Gly129Arg), which is shown along with ...",93,234,Oncogene_2014_Sep_4_33(36)_4464-4473.txt
c.385G>C,"... missense mutation in exon 7 was identified (EYA4:c.385G>C, p.Gly129Arg), which is shown along with ...",93,234,Oncogene_2014_Sep_4_33(36)_4464-4473.txt
c.34G>A,...A (p.G12S)	Reg Ascending LN & metachr Liver: KRAS c.34G>A (p.G12S)	None,36,98,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>A,"L (desc)	2,5 cm	T3	Not tested	KRAS c.35G>A (p.G12D)",37,36,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>A,"2	74	M	NS	5,8 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Paraaortic LN & metachr Brain & m...",38,34,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>A,"2	74	M	NS	5,8 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Paraaortic LN & metachr Brain & m...",38,34,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>T,"4	83	M	R (cecum)	10,0 cm	T3	MLH-1/PMS2	KRAS c.35G>T (p.G12V)	Reg LN WT	Multiple CBC, RCC",42,45,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>T,"4	83	M	R (cecum)	10,0 cm	T3	MLH-1/PMS2	KRAS c.35G>T (p.G12V)	Reg LN WT	Multiple CBC, RCC",42,45,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>A,"...les, 77%). Three mutations were noted: 3 cases of c.35G>A in KRAS codon 12 (p.G12D), 3 cases of c.35...",57,286,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>T,"... of c.35G>A in KRAS codon 12 (p.G12D), 3 cases of c.35G>T (p.G12V) in KRAS codon 12, and 1 case of c...",57,332,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.34G>A,"... c.35G>T (p.G12V) in KRAS codon 12, and 1 case of c.34G>A (p.G12S). A KRAS mutation in codon 13 (c.3...",57,381,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.38G>A,"...of c.34G>A (p.G12S). A KRAS mutation in codon 13 (c.38G>A [p.G13D]) was observed in 1 patient, and a...",57,428,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.34G>A,"... a mutation in KRAS codon 12 c.35G>A (p.G12D) and c.34G>A (p.G12S), respectively. Of the 2 cases tha...",59,442,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.2211A>G,"...ired bladder cancer tissues. We found three SNPs (c.2211A>G (5/31), c.3522A>T (14/31), c.4335A>G (4/...",86,488,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
c.4335A>G,"... three SNPs (c.2211A>G (5/31), c.3522A>T (14/31), c.4335A>G (4/31)) (Figure 4, Supplement table 2), ...",86,525,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
c.2211A>G,"...r sequence analysis showed genetic alterations A. c.2211A>G, B. c.3522A>T and C. c.4335A>G respectiv...",89,56,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
c.2211A>G,"...r sequence analysis showed genetic alterations A. c.2211A>G, B. c.3522A>T and C. c.4335A>G respectiv...",89,56,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
c.2211A>G,"...r sequence analysis showed genetic alterations A. c.2211A>G, B. c.3522A>T and C. c.4335A>G respectiv...",89,56,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
c.3522A>T,"...lysis showed genetic alterations A. c.2211A>G, B. c.3522A>T and C. c.4335A>G respectively",89,70,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
c.4335A>G,"...tic alterations A. c.2211A>G, B. c.3522A>T and C. c.4335A>G respectively",89,87,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
c.4335A>G,"...tic alterations A. c.2211A>G, B. c.3522A>T and C. c.4335A>G respectively",89,87,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
c.501A>G,"...eviously reported synonymous mutation, Ala167Ala (c.501A>G, rs71653621), in exon 7. No Ala167Ala car...",3,1940,Open_Neurol_J_2011_Mar_22_5_8-11.txt
c.501A>G,"...we identified the synonymous mutation, Ala167Ala (c.501A>G, rs71653621), in exon 7 of DJ-1 in two PD...",27,67,Open_Neurol_J_2011_Mar_22_5_8-11.txt
c.501A>G,"...encing of exon 7 in DJ-1 including the Ala167Ala (c.501A>G, rs71653621) mutation using a reverse seq...",40,97,Open_Neurol_J_2011_Mar_22_5_8-11.txt
c.501A>G,"...encing of exon 7 in DJ-1 including the Ala167Ala (c.501A>G, rs71653621) mutation using a reverse seq...",40,97,Open_Neurol_J_2011_Mar_22_5_8-11.txt
c.1361A>G,c.1361A>G (p.H454R)	c.571>A (p.E191K,166,1,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.648+1G>A,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,1,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.648+1G>A,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,1,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.648+1G>A,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,1,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.1250A>G,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,12,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.550C>T,"...orresponding to a severe mutation (c.1361 A>G and c.550C>T, respectively), the other being a mild mu...",182,189,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.571G>A,"...3 carry two heterozygous mutations, one moderate (c.571G>A or c.526G>A), the other one severe (c.136...",209,74,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.571G>A,"...3 carry two heterozygous mutations, one moderate (c.571G>A or c.526G>A), the other one severe (c.136...",209,74,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.571G>A,"...3 carry two heterozygous mutations, one moderate (c.571G>A or c.526G>A), the other one severe (c.136...",209,74,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.526G>A,"...heterozygous mutations, one moderate (c.571G>A or c.526G>A), the other one severe (c.1361A>G, c.550C...",209,86,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.526G>A,"...heterozygous mutations, one moderate (c.571G>A or c.526G>A), the other one severe (c.1361A>G, c.550C...",209,86,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.1361A>G,"...ate (c.571G>A or c.526G>A), the other one severe (c.1361A>G, c.550C>T or c.648+1G>A) [18]. This is a...",209,119,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.1250A>G,...ere found heterozygotes for the missense mutation c.1250A>G and c.212G>A. These mutations have a dom...,209,419,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.1250A>G,...ere found heterozygotes for the missense mutation c.1250A>G and c.212G>A. These mutations have a dom...,209,419,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.212G>A,...rozygotes for the missense mutation c.1250A>G and c.212G>A. These mutations have a dominant negative...,209,433,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.212G>A,...rozygotes for the missense mutation c.1250A>G and c.212G>A. These mutations have a dominant negative...,209,433,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.622-2A>T,...e found a novel heterozygous splice site mutation c.622-2A>T (g.30100162 T>A) in two patients (Figur...,75,199,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
c.622-2A>T,...e found a novel heterozygous splice site mutation c.622-2A>T (g.30100162 T>A) in two patients (Figur...,75,199,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
c.622-2A>T,The mutation (c.622-2A>T) is situated in the canonical sequence ...,79,15,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
c.622-2A>T,...of exon 5 or the use of cryptic splice sites. The c.622-2A>T mutation resides within the highly cons...,79,551,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
c.622-2A>T,c.622-2A>T	 	 	AT: 2 (1.8%)	AT: 0 (0%),99,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
c.914-6C>T,c.914-6C>T	 	 	CT: 3 (2.7%)	CT: 6 (3%),105,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
c.3182T>C,...PC1 gene. The two affected siblings presented the c.3182T>C (P.I1061T)/c.3182T>C (p.I1061T) genotype...,44,335,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.3182T>C,...PC1 gene. The two affected siblings presented the c.3182T>C (P.I1061T)/c.3182T>C (p.I1061T) genotype...,44,335,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.3182T>C,"...ected siblings presented the c.3182T>C (P.I1061T)/c.3182T>C (p.I1061T) genotype, while the third unr...",44,356,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.3182T>C,"...ected siblings presented the c.3182T>C (P.I1061T)/c.3182T>C (p.I1061T) genotype, while the third unr...",44,356,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.2795+1G>C,...ile the third unrelated NPC patient presented the c.2795+1G>C/c.3493G>A (p.V1165M) genotype. This st...,44,439,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.2795+1G>C,...ile the third unrelated NPC patient presented the c.2795+1G>C/c.3493G>A (p.V1165M) genotype. This st...,44,439,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.3493G>A,...d unrelated NPC patient presented the c.2795+1G>C/c.3493G>A (p.V1165M) genotype. This study was appr...,44,451,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.575G>A,"... novel mutations (c.468_469delTC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A and c.752-2A>G)...",12,930,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.752-2A>G,"..._800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A and c.752-2A>G) were identified",12,969,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.575G>A,"...T1 fibres	Low	19% of LLR	Pu, Me, Ico	c.240+1G >T, c.575G>A",48,137,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.751+5G>A,"...rmal	Low	37% of LLR	Mb, pons	c.312_320del10insAT, c.751+5G>A",49,138,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.516-2A>G,"...t COX, increased lipid	Low	UD	Dt, Cd, Mb, Me	Homo c.516-2A>G",51,133,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.516-2A>G,"...t COX, increased lipid	Low	UD	Dt, Cd, Mb, Me	Homo c.516-2A>G",51,133,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.516-2A>G,"...t COX, increased lipid	Low	UD	Dt, Cd, Mb, Me	Homo c.516-2A>G",51,133,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.516-2A>G,"...axia, RF	10	6y 6 m	NA	NA	NA	CT brain: normal	Homo c.516-2A>G",56,127,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.516-2A>G,"...axia, RF	10	6y 6 m	NA	NA	NA	CT brain: normal	Homo c.516-2A>G",56,127,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.516-2A>G,"...PW, ataxia, RF	4	24 m	T1FP	Low	50% of LLR	NA	Homo c.516-2A>G",59,92,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.516-2A>G,"...PW, ataxia, RF	4	24 m	T1FP	Low	50% of LLR	NA	Homo c.516-2A>G",59,92,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.324-11T>G,"... Cc, cystic changes in Dt, BG and central WM	Homo c.324-11T>G",66,166,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.833+1G>A,...ities in cerebral hemispheres and cerebellum	Homo c.833+1G>A,68,200,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.833+1G>A,...ities in cerebral hemispheres and cerebellum	Homo c.833+1G>A,68,200,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.240+1G>T,"...eep grey matter involvement of cerebellum, Mb, Pu	c.240+1G>T, c.574C>T",73,204,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.324-11T>G,"... pons, Scp, Dt, Me, WM tracts of spinal cord	Homo c.324-11T>G",75,209,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.240+1G>T,"...WM in cerebellar hemispheres	c.312_320del10insAT, c.240+1G>T",78,199,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.240+1G>T,"...ects (n = 5, 3 pedigrees) and the splice mutation c.240+1G>T which was observed in 5 individuals, al...",160,661,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.240+1G>T,"...ects (n = 5, 3 pedigrees) and the splice mutation c.240+1G>T which was observed in 5 individuals, al...",160,661,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.516-2A>G,...00delCT mutation or the c.324-11T>G mutation. The c.516-2A>G mutation segregated in two different In...,160,943,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.324-11T>G,...ecified mixed Caucasian Asian parenthood [7]. The c.324-11T>G genotype was observed in 4 individuals...,160,1128,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.751+5G>A,"...469delTC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G)",163,170,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.752-2A>G,"...800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G)",163,186,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.751+5G>A,"...was a compound heterozygote (c.312_321del10insAT, c.751+5G>A). She had an atypical milder clinical c...",167,441,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.751+5G>A,"...was a compound heterozygote (c.312_321del10insAT, c.751+5G>A). She had an atypical milder clinical c...",167,441,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.751+5G>A,"...was a compound heterozygote (c.312_321del10insAT, c.751+5G>A). She had an atypical milder clinical c...",167,441,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.575G>A,"... at 19 years of age. The novel missense mutation (c.575G>A, p.Arg192Gln) was found in a 12 year old ...",167,838,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.752-2A>G,...cle and play the violin. The splice site mutation c.752-2A>G was found in a patient (case 37) of Aus...,167,1238,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.752-2A>G,...cle and play the violin. The splice site mutation c.752-2A>G was found in a patient (case 37) of Aus...,167,1238,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.752-2A>G,...cle and play the violin. The splice site mutation c.752-2A>G was found in a patient (case 37) of Aus...,167,1238,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.985A>G,"... such as seizures, coma or even sudden death. The c.985A>G missense mutation on the ACADM gene (gene...",22,216,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,"... such as seizures, coma or even sudden death. The c.985A>G missense mutation on the ACADM gene (gene...",22,216,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,"2	c.985A>G	c.199T>C	0.67	2.7	DC, HG	44	29	58	-	-	-	-...",57,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,"2	c.985A>G	c.199T>C	0.67	2.7	DC, HG	44	29	58	-	-	-	-...",57,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,"2	c.985A>G	c.199T>C	0.67	2.7	DC, HG	44	29	58	-	-	-	-...",57,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.199T>C,4	c.985A>G	c.199T>C	0.74	2.8	Trace HG	36	34	44	10	18	4.5	1.1	...,59,12,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.734C>T,"6	c.985A>G	c.734C>T	1.41	3.0	Trace DC, 5-OH-C, HG, SG	41	17	1...",61,12,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.734C>T,"6	c.985A>G	c.734C>T	1.41	3.0	Trace DC, 5-OH-C, HG, SG	41	17	1...",61,12,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.928G>A,"7	c.985A>G	c.928G>A	2.28	3.2	5-OH-H, trace HG	48	23	0	16	15	3...",62,12,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,8	c.985A>G	Not found	0.70	1.3	Normal	28	-	-	25	18.5	...,63,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,9	c.985A>G	Not found	0.50	0.8	Normal	15	11	86	27	16....,64,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,9	c.985A>G	Not found	0.50	0.8	Normal	15	11	86	27	16....,64,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,9	c.985A>G	Not found	0.50	0.8	Normal	15	11	86	27	16....,64,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,"... 3 was the younger sister of case 2, carrying the c.985A>G/c.199T>C ACADM genotype. Case 5 was ident...",70,141,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.199T>C,"...e younger sister of case 2, carrying the c.985A>G/c.199T>C ACADM genotype. Case 5 was identified dur...",70,150,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,"... pathways [22]. In combination with the classical c.985A>G ACADM mutation, theoretical candidate gen...",108,1199,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.571G>A,...o sisters with the biallelic mutation NM_014762.3:c.571G>A in DHCR24. The recurrence of this mutatio...,31,64,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
c.613G>A,"1	CHILD syndrome	NSDHL: c.613G>A, p.G205S (heterozygous)	Yes",34,25,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
c.613G>A,"1	CHILD syndrome	NSDHL: c.613G>A, p.G205S (heterozygous)	Yes",34,25,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
c.262C>T,"3	CHILD syndrome	NSDHL: c.262C>T, p.R88X (heterozygous)	Yes",40,25,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
c.1516C>G,...alized to the chromosome 12 candidate region: The c.1516C>G (p.Arg506Gly) variant in SLC11A2 has bee...,115,232,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
c.1516C>G,...alized to the chromosome 12 candidate region: The c.1516C>G (p.Arg506Gly) variant in SLC11A2 has bee...,115,232,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
c.53G>A,"...C11A2 mutations cause ADNSHL. A missense variant, c.53G>A (p.Arg18His), was identified in CELA1 (chy...",115,600,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
c.1202G>C,...he candidate region on chromosome 20: The variant c.1202G>C (p.Arg401Pro) in GTPBP5 affects an evolu...,117,120,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
c.287C>G,"A nonsense mutation, c.287C>G (p.Ser96*), was found in both patients in...",119,22,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
c.464G>A,"3		22,1			c.464G>A heterozygous de nov",37,11,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.961G>T,"4		31,8	2	0	c.961G>T heterozygous	p.Glu321",40,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.1065+1G>T,"6		25,4	3	1	c.1065+1G>T heterozygous	IVS7+1G>T ds	Splice site ...",43,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.1065+1G>T,"6		25,4	3	1	c.1065+1G>T heterozygous	IVS7+1G>T ds	Splice site ...",43,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.1065+1G>T,"6		25,4	3	1	c.1065+1G>T heterozygous	IVS7+1G>T ds	Splice site ...",43,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.1087C>T,"7		17,1	4	1	c.1087C>T heterozygous	p.Gln363",44,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.3742C>T,"17		16,6	2	1	c.3742C>T heterozygous	p.Gln1248",62,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.3742C>T,"17		16,6	2	1	c.3742C>T heterozygous	p.Gln1248",62,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.5686G>A,"30,7	1	0	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splic...",76,11,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.5686G>A,"28,9	3	1	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splic...",78,11,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.5686G>A,"28,9	3	1	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splic...",78,11,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.6321C>A,"25		47,0	2	1	c.6321C>A heterozygous	p.Cys2107",81,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.6321C>A,"25		47,0	2	1	c.6321C>A heterozygous	p.Cys2107",81,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.6908-2A>G,"27		24,9	1	2	c.6908-2A>G heterozygous	IVS42-2A>G	Splice site mu...",85,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.7255C>T,"34		1,0	4	2	c.7255C>T heterozygous	p.Arg2419",97,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.7714G>A,"36		7,9	4	1	c.7714G>A heterozygous; unclassified variant	p.Val...",101,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.7714G>A,"36		7,9	4	1	c.7714G>A heterozygous; unclassified variant	p.Val...",101,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.289C>T,...or one of these two missense variants p.Pro97Ser (c.289C>T) the absence in both parental samples fur...,149,283,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.5686G>A,... potentially truncating FLNA splice site mutation c.5686G>A in mosaic state estimated to affect 40 t...,156,141,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.986G>A,(NM_001605.2)	3	c.986G>A	p.Arg329His,141,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.986G>A,(NM_001605.2)	3	c.986G>A	p.Arg329His,141,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.2981C>T,(NM_000052.6)	1	c.2981C>T	p.Thr994Ile,144,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.2981C>T,(NM_000052.6)	1	c.2981C>T	p.Thr994Ile,144,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.715C>T,(NM_018972.2)	1	c.715C>T	p.Leu239Phe,171,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.715C>T,(NM_018972.2)	1	c.715C>T	p.Leu239Phe,171,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.21G>T,(NM_006308.2)	1	c.21G>T	p.Arg7Ser,195,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.21G>T,(NM_006308.2)	1	c.21G>T	p.Arg7Ser,195,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.334G>A,(NM_001136472.1)	1	c.334G>A	p.Gly112Ser,207,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.701T>A,(NM_014874.3)	1	c.701T>A	p.Met234Lys,219,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.839G>A,(NM_014874.3)	1	c.839G>A	p.Arg280His,222,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.880C>T,(NM_014874.3)	1	c.880C>T	p.Arg294*,225,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.1081C>T,(NM_014874.3)	1	c.1081C>T	p.His361Tyr,228,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.1574A>G,(NM_014874.3)	1	c.1574A>G	p.Asn525Ser,234,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.124T>C,(NM_153322.1)	1	c.124T>C	p.Cys42Arg,246,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.124T>C,(NM_153322.1)	1	c.124T>C	p.Cys42Arg,246,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.2812C>T,(NM_024577.3)	1	c.[2860C>T];[c.2812C>T]	p.[Arg954*];[His938Tyr],267,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.2812C>T,(NM_024577.3)	1	c.[2860C>T];[c.2812C>T]	p.[Arg954*];[His938Tyr],267,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.2812C>T,(NM_024577.3)	1	c.[2860C>T];[c.2812C>T]	p.[Arg954*];[His938Tyr],267,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.1144G>C,(NM_004863.3)	1	c.1144G>C	p.Gly382Arg,270,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.557G>A,(NM_021625.4)	1	c.557G>A	p.Arg186Gln,273,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.557G>A,(NM_021625.4)	1	c.557G>A	p.Arg186Gln,273,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.1540G>A,(NM_001003800.1)	c.1540G>A	p.Gly514Ser	SIFT:,326,19,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.1540G>A,(NM_001003800.1)	c.1540G>A	p.Gly514Ser	SIFT:,326,19,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.487G>A,(NM_004082.4)	c.487G>A	p.Ala163Thr	SIFT:,332,16,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.890G>T,(NM_001005360)	c.890G>T	p.Arg297Leu	SIFT:,338,17,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.796C>T,(NM_001005360)	c.796C>T	p.Arg266Trp	SIFT:,344,17,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.3190A>G,(NM_002224.3)	c.3190A>G	p.Met1064Val	SIFT:,356,16,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.218A>G,(NM_001142386.2)	c.218A>G	p.Asn73Ser	SIFT:,366,19,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.5825T>C,(NM_015046.5)	c.5825T>C	p.Ile1942Thr	SIFT:,371,16,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.446T>G,"... case of an exon4 heterozygous nucleotide change, c.446T>G, leading to the missense amino acid subst...",15,254,Pediatr_Rheumatol_Online_J_2015_Sep_28_13(Suppl_1)_P57.txt
c.1459C>T,"...C_2752377_10), c.1375A>G (assay ID C_2741754_10), c.1459C>T (assay ID C_30634242_40), g.3003T>C (ass...",41,241,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
c.1459C>T,"...C_2752377_10), c.1375A>G (assay ID C_2741754_10), c.1459C>T (assay ID C_30634242_40), g.3003T>C (ass...",41,241,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
c.785A>G,...assay ID C_22275631_10). The genotyping of CYP2B6 c.785A>G was performed by custom TaqMan assays (Ap...,41,378,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
c.785A>G,...assay ID C_22275631_10). The genotyping of CYP2B6 c.785A>G was performed by custom TaqMan assays (Ap...,41,378,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
c.785A>G,"... of primers and probes were the following: CYP2B6 c.785A>G, TGGAGAAGCACCGTGAAACC (forward), TGGAGCAG...",41,510,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
c.388T>C,"... the single‐nucleotide polymorphisms, NM_000041.2:c.388T>C (p.Cys130Arg; rs429358) and c.526C>T (p.A...",170,737,Physiol_Rep_2016_Apr_25_4(8)_e12733.txt
c.58+181G>A,"...allele of Zeb1 (Zeb1Tw). A knockin mouse model of c.58+181G>A recapitulated the Tw phenotype, wherea...",5,1445,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
c.58+181G>A,...os. (B) c.58+181G is evolutionarily conserved and c.58+181G>A disrupts a consensus binding sequence ...,61,377,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
c.58+181G>A,"To confirm the pathogenic effect of c.58+181G>A, we generated two knockin mouse lines:...",82,37,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
c.2278C>T,...the WT (c.2278C) (P1 and P3C) versus the mutated (c.2278C>T) (P2 and P3C) alleles. The WT PCR produc...,162,921,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...the WT (c.2278C) (P1 and P3C) versus the mutated (c.2278C>T) (P2 and P3C) alleles. The WT PCR produc...,162,921,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...cay (NMD). Cycleave-qPCR confirmed that the ATRIP c.2278C>T mutant allele was expressed exclusively ...,162,1999,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...ent probes were used to distinguish the WT versus c.2278C>T allele (probe1 and probe2, respectively)...",162,2237,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...tive amplification of the WT and mutant products (c.2278C>T mutant as well as the mis-spliced produc...,164,136,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...P6C would be equally derived from the c.2278C and c.2278C>T alleles, which have, therefore, been dep...",166,1093,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...ther columns in Figure 2D). Similarly, the mutant c.2278C>T allele is likely to be expressed at an e...",166,1255,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"... left hand panel in Figure 2D). Assuming that the c.2278C>T allele is fully inactivated (see below),...",166,1623,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...l (probe 1) allele. We confirmed detection of the c.2278C>T allele exclusively in the patient and mo...,168,555,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...n the mother, the wild type (c.2278C) and mutant (c.2278C>T) signals were detected at equal levels r...",168,714,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,It is likely that ATRIP c.2278C>T causes an impacting mutational change si...,173,25,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,It is likely that ATRIP c.2278C>T causes an impacting mutational change si...,173,25,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,It is likely that ATRIP c.2278C>T causes an impacting mutational change si...,173,25,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...ble to rescue ATR–SS cells. Finally expression of c.2278C>T ATRIP cDNA in WT cells did not affect G2...,173,1521,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...pt levels of the ATRIP–c.2278C (normal) and ATRIP–c.2278C>T (p.Arg760*) alleles in LBLs from patient...,234,59,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...pt levels of the ATRIP–c.2278C (normal) and ATRIP–c.2278C>T (p.Arg760*) alleles in LBLs from patient...,234,59,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...pt levels of the ATRIP–c.2278C (normal) and ATRIP–c.2278C>T (p.Arg760*) alleles in LBLs from patient...,234,59,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...robes that specifically recognize the c.2278C and c.2278C>T alleles were used for the assay. qPCR re...,234,482,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...robes that specifically recognize the c.2278C and c.2278C>T alleles were used for the assay. qPCR re...,234,482,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...robes that specifically recognize the c.2278C and c.2278C>T alleles were used for the assay. qPCR re...,234,482,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.3477G>T,...observed in ATR in patients 27-4BI and 19-8BI. A) c.3477G>T mutational change in patients 27-4BI and...,275,81,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.3477G>T,...observed in ATR in patients 27-4BI and 19-8BI. A) c.3477G>T mutational change in patients 27-4BI and...,275,81,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.341G>A,...n (exon 3) of the RET protein (RETR114H mutation; c.341G>A according to NP_066124.1 and NM_020975.4 ...,21,294,PLoS_One_2010_Jun_2_5(6)_e10918.txt
c.341G>A,...M represents the allele change from the wild type c.341G>A for RETR114H; T represents the high risk ...,57,472,PLoS_One_2010_Jun_2_5(6)_e10918.txt
c.52-47A>G,"...like males. However, two novel intronic variants, c.52-47A>G and c.105-179G>T, were identified in FM...",66,148,PLoS_One_2010_Mar_5_5(3)_e9476.txt
c.105-179G>T,Intron 2	c.105-179G>T	0.01	1.06	1/51,71,10,PLoS_One_2010_Mar_5_5(3)_e9476.txt
c.3005+25C>T,"...p.H463H(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1...",111,191,PLoS_One_2010_Nov_23_5(11)_e14096.txt
c.2832A>G,"... more relaxed threshold of P = 0.05. The SNP CAST:c.2832A>G, which is not part of the Bovine SNP50 a...",30,843,PLoS_One_2011_Dec_28_6(12)_e29601.txt
c.3293A>G,...a homozygous A-to-G nucleotide change in exon 22 (c.3293A>G) (Figure 1A). The mutation caused a glut...,21,153,PLoS_One_2011_Jun_9_6(6)_e20854.txt
c.5210+5G>C,5	Atypical	c.5210+5G>C		Splice site	Exon 23 skipping	Deterior...,64,12,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.5405-7G>A,...l three prediction programs. The other variation (c.5405-7G>A) resulted in appearance of a new crypt...,70,488,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.5405-7G>A,...l three prediction programs. The other variation (c.5405-7G>A) resulted in appearance of a new crypt...,70,488,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.5210+5G>C,...d supported the prediction results. The variation c.5210+5G>C caused exon skipping as a result of sp...,72,172,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.5210+5G>C,...d supported the prediction results. The variation c.5210+5G>C caused exon skipping as a result of sp...,72,172,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.5405-7G>A,...s a result of splice donor site deterioration and c.5405-7G>A introduced a 5-bp intronic sequence by...,72,256,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.5210+5G>C,"...ping analysis of the novel splice site variation, c.5210+5G>C. For the c.5210+5G>C variation, exons ...",170,71,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.5405-7G>A,"... Exon-trapping analysis of splice site variation, c.5405-7G>A. For the c.5405-7G>A variation, exon 2...",176,61,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.5405-7G>A,"...is of splice site variation, c.5405-7G>A. For the c.5405-7G>A variation, exon 26 of CHD7 was introdu...",176,82,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.786G>C,"...mous BACE1 polymorphism at codon 262 (NM_012104.3:c.786G>C, rs638405) with sporadic CJD (sCJD)",18,391,PLoS_One_2012_Aug_30_7(8)_e43926.txt
c.755C>G,... undertaken for two different mutations of FGFR2 (c.755C>G encoding p.Ser252Trp and c.758C>G encodin...,26,398,PLoS_One_2012_Aug_6_7(8)_e42382.txt
c.758C>G,"...tions of FGFR2 (c.755C>G encoding p.Ser252Trp and c.758C>G encoding p.Pro253Arg, both causing Apert ...",26,432,PLoS_One_2012_Aug_6_7(8)_e42382.txt
c.188-31G>A,The potential effect on mRNA splicing of the c.188-31G>A mutation was analyzed using the splice...,71,46,PLoS_One_2012_Jan_3_7(1)_e29205.txt
c.1468C>T,"... unaffected sisters did not carry the mutation. A c.1468C>T transition, resulting in R490X in exon 3...",37,247,PLoS_One_2012_Mar_20_7(3)_e33667.txt
c.1068G>A,"...y proband from family #237, it was accompanied by c.1068G>A, resulting in W356X in exon 3. In two af...",37,428,PLoS_One_2012_Mar_20_7(3)_e33667.txt
c.504C>T,"...on of PCD cases among the Slavic people. Although c.504C>T (Q154X), reported earlier in four Pakista...",155,151,PLoS_One_2012_Mar_20_7(3)_e33667.txt
c.1468C>T,... backgrounds. Since the mutation results from the c.1468C>T transition at a fast-mutating CpG dinucl...,157,729,PLoS_One_2012_Mar_20_7(3)_e33667.txt
c.1468C>T,... backgrounds. Since the mutation results from the c.1468C>T transition at a fast-mutating CpG dinucl...,157,729,PLoS_One_2012_Mar_20_7(3)_e33667.txt
c.-21+639G>A,"rs5742938, c.-21+639G>A	AA vs GG/GA	2.29(0.67−7.79)	0.182",67,12,PLoS_One_2012_May_18_7(5)_e36962.txt
c.699+3331G>A,"rs13404927, c.699+3331G>A	AA vs GG/GA	0.56(0.23−1.38)	0.210	0....",71,13,PLoS_One_2012_May_18_7(5)_e36962.txt
c.699+3331G>A,"rs13404927, c.699+3331G>A	AA vs GG/GA	0.56(0.23−1.38)	0.210	0....",71,13,PLoS_One_2012_May_18_7(5)_e36962.txt
c.699+3331G>A,"rs13404927, c.699+3331G>A	AA vs GG/GA	0.56(0.23−1.38)	0.210	0....",71,13,PLoS_One_2012_May_18_7(5)_e36962.txt
c.-21+639G>A,...ncreased the risk for cancer. The intronic change c.-21+639G>A (rs5742938) has not been identified i...,182,346,PLoS_One_2012_May_18_7(5)_e36962.txt
c.2635-765G>A,"...ted (rs17217772, Asn127Ser, c.380A>G; rs10188090, c.2635-765G>A; and rs3771280, c.1510+118T>C), thre...",204,910,PLoS_One_2012_May_18_7(5)_e36962.txt
c.2635-765G>A,"...ted (rs17217772, Asn127Ser, c.380A>G; rs10188090, c.2635-765G>A; and rs3771280, c.1510+118T>C), thre...",204,910,PLoS_One_2012_May_18_7(5)_e36962.txt
c.1510+118T>C,"...380A>G; rs10188090, c.2635-765G>A; and rs3771280, c.1510+118T>C), three in MSH3 (rs26279, Ala1045Thr...",204,940,PLoS_One_2012_May_18_7(5)_e36962.txt
c.1510+118T>C,"...380A>G; rs10188090, c.2635-765G>A; and rs3771280, c.1510+118T>C), three in MSH3 (rs26279, Ala1045Thr...",204,940,PLoS_One_2012_May_18_7(5)_e36962.txt
c.1341-12568A>G,"... MSH3 (rs26279, Ala1045Thr, c.3133G>A; rs1428030, c.1341-12568A>G; and rs1805355, Pro231Pro, c.693G>...",204,1014,PLoS_One_2012_May_18_7(5)_e36962.txt
c.693G>A,"...28030, c.1341-12568A>G; and rs1805355, Pro231Pro, c.693G>A), two in PMS1 (rs5742938, c. −21+639G>A; ...",204,1057,PLoS_One_2012_May_18_7(5)_e36962.txt
c.546-191T>C,"...3404927, c.699+3331G>A), one in MLH1 (rs13320360, c.546-191T>C), and one in MLH3 (rs28756991, Arg797...",204,1164,PLoS_One_2012_May_18_7(5)_e36962.txt
c.2390G>A,"...-191T>C), and one in MLH3 (rs28756991, Arg797His, c.2390G>A). No polymorphisms were selected in MSH6...",204,1219,PLoS_One_2012_May_18_7(5)_e36962.txt
c.2390G>A,"...-191T>C), and one in MLH3 (rs28756991, Arg797His, c.2390G>A). No polymorphisms were selected in MSH6...",204,1219,PLoS_One_2012_May_18_7(5)_e36962.txt
c.1091-2A>G,"...810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.8...",76,105,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"...810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.8...",76,105,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"...810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.8...",76,140,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"..._810del17insGC, c.1091-2A>G	c.802-8_810del17insGC	c.1091-2A>G	c.802-8_810del17insGC	–	–	c.802-8_810d...",76,209,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"Among the mutations identified in this pedigree, c.1091-2A>G of CYP4V2 was predicted to disrupt the...",111,50,PLoS_One_2012_May_31_7(5)_e33673.txt
c.895G>A,...d from patients with LGMD2B: DYSF c.855+1delG and c.895G>A; p.G299R; homozygosity for DYSF c.4022T>C...,91,454,PLoS_One_2012_Nov_20_7(11)_e49603.txt
c.895G>A,...d from patients with LGMD2B: DYSF c.855+1delG and c.895G>A; p.G299R; homozygosity for DYSF c.4022T>C...,91,454,PLoS_One_2012_Nov_20_7(11)_e49603.txt
c.4022T>C,...). DYSF c.895G>A leading to DYSF p.G299R and DYSF c.4022T>C leading to DYSF p.L1431P were cloned int...,97,235,PLoS_One_2012_Nov_20_7(11)_e49603.txt
c.1440A>G,... SLC41A1 variants (c.436A>G resulting in p.K146E; c.1440A>G resulting in p.P480P; and c.552+50G>A) i...,19,168,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.552+50G>A,...g in p.K146E; c.1440A>G resulting in p.P480P; and c.552+50G>A) in the Chinese population [24] and of...,19,204,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,...TGSH-HA-strep-SLC41A1 and pNTGSH-HA-strep-SLC41A1-c.1049C>T were separately electroporated into the ...,27,547,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,"...oth transgenic variants of SLC41A1, namely wt and c.1049C>T, by the quantitative real time PCR (q-RT...",37,95,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,...) Quantitative real time PCR analysis of SLC41A1-(c.1049C>T) expression in -tet and +tet cells. The ...,75,364,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,...) Quantitative real time PCR analysis of SLC41A1-(c.1049C>T) expression in -tet and +tet cells. The ...,75,364,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,... significantly higher amount of ∼14.25 fold (+tet c.1049C>T ddCt mean 144.9±34.62/-tet c.1049C>T ddC...,76,335,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,...5 fold (+tet c.1049C>T ddCt mean 144.9±34.62/-tet c.1049C>T ddCt mean 10.17±0.79; P = 1.84e-08) of t...,76,372,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,...know whether the over-expression of wt SLC41A1 or c.1049C>T mutant could influence the expression of...,76,707,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.-14C>T,...ic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients . J Med Genet 50...,121,171,PLoS_One_2013_Aug_20_8(8)_e72337.txt
c.-14C>T,...ic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients . J Med Genet 50...,121,171,PLoS_One_2013_Aug_20_8(8)_e72337.txt
c.-14C>T,...ic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients . J Med Genet 50...,121,171,PLoS_One_2013_Aug_20_8(8)_e72337.txt
c.547+2T>A,IVS8+2T>Ac	c.547+2T>A	D	skipping of exon 8	r.[442_547del]	mon...,62,12,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.475+1G>A,IVS5+1G>A	c.475+1G>A	D	skipping of exon 5	r.[426_475del]	mon...,68,11,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4097G>A,4216G>A	c.4097G>A	A	none	r.[4097g>a]	bi-allelic	aa change ...,96,9,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+5G>A,IVS16+5G>A	c.4986+5G>A	D	retention of 65 bp atthe 5′-end of i...,98,12,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+5G>A,IVS16+5G>A	c.4986+5G>A	D	retention of 65 bp atthe 5′-end of i...,98,12,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.5333A>G,5452A>Gf	c.5333A>G	A	none	r.[5333a>g]	bi-allelic	aa change ...,99,10,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.631G>A,859G>Ag*	c.631G>A	D	skipping of exon 7	r.[517_631del]	mono-...,101,10,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.631G>A,859G>Ag*	c.631G>A	D	skipping of exon 7	r.[517_631del]	mono-...,101,10,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.631G>A,859G>Ag*	c.631G>A	D	skipping of exon 7	r.[517_631del]	mono-...,101,10,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9116C>T,9344C>Ti*	c.9116C>T	D	none	r.[9116c>u]	bi-allelic	aa change ...,103,11,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9117G>A,9345G>Aj	c.9117G>A	D	skipping of exon 23	r.[8954_9117del]	m...,104,10,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.547+2T>A,"...at had been already analyzed in previous studies (c.547+2T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, ...",125,98,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.547+2T>A,"...at had been already analyzed in previous studies (c.547+2T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, ...",125,98,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+1G>T,"...45] and 6 not previously characterized (441+2T>G, c.4986+1G>T, c.4987−1G>A, c.5278−2delA, c.5332+1G>...",125,267,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+1G>T,"...45] and 6 not previously characterized (441+2T>G, c.4986+1G>T, c.4987−1G>A, c.5278−2delA, c.5332+1G>...",125,267,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.5332+1G>A,"...441+2T>G, c.4986+1G>T, c.4987−1G>A, c.5278−2delA, c.5332+1G>A in BRCA1and c.475+1G>A in BRCA2). In p...",125,307,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.547+2T>A,"...CA1and c.475+1G>A in BRCA2). In particular, BRCA1 c.547+2T>A, c.4987−1G>A and c.5332+1G>A caused the...",125,374,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.441+2T>G,...al loss of exon 7 (62 bp at the 3′-end) for BRCA1 c.441+2T>G (Fig. 1E) and partial retention of intr...,125,672,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+1G>T,...tion of intron 16 (65 bp at the 5′-end) for BRCA1 c.4986+1G>T (Fig. 1F). BRCA2 c.476−2A>G was found ...,125,760,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.212G>A,"...ons of group B included 6 already analyzed (BRCA1 c.212G>A, c.213−11T>G, and c.4484G>T, and BRCA2 c....",130,70,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.212G>A,"...ons of group B included 6 already analyzed (BRCA1 c.212G>A, c.213−11T>G, and c.4484G>T, and BRCA2 c....",130,70,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4484G>T,"...lready analyzed (BRCA1 c.212G>A, c.213−11T>G, and c.4484G>T, and BRCA2 c.631G>A, c.8754+3G>C, and c....",130,97,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4484G>T,"...lready analyzed (BRCA1 c.212G>A, c.213−11T>G, and c.4484G>T, and BRCA2 c.631G>A, c.8754+3G>C, and c....",130,97,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.8754+3G>C,"..., c.213−11T>G, and c.4484G>T, and BRCA2 c.631G>A, c.8754+3G>C, and c.9117G>A) [11], [18], [19], [21]...",130,128,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9117G>A,"...d c.4484G>T, and BRCA2 c.631G>A, c.8754+3G>C, and c.9117G>A) [11], [18], [19], [21], [22], [26], [44...",130,145,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.631G>A,"... exon: BRCA1 c.4484G>T (exon 14) (Fig. 2A), BRCA2 c.631G>A (exon 7) (Fig. 2B) and BRCA2 c.9117G>A (e...",130,372,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+5G>A,"...59 bp at the 3′-end of intron 5) (Fig. 2D), BRCA1 c.4986+5G>A (65 bp at the 5′-end of intron 16) (Fi...",130,615,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+5G>A,"...59 bp at the 3′-end of intron 5) (Fig. 2D), BRCA1 c.4986+5G>A (65 bp at the 5′-end of intron 16) (Fi...",130,615,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.212G>A,"... 2F). Finally, the BRCA1 c.134+3_134+6delAAGT and c.212G>A variants were associated with a relevant ...",130,789,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.1114C>A,...ance of the constitutional heterozygosity for the c.1114C>A SNP (exon 10; rs144848) and the c.9876G>...,135,517,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.1114C>A,...ance of the constitutional heterozygosity for the c.1114C>A SNP (exon 10; rs144848) and the c.9876G>...,135,517,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9116C>T,"...s of group B, including BRCA1 c.5333A>G and BRCA2 c.9116C>T, already analyzed [20]–[22] and BRCA1 c....",139,112,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9116C>T,"...s of group B, including BRCA1 c.5333A>G and BRCA2 c.9116C>T, already analyzed [20]–[22] and BRCA1 c....",139,112,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4097G>A,"...yzed [20]–[22] and BRCA1 c.548−3delT, c.594−4A>G, c.4097G>A, not previously characterized. To accoun...",139,185,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4484G>T,c.4484G>T	YES	−13.4%; S (C)	−47.4%; S (C)	−9.8%; S...,165,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+5G>A,c.4986+5G>A	YES	−100%; S (C)	−100%; S (C)	−100%; S...,166,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.5333A>G,c.5333A>G	NO	+5.4%; NS (C)	+12.3%; NS (C)	+32.5%; ...,167,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9116C>T,c.9116C>T	NO		−43.6%; S (D)	−100%; S (D)		0.0%; NS...,171,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9117G>A,c.9117G>A	YES		−100%; S (C)	−100%; S (C)		−14.7%; ...,172,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9117G>A,c.9117G>A	YES		−100%; S (C)	−100%; S (C)		−14.7%; ...,172,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.212G>A,"...ontaining PTCs, 2 (BRCA1 c.134+3_134+6delAAGT and c.212G>A) to the up-regulation of naturally occurr...",179,463,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.6853A>G,"...is is supported by the observation that the BRCA2 c.6853A>G variant, resulting in increased exclusio...",191,431,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.411C>A,"...ncluding 16 polymorphisms (7 novel polymorphisms: c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c...",73,82,PLoS_One_2013_Jul_2_8(7)_e66526.txt
c.2289C>T,"...s (7 novel polymorphisms: c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), ...",73,106,PLoS_One_2013_Jul_2_8(7)_e66526.txt
c.2289C>T,"...s (7 novel polymorphisms: c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), ...",73,106,PLoS_One_2013_Jul_2_8(7)_e66526.txt
c.3973C>T,"...c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (p.Leu1325Leu), c.3999G>T (p.Leu1333Leu)...",73,156,PLoS_One_2013_Jul_2_8(7)_e66526.txt
c.1A>G,...cted with HSCR and meningocele. + indicates EDNRB c.1A>G; * indicates EDN3 c.-248G>A,27,204,PLoS_One_2013_Jun_26_8(6)_e66631.txt
c.1A>G,...cted with HSCR and meningocele. + indicates EDNRB c.1A>G; * indicates EDN3 c.-248G>A,27,204,PLoS_One_2013_Jun_26_8(6)_e66631.txt
c.249C>T,Exon 2	c.249C>T (rs73415876)	Y83Y	II-6,81,8,PLoS_One_2013_Jun_26_8(6)_e66631.txt
c.249C>T,Exon 2	c.249C>T (rs73415876)	Y83Y	II-6,81,8,PLoS_One_2013_Jun_26_8(6)_e66631.txt
c.249C>T,Exon 2	c.249C>T (rs73415876)	Y83Y	II-6,81,8,PLoS_One_2013_Jun_26_8(6)_e66631.txt
c.10762T>C,...romatogram of Fras1 gene sequence identifying the c.10762T>C mutation in Fras1bfb/bfb mice. (B) Sequ...,72,57,PLoS_One_2013_Oct_15_8(10)_e76342.txt
c.217C>T,"... for a variant in RGS6: c.37del; p.Val13LeufsX11, c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c....",99,384,PLoS_One_2013_Oct_29_8(10)_e76973.txt
c.217C>T,"... for a variant in RGS6: c.37del; p.Val13LeufsX11, c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c....",99,384,PLoS_One_2013_Oct_29_8(10)_e76973.txt
c.1382C>T,"..., c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.1382C>T; p.Ala461Val were evaluated in parallel ...",99,432,PLoS_One_2013_Oct_29_8(10)_e76973.txt
c.184C>T,"... NL , Kay GW , et al (2006 ) A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lip...",159,100,PLoS_One_2013_Oct_4_8(10)_e75963.txt
c.1129T>G,II-1	28	F	4.47	1.47	1.26	4.02	p.Cys356Gly (c.1129T>G),109,44,PLoS_One_2014_Apr_10_9(4)_e94697.txt
c.1129T>G,II-1	28	F	4.47	1.47	1.26	4.02	p.Cys356Gly (c.1129T>G),109,44,PLoS_One_2014_Apr_10_9(4)_e94697.txt
c.1268T>C,II-2	34	M	5.10	0.96	1.53	3.41	p.IIe402Thr (c.1268T>C),110,44,PLoS_One_2014_Apr_10_9(4)_e94697.txt
c.793C>T,... were identified. One recurrent mutation in MLH1 (c.793C>T) was also observed. 92.9% sensitivity for...,14,222,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.1779T>A,"...with non-hereditary origin, the mutation hotspot (c.1779T>A, p.V600E) of BRAF was scanned via HRM fo...",55,111,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.1779T>A,"...with non-hereditary origin, the mutation hotspot (c.1779T>A, p.V600E) of BRAF was scanned via HRM fo...",55,111,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2041G>A,MLH1/Exon 18	c.2041G>A	p.Ala681Thr	Chinese	1	1	Pathogenic	Dis c...,85,14,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2041G>A,MLH1/Exon 18	c.2041G>A	p.Ala681Thr	Chinese	1	1	Pathogenic	Dis c...,85,14,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.508C>T,MSH2/Exon 3	c.508C>T	p.Gln170X	Chinese	1	1	Pathogenic	Dis caus...,87,13,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.1216C>T,MSH2/Exon 7	c.1216C>T	p. Arg406X	Malay	1	2	Pathogenic	Dis caus...,88,13,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2041C>T,"52	MSH2/Exon 13, c.2041C>T, p.Gln681X	Novel Pathogenic	Normal	Lost	...",117,18,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2210+1G>A,"27	MSH2/Intron 13, c.2210+1G>A	Pathogenic, skipping of exon	Normal	Lo...",118,20,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.1558+14G>A,"368	MLH1/Intron 13, c.1558+14G>A; PMS2/Intron 11, c.2006 +6 G>A	MLH1, ...",129,21,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.1558+14G>A,"368	MLH1/Intron 13, c.1558+14G>A; PMS2/Intron 11, c.2006 +6 G>A	MLH1, ...",129,21,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.1168C>T,"68	MSH2/Exon 7, c.1168C>T, p.Leu390Phe	Probably dis causing by HGM...",131,17,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2246G>C,"8	MSH6/Exon 4, c.2246G>C, p.Gly749Ala	Novel VUS	Normal	Normal	Nor...",132,16,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.793C>T,"...erogeneity observed, one recurrent mutation (MLH1 c.793C>T) was identified in five patients from thr...",193,81,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.793C>T,...and the germline hotspot mutation testing at MLH1 c.793C>T. This is followed by thorough mutation sc...,203,994,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.793C>T,...and the germline hotspot mutation testing at MLH1 c.793C>T. This is followed by thorough mutation sc...,203,994,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.803G>A,"...s study, we identified a novel missense mutation (c.803G>A, p.R268Q) in the plasma membrane calcium ...",7,579,PLoS_One_2014_Aug_13_9(8)_e104790.txt
c.803G>A,"...c), and we identified a novel causative mutation, c.803G>A, p.R268Q in the PMCA4 gene",15,212,PLoS_One_2014_Aug_13_9(8)_e104790.txt
c.280G>C,exon 3	c.280G>C	p.A94P	28	M	—	—	—	rs201350646,53,9,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.280G>C,exon 3	c.280G>C	p.A94P	28	M	—	—	—	rs201350646,53,9,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.583C>G,FOXC2	exon 1	c.583C>G	p.P195A	78	P	0.2	—	—	rs200751941,62,14,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.-333T>C,c.-333T>C	n/a	76	P	0.6	—	—	rs147276162,65,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.699G>A,GATA4	exon 2	c.699G>A	p.T233T	323	—	—	0.3	0.1	rs55788387,70,14,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.699G>A,GATA4	exon 2	c.699G>A	p.T233T	323	—	—	0.3	0.1	rs55788387,70,14,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.1037C>T,exon 5	c.1037C>T	p.A346V	59	—	0.4	0.31	0.13	rs115372595,74,9,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*886G>A,c.*886G>A	n/a (3'UTR)	319	M	—	—	0.4	rs146304341,77,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*1012G>C,c.*1012G>C	n/a (3'UTR)	67	—	0.1	—	0.13	rs139566390...,79,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*1012G>C,c.*1012G>C	n/a (3'UTR)	67	—	0.1	—	0.13	rs139566390...,79,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*245A>G,3'UTR	c.*245A>G	n/a	44	M	—	—	—	—,83,8,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*651A>G,c.*651A>G	n/a	39	M	0.5	—	—	—,84,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*271C>T,c.*271C>T	n/a	330	P	0.1	—	—	—,86,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*699C>T,c.*699C>T	n/a	32	M	0.9	—	0.5	rs150572228,87,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*699C>T,c.*699C>T	n/a	32	M	0.9	—	0.5	rs150572228,87,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*699C>T,c.*699C>T	n/a	32	M	0.9	—	0.5	rs150572228,87,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.364A>G,exon 2	c.364A>G	p.I122V	31	M	0.2	—	—	—,90,9,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*11C>T,exon 9a	c.*11C>T	n/a (3'UTR)	57	M	0.1	0.16	—	rs72646973,93,10,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*11C>T,exon 9a	c.*11C>T	n/a (3'UTR)	57	M	0.1	0.16	—	rs72646973,93,10,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.1037C>T,... was present in a single patient apart from GATA4 c.1037C>T (p.A346V) and c.*1012G>C; and FOXH1 c.-3...,98,217,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*886G>A,...ee patients. The first patient carried both GATA4 c.*886G>A and TBX1 c.*1074G>A (both maternal in or...,98,682,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*886G>A,...ee patients. The first patient carried both GATA4 c.*886G>A and TBX1 c.*1074G>A (both maternal in or...,98,682,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*886G>A,...ee patients. The first patient carried both GATA4 c.*886G>A and TBX1 c.*1074G>A (both maternal in or...,98,682,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*271C>T,"...maternal in origin); the second carried BOP/SMYD1 c.*271C>T and TBX1 c.129_185del, p.P43_G61del PPPP...",98,768,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.280G>C,"..._76insGCCGCC, p.A25_A26insAA (maternal) and FOXA2 c.280G>C, p.A94P (maternal). The second patient ca...",98,1187,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.219-3C>T,The mutant minigene constructs for ISL1 c.219-3C>T and GATA4 c.699G>A p.T233T produced an ...,119,41,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.446G>T,...g NOTCH3 mutation at the nucleotide position 446 (c.446G>T; p.G149V) in a Chinese family with CADASI...,15,101,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,... with respect to the normal control (B). P.G149V (c.446G>T) was indicated with an arrow,76,729,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,... with respect to the normal control (B). P.G149V (c.446G>T) was indicated with an arrow,76,729,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,"...to T transversion at the nucleotide position 446 (c.446G>T), resulting in a change of glycine (GGC) ...",81,196,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,"...to T transversion at the nucleotide position 446 (c.446G>T), resulting in a change of glycine (GGC) ...",81,196,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,"...to T transversion at the nucleotide position 446 (c.446G>T), resulting in a change of glycine (GGC) ...",81,196,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,...ly pathogenic nucleotide change was detected. The c.446G>T change causes a loss of MscI restriction ...,81,441,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,"...48 instead of T. By MscI enzyme, the heterozygous c.446G>T mutation was found in all the affected in...",81,708,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,"...48 instead of T. By MscI enzyme, the heterozygous c.446G>T mutation was found in all the affected in...",81,708,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,"...) domain. By genetic testing, we revealed a novel c.446G>T (p.G149V) mutation located in exon 4 of t...",91,861,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.131T>C,"...ncing of the candidate GJA8 gene revealed a novel c.131T>C transition in exon 2, which cosegregated ...",14,63,PLoS_One_2014_Dec_17_9(12)_e115406.txt
c.131T>C,"...ncing of the candidate GJA8 gene revealed a novel c.131T>C transition in exon 2, which cosegregated ...",14,63,PLoS_One_2014_Dec_17_9(12)_e115406.txt
c.131T>C,"...ncing of the candidate GJA8 gene revealed a novel c.131T>C transition in exon 2, which cosegregated ...",14,63,PLoS_One_2014_Dec_17_9(12)_e115406.txt
c.131T>C,...ual. The black box shows a heterozygous mutation (c.131T>C) in exon 2. E: Conservation analysis of p...,73,568,PLoS_One_2014_Dec_17_9(12)_e115406.txt
c.131T>C,...ual. The black box shows a heterozygous mutation (c.131T>C) in exon 2. E: Conservation analysis of p...,73,568,PLoS_One_2014_Dec_17_9(12)_e115406.txt
c.131T>C,"...ne sequencing, we identified a novel heterozygous c.131T>C mutation in the GJA8 gene (RefSeq NM_0052...",76,59,PLoS_One_2014_Dec_17_9(12)_e115406.txt
c.615+5G>A,... mutations and the mRNA product from the mutation c.615+5G>A. This study aims to investigate the eff...,8,291,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...ng, the patient proved a compound heterozygote of c.615+5G>A and a novel c.1064G>A (p.Arg355Gln) mut...",11,124,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,...a compound heterozygote of c.615+5G>A and a novel c.1064G>A (p.Arg355Gln) mutation. An aberrant tran...,11,147,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,...a compound heterozygote of c.615+5G>A and a novel c.1064G>A (p.Arg355Gln) mutation. An aberrant tran...,11,147,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,"... nature of the c.615+5G>A mutation, and the novel c.1064G>A variation, which proved a pathogenic mut...",14,248,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,"... nature of the c.615+5G>A mutation, and the novel c.1064G>A variation, which proved a pathogenic mut...",14,248,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...tion along with the possible splice-site mutation c.615+5G>A. In this paper, by using an agc1Δ yeast...",23,178,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...tion along with the possible splice-site mutation c.615+5G>A. In this paper, by using an agc1Δ yeast...",23,178,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...tion along with the possible splice-site mutation c.615+5G>A. In this paper, by using an agc1Δ yeast...",23,178,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...eral blood lymphocytes (PBLs) due to the mutation c.615+5G>A was also explored. We herein reported t...,23,384,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...	Amplification the transcript from the allelewith c.615+5G>A,44,78,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...d heterozygote of a maternally-inherited mutation c.615+5G>A and a novel missense mutation c.1064G>A...,103,137,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...d heterozygote of a maternally-inherited mutation c.615+5G>A and a novel missense mutation c.1064G>A...,103,137,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...esis on the left illustrated the screening of the c.615+5G>A mutation by mean of a PCR-RFLP approach...,106,66,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...esis on the left illustrated the screening of the c.615+5G>A mutation by mean of a PCR-RFLP approach...,106,66,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...e patient carried a maternally-inherited mutation c.615+5G>A. SLC25A13 gene sequencing results on th...,106,484,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,...the right demonstrated that the patient habored a c.1064G>A mutation which was inherited from his fa...,106,582,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...789 bp) of SLC25A13 gene, along with the mutation c.615+5G>A, was retained in the 2292 bp product (F...",115,335,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...p product retained the entire intron 6 due to the c.615+5G>A mutation,118,406,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,...YX212 vector and the citrin variant with mutation c.1064G>A was named as pYX212-mutant. The growth a...,124,71,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...ysis (Fig. 3) unveiled a compound heterozygote of c.615+5G>A and c.1064G>A (p.Arg355Gln). The former...,130,768,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,Our study in this paper documented c.615+5G>A a real splice-site mutation that led to...,134,36,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...hus the transcripts from the SLC25A13 allele with c.615+5G>A were degraded soon after transcription,...",134,1004,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,"...on of citrin protein. As illustrated in Figure 6, c.1064G>A caused complete loss of AGC2 function of...",137,303,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,"...on of citrin protein. As illustrated in Figure 6, c.1064G>A caused complete loss of AGC2 function of...",137,303,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,"...a compound heterozygote of c.615+5G>A and a novel c.1064G>A mutation by means of a clinical, genetic...",139,109,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,"... nature of the c.615+5G>A mutation, and the novel c.1064G>A variation, which proved a pathogenic mut...",139,333,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,"... nature of the c.615+5G>A mutation, and the novel c.1064G>A variation, which proved a pathogenic mut...",139,333,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.166G>A,"...mutations have a recessive mode of inheritance, a c.166G>A (p.G56R) mutation in the NR2E3 gene is as...",14,1333,PLoS_One_2014_Jan_31_9(1)_e87942.txt
c.166G>A,"...mutations have a recessive mode of inheritance, a c.166G>A (p.G56R) mutation in the NR2E3 gene is as...",14,1333,PLoS_One_2014_Jan_31_9(1)_e87942.txt
c.43C>T,...2	rs3802829	G	G/A	0.093**	0.089	0.85	0.113	0.48	C	c.43C>T	p.Pro15Ser	missense	1	NH2-terminal region,92,62,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.43C>T,...2	rs3802829	G	G/A	0.093**	0.089	0.85	0.113	0.48	C	c.43C>T	p.Pro15Ser	missense	1	NH2-terminal region,92,62,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.43C>T,...2	rs3802829	G	G/A	0.093**	0.089	0.85	0.113	0.48	C	c.43C>T	p.Pro15Ser	missense	1	NH2-terminal region,92,62,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.43C>T,...2	rs3802829	G	G/A	0.093**	0.089	0.85	0.113	0.48	C	c.43C>T	p.Pro15Ser	missense	1	NH2-terminal region,92,62,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.43C>T,...2	rs3802829	G	G/A	0.093**	0.089	0.85	0.113	0.48	C	c.43C>T	p.Pro15Ser	missense	1	NH2-terminal region,92,62,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.170+70G>A,...95	rs17096918	C	C/T	0.083	0.069	0.52	0.081	0.93	G	c.170+70G>A		intron,93,61,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.171-20A>G,...49	rs10501986	T	T/C	0.480	0.495	0.71	0.492	0.81	A	c.171-20A>G		intron,94,61,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.888G>A,...1374812	rs144891994	C	C/T	0 ∧	0.005	NA	0.008	NA	G	c.888G>A	p.Thr296Thr	synonymous	2	CCD,95,56,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.945+129C>T,...626	rs4542378	G	G/A	0.480	0.490	0.80	0.492	0.81	C	c.945+129C>T		intron,96,60,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.945+129C>T,...626	rs4542378	G	G/A	0.480	0.490	0.80	0.492	0.81	C	c.945+129C>T		intron,96,60,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.1683T>C,...	rs12366144	A	A/G	0.250**	0.292	0.20	0.347	0.02	T	c.1683T>C	p.Asn561Asn	synonymous	6	linker region b...,98,63,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.1683T>C,...	rs12366144	A	A/G	0.250**	0.292	0.20	0.347	0.02	T	c.1683T>C	p.Asn561Asn	synonymous	6	linker region b...,98,63,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.2115C>T,...58	rs61743044	G	G/A	0.020	0.020	1.00	0.024	0.75	C	c.2115C>T	p.Tyr705Tyr	synonymous	8	linker region b...,99,61,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.2142G>T,...42931	rs144891994	C	C/A	0.008	0.005	0.66	0	0.32	G	c.2142G>T	p.Thr714Thr	synonymous	8	TMD 6,100,58,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.2142G>T,...42931	rs144891994	C	C/A	0.008	0.005	0.66	0	0.32	G	c.2142G>T	p.Thr714Thr	synonymous	8	TMD 6,100,58,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.2485-138C>T,...970	rs7105083	G	G/A	0.263	0.238	0.47	0.266	0.93	C	c.2485-138C>T		intron,101,60,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.2485-138C>T,...970	rs7105083	G	G/A	0.263	0.238	0.47	0.266	0.93	C	c.2485-138C>T		intron,101,60,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.888G>A,...ee Methods for definitions). These rare variants (c.888G>A and c.2142G>T) were both encountered once...,117,244,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.888G>A,...ee Methods for definitions). These rare variants (c.888G>A and c.2142G>T) were both encountered once...,117,244,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.2142G>T,...r definitions). These rare variants (c.888G>A and c.2142G>T) were both encountered once in two diffe...,117,257,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.27-21086A>T,"...ing region of HIF2A gene (rs11125070, NM_001430.4:c.27-21086A>T; minor allele frequency: 30.4% in ph...",260,399,PLoS_One_2014_Nov_18_9(11)_e113513.txt
c.27-21086A>T,"...ing region of HIF2A gene (rs11125070, NM_001430.4:c.27-21086A>T; minor allele frequency: 30.4% in ph...",260,399,PLoS_One_2014_Nov_18_9(11)_e113513.txt
c.479T>A,"...sociated with other CYP2A6 SNPs, e.g., rs1801272 (c.479T>A/p.L160H), with effect size of 0.68 CPD (N...",176,507,PLoS_One_2015_Jul_1_10(7)_e0126113.txt
c.479T>A,"...sociated with other CYP2A6 SNPs, e.g., rs1801272 (c.479T>A/p.L160H), with effect size of 0.68 CPD (N...",176,507,PLoS_One_2015_Jul_1_10(7)_e0126113.txt
c.479T>A,"...sociated with other CYP2A6 SNPs, e.g., rs1801272 (c.479T>A/p.L160H), with effect size of 0.68 CPD (N...",176,507,PLoS_One_2015_Jul_1_10(7)_e0126113.txt
c.489C>A,"... novel nucleotide change in C1QTNF5 (NM_015645.3: c.489C>A), leading to the missense mutation p.Ser1...",97,647,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
c.376C>T,"...sis [10–15,20–27]. Recently, a nonsense mutation (c.376C>T) of LGR4, which abolishes the signal tran...",84,173,PLoS_One_2015_Mar_26_10(3)_e0119599.txt
c.376C>T,"...sis [10–15,20–27]. Recently, a nonsense mutation (c.376C>T) of LGR4, which abolishes the signal tran...",84,173,PLoS_One_2015_Mar_26_10(3)_e0119599.txt
c.376C>T,"...sis [10–15,20–27]. Recently, a nonsense mutation (c.376C>T) of LGR4, which abolishes the signal tran...",84,173,PLoS_One_2015_Mar_26_10(3)_e0119599.txt
c.448G>C,"...nucleotide change (black arrow) in exon 2 of MIP (c.448G>C), which leads to the replacement of aspar...",63,200,PLoS_One_2015_May_6_10(5)_e0126679.txt
c.448G>C,"MIP: c.448G>C, p.D150H		1.628	1.718	1.797	1.806",77,6,PLoS_One_2015_May_6_10(5)_e0126679.txt
c.6982C>T,"... as exon 3 deletion) or point mutations p.P2328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.1234...",31,356,PLoS_One_2015_May_8_10(5)_e0125366.txt
c.12602A>G,"...38R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c.13957G>T). Mutation nom...",31,423,PLoS_One_2015_May_8_10(5)_e0125366.txt
c.12602A>G,"...38R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c.13957G>T). Mutation nom...",31,423,PLoS_One_2015_May_8_10(5)_e0125366.txt
c.12602A>G,"...38R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c.13957G>T). Mutation nom...",31,423,PLoS_One_2015_May_8_10(5)_e0125366.txt
c.2168A>G,"...tions in three genes associated with HL. Mutation c.2168A>G (SLC26A4) was found in one family, a nov...",7,1133,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...TOF) was revealed in another family, and mutation c.5254G>A (RAI1) was found in two families. Sanger...",7,1257,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...sociation of homozygosity for discovered variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G ...",7,1641,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"... variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL in Altaian patients. L...",7,1681,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...ndrome. Presumed association of RAI1 gene variant c.5254G>A with isolated HL needs to be proved by f...,7,2092,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,... and S1 Fig. A novel homozygous missense mutation c.5254G>A (p.Gly1752Arg) in gene RAI1 (retinoic ac...,44,183,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...F38 and F40; a novel homozygous missense mutation c.1111C>G (p.Gly371Arg) in gene OTOF (otoferlin, M...",44,362,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...F38 and F40; a novel homozygous missense mutation c.1111C>G (p.Gly371Arg) in gene OTOF (otoferlin, M...",44,362,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...ge (Amino acid change)	c.5254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg) *	c.2168A>G (p.His723Arg),63,66,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,...254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg) *	c.2168A>G (p.His723Arg),63,92,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...rnal.pone.0153841.g001Fig 1 Identification of the c.5254G>A (p.Gly1752Arg) mutation in the RAI1 gene...,81,62,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...rnal.pone.0153841.g001Fig 1 Identification of the c.5254G>A (p.Gly1752Arg) mutation in the RAI1 gene...,81,62,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...ian families F18, F37, F42, and F43 with mutation c.5254G>A (p.Gly1752Arg) in the RAI1 gene. (B) Val...",82,119,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...ian families F18, F37, F42, and F43 with mutation c.5254G>A (p.Gly1752Arg) in the RAI1 gene. (B) Val...",82,119,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,... sleep disturbances in the patients with mutation c.5254G>A. All patients have not shown evident int...,84,778,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...t. Mother in family F38 (38-I-1) heterozygous for c.5254G>A (Fig 1) had no hearing complaints during...,84,1261,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...found sensorineural HL. Subjects heterozygous for c.5254G>A (18-II-1, 37-II-1, and 43-II-2) had vary...",86,257,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...found sensorineural HL. Subjects heterozygous for c.5254G>A (18-II-1, 37-II-1, and 43-II-2) had vary...",86,257,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...found sensorineural HL. Subjects heterozygous for c.5254G>A (18-II-1, 37-II-1, and 43-II-2) had vary...",86,257,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...itis media. None of additional five patients with c.5254G>A demonstrated any signs or symptoms consi...,86,698,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...aring Altaians four individuals were heterozygous c.5254G>A carriers (4/120, 3.33%)",86,860,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,... additional deleterious variants in compound with c.5254G>A in affected heterozygotes for c.5254G>A ...,88,70,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...3-II-3, 38-II-1) (see Fig 1), and two carriers of c.5254G>A from Altaian controls whose DNAs were av...",88,635,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...)10 del(CAG) CAA]-G-c.5254G>A was observed in all c.5254G>A homozygote which was suggested as the co...,88,1235,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...was suggested as the common allelic haplotype for c.5254G>A. For all c.5254G>A heterozygotes, the ha...",88,1312,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...e common allelic haplotype for c.5254G>A. For all c.5254G>A heterozygotes, the haplotypes were recon...",88,1331,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"... of Altaian ethnicity. For accurate estimation of c.5254G>A allelic frequency, we also screened this...",90,110,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...aian patients with HL. Nobody from this group had c.5254G>A. We compared frequency of c.5254G>A in a...,90,240,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...his group had c.5254G>A. We compared frequency of c.5254G>A in a total sample of Altaian patients (0...,90,276,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...the control sample. Again, a statistically higher c.5254G>A frequency (p = 0.0026) was observed amon...",90,839,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...the control sample. Again, a statistically higher c.5254G>A frequency (p = 0.0026) was observed amon...",90,839,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,We found a novel mutation c.1111C>G (p.Gly371Arg) in the OTOF gene in two si...,93,27,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,We found a novel mutation c.1111C>G (p.Gly371Arg) in the OTOF gene in two si...,93,27,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,...G (p.Gly371Arg) mutation in the OTOF gene and the c.2168A>G (p.His723Arg) mutation in the SLC26A4 ge...,95,120,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,... in the OTOF gene denoted as M. (B) Validation of c.1111C>G by Sanger sequencing. (C) Pedigree of th...,96,167,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,... (C) Pedigree of the WES family F53 with mutation c.2168A>G (p.His723Arg) in the SLC26A4 gene which ...,96,248,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,... (C) Pedigree of the WES family F53 with mutation c.2168A>G (p.His723Arg) in the SLC26A4 gene which ...,96,248,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,... (C) Pedigree of the WES family F53 with mutation c.2168A>G (p.His723Arg) in the SLC26A4 gene which ...,96,248,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...x26-negative patients revealed heterozygosity for c.1111C>G in individual 24-II-2 with prelingual pr...,98,79,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...-1, 54-II-4, 54-II-7, 54-III-1,) was affected and c.1111C>G was absent in his relatives 24–1 (with c...",98,555,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...-1, 54-II-4, 54-II-7, 54-III-1,) was affected and c.1111C>G was absent in his relatives 24–1 (with c...",98,555,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...erate HL). On the other hand, all homozygotes for c.1111C>G (54-II-2, 54-II-3, 54-II-5, 54-II-6) wer...",98,699,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...erate HL). On the other hand, all homozygotes for c.1111C>G (54-II-2, 54-II-3, 54-II-5, 54-II-6) wer...",98,699,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...branch F24 of combined pedigree F24-F54. Mutation c.1111C>G was not found among 120 normal hearing A...,98,931,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,Variant c.2168A>G (p.His723Arg) in gene SLC26A,100,9,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,Homozygous mutation c.2168A>G (p.His723Arg) in gene SLC26A4 was found ...,101,21,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,...in his affected sister (53-II-2) and heterozygous c.2168A>G state in their normal hearing mother (53...,101,267,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,...al bone computed tomography examination. Mutation c.2168A>G was found neither in other Cx26-negative...,103,832,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...us RAI1 missence mutation detected in this study, c.5254G>A, with isolated HL in Altaian patients. T...",114,110,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...tion 1752 in the C-terminal part of RAI1. Variant c.5254G>A has been predicted ‘possibly damaging’ b...,114,471,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...indeed detected significantly higher frequency of c.5254G>A in Altaian patients compared with Altaia...,114,1634,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...indeed detected significantly higher frequency of c.5254G>A in Altaian patients compared with Altaia...,114,1634,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...llelemut: C-A-Q13[CAG CAA (CAG)10 del(CAG) CAA]-G-c.5254G>A was shared by all studied carriers of c....,114,1911,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...llelemut: C-A-Q13[CAG CAA (CAG)10 del(CAG) CAA]-G-c.5254G>A was shared by all studied carriers of c....,114,1911,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...G-c.5254G>A was shared by all studied carriers of c.5254G>A that supports the common origin of c.525...,114,1959,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...G-c.5254G>A was shared by all studied carriers of c.5254G>A that supports the common origin of c.525...,114,1959,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...G-c.5254G>A was shared by all studied carriers of c.5254G>A that supports the common origin of c.525...,114,1959,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...s of c.5254G>A that supports the common origin of c.5254G>A in Altaians,114,2004,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.4685A>G,"...217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) (all are in C-...",116,1358,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,... in genome databases) (Table 2) missense mutation c.1111C>G in exon 12 of OTOF leads to substitution...,124,80,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,Variant c.1111C>G found in this study has been predicted ‘...,126,9,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,Variant c.1111C>G found in this study has been predicted ‘...,126,9,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,Variant c.1111C>G found in this study has been predicted ‘...,126,9,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...1C>G with recessive HL in Altaian family F54: all c.1111C>G homozygous siblings from this family wer...,126,297,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...1C>G with recessive HL in Altaian family F54: all c.1111C>G homozygous siblings from this family wer...,126,297,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...support plausible association of homozygosity for c.1111C>G with recessive HL in Altaian patients. T...,126,528,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...support plausible association of homozygosity for c.1111C>G with recessive HL in Altaian patients. T...,126,528,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...support plausible association of homozygosity for c.1111C>G with recessive HL in Altaian patients. T...,126,528,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...om the combined pedigree F24-F54 (Fig 2) with one c.1111C>G copy (24-II-2) or without c.1111C>G (24–...,126,694,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...g 2) with one c.1111C>G copy (24-II-2) or without c.1111C>G (24–1 and 24-II-1). Presence of other de...,126,730,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...g 2) with one c.1111C>G copy (24-II-2) or without c.1111C>G (24–1 and 24-II-1). Presence of other de...,126,730,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"Distribution of all alleles with mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G ...",130,44,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"...mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) identified in Altaian patients...",130,84,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"...tern district of the Altai Republic, and mutation c.2168A>G (SLC26A4) was found in the only Altaian ...",130,1061,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...by fully or half-colored circle, correspondingly: c.5254G>A (RAI1)–by red; c.1111C>G (OTOF)–by blue;...",133,144,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...by fully or half-colored circle, correspondingly: c.5254G>A (RAI1)–by red; c.1111C>G (OTOF)–by blue;...",133,144,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,....5254G>A (RAI1)–by red; c.1111C>G (OTOF)–by blue; c.2168A>G (SLC26A4)–by green. (B) Distribution of ...,133,195,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...sociation of homozygosity for identified variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G ...",136,403,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...ygosity for identified variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL ...",136,421,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"... variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL in Altaian patients. L...",136,443,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"... variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL in Altaian patients. L...",136,443,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...ndrome. Presumed association of RAI1 gene variant c.5254G>A with isolated HL needs to be proved by f...,136,842,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...ng in individuals homozygous and heterozygous for c.5254G>A,164,131,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.293A>G,...C_000002.11:g.47388990T>C; cDNA code: NM_001743.4:c.293A>G),37,1969,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
c.293A>G,...C_000002.11:g.47388990T>C; cDNA code: NM_001743.4:c.293A>G),37,1969,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
c.-938C>A,"...e functional single nucleotide polymorphism (SNP) c.-938C>A (rs2279115), located in the promoter reg...",7,718,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
c.-938C>A,"...e functional single nucleotide polymorphism (SNP) c.-938C>A (rs2279115), located in the promoter reg...",7,718,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
c.-938C>A,"...e functional single nucleotide polymorphism (SNP) c.-938C>A (rs2279115), located in the promoter reg...",7,718,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
c.-938C>A,"...e functional single nucleotide polymorphism (SNP) c.-938C>A (rs2279115), located in the promoter reg...",7,718,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
c.1399G>A,The c.1399G>A mutation in exon 7 of POLG produces an a...,15,5,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
c.1399G>A,The c.1399G>A mutation in exon 7 of POLG produces an a...,15,5,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
c.1399G>A,...hange at nucleotide position (np) 1399 in exon 7 (c.1399G>A; p.A467T) in all four individuals,93,532,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
c.649C>T,"...ands with aniridia. In addition, a known variant (c.649C>T; p.Arg217*) in PAX6 segregated in a famil...",14,270,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.225C>A,...oth eyes. A novel heterozygous nonsense mutation (c.225C>A; p.Tyr75*) in the PAX6 gene was identifie...,41,359,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.649C>T,... the right eye. A heterozygous nonsense mutation (c.649C>T; p.Arg217*) in the PAX6 gene was detected...,48,465,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.454T>C,...ree and segregation of a novel missense mutation (c.454T>C; p.Trp152Arg) in the FOXC1 gene. (B). Sys...,57,60,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.225C>A,... proband with aniridia. A novel de novo mutation (c.225C>A; p.Tyr75*) was identified in the PAX6 gen...,69,131,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.225C>A,... proband with aniridia. A novel de novo mutation (c.225C>A; p.Tyr75*) was identified in the PAX6 gen...,69,131,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.454T>C,"...ilies with ARS: a heterozygous missense mutation (c.454T>C; p.Trp152Arg), and a homozygous in-frame ...",73,132,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.1444G>A,"UBQLN4	1	NM_020131.3	[c.1444G>A, p.Glu482Lys]	A/G	G/G	G/G	G/G	G/G",61,23,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
c.1373C>A,"SRPK3	X	NM_014370.2	[c.1373C>A, p.Thr458Asn]	hemiA	A/C	hemi C	hemi C	C/...",63,22,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
c.357-2A>G,"...% for family studies. The results identified LMNA c.357-2A>G, a novel heterozygous splice-site mutat...",7,1871,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,"...% for family studies. The results identified LMNA c.357-2A>G, a novel heterozygous splice-site mutat...",7,1871,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.625G>A,1. ACADS	chr12:121176083	c.625G>A	Gly209Ser; splicing	rs1799958	18	26	Risk ...,82,26,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.625G>A,1. ACADS	chr12:121176083	c.625G>A	Gly209Ser; splicing	rs1799958	18	26	Risk ...,82,26,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.991A>G,5. FGA	chr4:155507590	c.991A>G	Thr331Ala	rs6050	33	25	Risk allele for th...,86,23,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.991A>G,5. FGA	chr4:155507590	c.991A>G	Thr331Ala	rs6050	33	25	Risk allele for th...,86,23,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.340+4T>C,7. HFE	chr6:26091336	c.340+4T>C	Splicing	rs2071303	46	33	-,88,22,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.340+4T>C,7. HFE	chr6:26091336	c.340+4T>C	Splicing	rs2071303	46	33	-,88,22,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.193G>A,11. KCNMB1	chr5:169810796	c.193G>A	Glu65Lys	rs11739136	9.8	10	Risk allele fo...,92,27,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.2686G>A,14. MYBPC3c	chr11:47357479	c.2686G>A	Val895Met	rs35078470	0.3	0.5	Mutation or...,95,28,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.2384G>A,16. PKP4c	chr2:159519581	c.2384G>A	Arg795Lys	rs139221917	0.1	0.1	-,97,26,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.2068C>T,19. TMPOc	chr12:98928103	c.2068C>T	Arg690Cys	rs17028450	0.1	0.1	Mutation fo...,100,26,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.18053G>C,20. TTNc	chr2:179587949	c.18053G>C	Thr6018Ser	novel	nd	nd	-,101,25,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.21332C>A,21. TTN	chr2:179582537	c.21332C>A	Ala7111Glu; splicing	rs2627043	39	20	-,102,24,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.21332C>A,21. TTN	chr2:179582537	c.21332C>A	Ala7111Glu; splicing	rs2627043	39	20	-,102,24,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,"...Table 2 and Fig 4). These results identified LMNA c.357-2A>G (p.N120Lfs*5) (NM_170707.3), a novel he...",119,598,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,... (+) or absence (-) of the DNA variant. Only LMNA c.357-2A>G (marked in gray) was present in all aff...,125,390,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,... unaffected individuals and heterozygous mutation c.357-2A>G / c.357-2A for the proband and affected...,128,317,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.1698C>T,... variant located in exon 10 (rs4641: NM_1701707.3:c.1698C>T). These findings are consistent with the...,136,432,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,Lamin A/C and the predicted impact of LMNA c.357-2A>,154,44,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,Lamin A/C and the predicted impact of LMNA c.357-2A>,154,44,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,Lamin A/C and the predicted impact of LMNA c.357-2A>,154,44,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-1G>T,"...nucleotide in the same splice acceptor site, LMNA c.357-1G>T was reported in three patients with arr...",157,226,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-1G>T,"...ntractions (PVCs), and a pacemaker/ICD [31]. LMNA c.357-1G>T also was found in one French patient wi...",157,634,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-1G>T,...icted with the RNA studies conducted for the LMNA c.357-1G>T family [31]. Since both mutations are a...,161,139,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-1G>T,"...at would be subject to NMD. However, for the LMNA c.357-1G>T, RNA studies showed skipping of exon 2 ...",161,356,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.1076-1G>C,1	F	50	Proximal weakness LL + axial	IVS1-13T>G	c.1076-1G>C	251	Yes	47	N	N,107,48,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.2173C>T,...+ respiratory insufficiency	IVS1-13T>G IVS1-13T>G	c.2173C>T	779	Yes	39	Y	Y,108,94,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.573C>A,5	M	11	HyperCKemia	IVS1-13T>G	c.573C>A	276	No	-	N	N,111,31,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1532C>A,6	F	45	Proximal weakness LL	IVS1-13T>G	c.1532C>A	322	Yes	42	N	N,112,40,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1933G>T,...M	66	Axial + respiratory insufficiency	IVS1-13T>G	c.1933G>T	406	No	-	N	N,114,53,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1933G>T,...M	66	Axial + respiratory insufficiency	IVS1-13T>G	c.1933G>T	406	No	-	N	N,114,53,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.573C>A,...LL + axial + respiratory insufficiency	IVS1-13T>G	c.573C>A	606	Yes	39	N	Y,117,77,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.573C>A,...LL + axial + respiratory insufficiency	IVS1-13T>G	c.573C>A	606	Yes	39	N	Y,117,77,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1637A>G,... UL and LL + respiratory insufficiency	IVS1-13T>G	c.1637A>G	391	Yes	24	Y	Y,118,76,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1637A>G,... UL and LL + respiratory insufficiency	IVS1-13T>G	c.1637A>G	391	Yes	24	Y	Y,118,76,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.2173C>T,...	Proximal weakness LL + respiratory insufficiency	c.2173C>T	c.2173C>T	508	Yes	45	N	Y,120,58,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1657C>T,...eakness LL + respiratory insufficiency	IVS1-13T>G	c.1657C>T	709	Yes	45	N	Y,121,69,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.271G>A,18	M	49	HyperCKemia	c.271G>A	c.2510G>A	641	No	-	N	N,124,21,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.271G>A,18	M	49	HyperCKemia	c.271G>A	c.2510G>A	641	No	-	N	N,124,21,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.2510G>A,18	M	49	HyperCKemia	c.271G>A	c.2510G>A	641	No	-	N	N,124,30,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1781G>A,...	Proximal weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	68	Yes	64	N	N,126,58,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1194+5G>A,...weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	68	Yes	64	N	N,126,68,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1781G>A,...	Proximal weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	907	Yes	45	N	N,129,58,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1194+5G>A,...weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	907	Yes	45	N	N,129,68,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1194+5G>A,...weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	907	Yes	45	N	N,129,68,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1889-1G>A,25	M	8	HyperCKemia	IVS1-13T>G	c.1889-1G>A	1077	No	-	N	N,131,31,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1889-1G>A,25	M	8	HyperCKemia	IVS1-13T>G	c.1889-1G>A	1077	No	-	N	N,131,31,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1933G>T,28	M	51	Proximal weakness LL	IVS1-13T>G	c.1933G>T	952	Yes	51	N	Y,134,41,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1933G>T,29	M	51	Proximal weakness LL	IVS1-13T>G	c.1933G>T	432	No	-	N	Y,135,41,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.66G>A,ER23/23EK	c.66G>A (p.Glu22Glu)	rs6189	2.19%	2.98% (ss1317539...,129,11,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
c.1088A>G,N363S	c.1088A>G (p.Asn363Ser)	rs56149945 (former rs6195 ...,131,7,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
c.1184+646C>G,BclI	c.1184+646C>G (p.?)	rs41423247	32.8%	37.97% (ss131...,132,6,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
c.1184+646C>G,BclI	c.1184+646C>G (p.?)	rs41423247	32.8%	37.97% (ss131...,132,6,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
c.1184+646C>G,BclI	c.1184+646C>G (p.?)	rs41423247	32.8%	37.97% (ss131...,132,6,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
c.521T>C,...er LE  Uitterlinden AG  Klungel OH    The SLCO1B1 c.521T>C polymorphism is associated with dose decr...,68,94,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
c.20A>T,"...n is termed Hb C-Harlem (or Hb C-Georgetown) (HBB:c.20A>T, HBB:c.220G>A), because it migrates to the...",17,242,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
c.20A>T,"...n is termed Hb C-Harlem (or Hb C-Georgetown) (HBB:c.20A>T, HBB:c.220G>A), because it migrates to the...",17,242,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
c.20A>T,"...n is termed Hb C-Harlem (or Hb C-Georgetown) (HBB:c.20A>T, HBB:c.220G>A), because it migrates to the...",17,242,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
c.482G>A,...ozygosity for a mutation in the GCDH-coding gene (c.482G>A;p.R161Q). This case alerts pediatricians ...,26,381,Saudi_Med_J_2015_Nov_36(11)_1269.txt
c.329A>G,...-sequencing detected a homozygous novel mutation (c.329A>G; p.Y110C) in the MUT gene in patient 1 an...,3,1715,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
c.2200C>T,...we detected a novel homozygous nonsense mutation (c.2200C>T; p.Q734X) and a heterozygous in parents....,3,1950,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
c.329A>G,"In patient 1, we detected a homozygous mutation (c.329A>G;p.Y110C) and heterozygous in both his par...",23,50,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
c.2200C>T,"...nt 2, we detected a homozygous nonsense mutation (c.2200C>T;p.Q734X) in the patient and heterozygous...",25,59,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
c.481+1G>T,"...evels, and each additional LoF allele in SLCO1B1 (c.481+1G>T) demonstrated an increasing effect on h...",50,479,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.481+1G>T,"...evels, and each additional LoF allele in SLCO1B1 (c.481+1G>T) demonstrated an increasing effect on h...",50,479,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.975T>G,... levels. (A) Octanoylcarnitine levels among CD36 (c.975T>G) LoF mutation carriers. (B) Decanoylcarni...,53,145,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.975T>G,...arriers. (B) Decanoylcarnitine levels among CD36 (c.975T>G) LoF mutation carriers. (C) Hexadecanedio...,53,219,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.481+1G>T,...riers. (C) Hexadecanedioate levels among SLCO1B1 (c.481+1G>T) LoF mutation carriers. (D) Deoxycarnit...,53,295,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.933+2T>A,...carriers. (D) Deoxycarnitine levels among LRRC69 (c.933+2T>A) LoF mutation carriers,53,370,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.933+2T>A,...carriers. (D) Deoxycarnitine levels among LRRC69 (c.933+2T>A) LoF mutation carriers,53,370,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.481+1G>T,...10−9). We next genotyped the LoF site in SLCO1B1 (c.481+1G>T) among the entire ARIC participants (10...,57,726,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.481+1G>T,...10−9). We next genotyped the LoF site in SLCO1B1 (c.481+1G>T) among the entire ARIC participants (10...,57,726,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.481+1G>T,"...cation, three LoF sites—CD36 (c.975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both ...",77,75,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.1349G>A,"...at revealed a TULP1 homozygous nonsense mutation (c.1349G>A, p.W450*) which cosegregated with LCA in...",25,368,Sci_Rep_2015_Aug_26_5_13187.txt
c.1349G>A,"...at revealed a TULP1 homozygous nonsense mutation (c.1349G>A, p.W450*) which cosegregated with LCA in...",25,368,Sci_Rep_2015_Aug_26_5_13187.txt
c.1087T>A,ADAM9	c.1087T>A	p.C363S	0	arRP	Iraqi Jew	MOL0827 MOL0838...,85,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.479G>A,BBS1	c.479G>A	p.R160Q	4*10−5	arRP	Arab Muslim	MOL0745	—...,87,6,Sci_Rep_2015_Aug_26_5_13187.txt
c.94C>T,CNGA1	c.94C>T	p.R32*	0	arRP	Moroccan Jew	MOL0927	—	Heter...,89,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1540C>T,CNGA1	c.1540C>T	p.R514*	0	arRP	Moroccan Jew	MOL0927	—	He...,90,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.2284C>T,CNGB1	c.2284C>T	p.R762C	0	arRP	Buchara Jew	MOL0990	4	Hom...,91,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.2760G>A,CNGB1	c.2760G>A	p.W920*	8*10−6	arRP	Ashkenazi Jew	CHRD	—...,92,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.2760G>A,CNGB1	c.2760G>A	p.W920*	8*10−6	arRP	Ashkenazi Jew	CHRD	—...,92,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.2950C>T,"C2ORF71	c.2950C>T	p.R984*	2*10−5	arRP	Jew (Iran, Turkey)	M...",95,9,Sci_Rep_2015_Aug_26_5_13187.txt
c.3289C>T,"C2ORF71	c.3289C>T	p.Q1097*	4*10−5	arRP	Jew (Iran, Turkey)	...",96,9,Sci_Rep_2015_Aug_26_5_13187.txt
c.119-2A>C,NR2E3	c.119-2A>C	 	8*10−6	arRP	Arab Muslim	MOL1266	1	Hom...,100,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1960C>T,PDE6A	c.1960C>T	p.Q654*	0	arRP	Arab Muslim	MOL0271	—	Hom...,101,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1960C>T,PDE6A	c.1960C>T	p.Q654*	0	arRP	Arab Muslim	MOL0271	—	Hom...,101,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1960C>T,PDE6A	c.1960C>T	p.Q654*	0	arRP	Arab Muslim	MOL0271	—	Hom...,101,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1960C>T,PDE6A	c.1960C>T	p.Q654*	0	arRP	Arab Muslim	MOL0271	—	Hom...,101,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1481C>T,PRPF3	c.1481C>T	p.T494M	0	adRP	Yemenite Jew	MOL0108	—	He...,102,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1481C>T,PRPF3	c.1481C>T	p.T494M	0	adRP	Yemenite Jew	MOL0108	—	He...,102,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.377C>T,RDH12	c.377C>T	p.A126V	8*10−6	arRP	Arab Muslim	MOL1389	—...,106,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.722A>T,RPE65	c.722A>T	p.H241L	0	arRP	Ashkenazi Jew	MOL0942	—	Ho...,107,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.722A>T,RPE65	c.722A>T	p.H241L	0	arRP	Ashkenazi Jew	MOL0942	—	Ho...,107,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.542G>T,TSPAN12	c.542G>T	p.C181F	0	arFEVR	Beduin	MOL0513	—	Homozyg...,110,9,Sci_Rep_2015_Aug_26_5_13187.txt
c.6937G>T,USH2A	c.6937G>T	p.G2313C	1*10−4	arRP	Arab Muslim	MOL1234...,113,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.6937G>T,USH2A	c.6937G>T	p.G2313C	1*10−4	arRP	Arab Muslim	MOL1234...,113,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1T>G,CDHR1	c.1T>G	p.M1L	0	arRP	Druze	MOL1275	—	Homozygous	 ,123,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.227A>C,RPE65	c.227A>C	p.H76P	0	arRP	Arab Muslim	MOL1026	—	Homoz...,124,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.329A>G,RPE65	c.329A>G	p.D110G	0	arLCA	Arab Muslim	MOL0093	—	Hom...,125,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.329A>G,RPE65	c.329A>G	p.D110G	0	arLCA	Arab Muslim	MOL0093	—	Hom...,125,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1087T>A,ADAM9	c.1087T>A	p.C363S	Disease causing	1	0.00 Damaging	...,131,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1494C>A,CNNM4	c.1494C>A	p.D498E	Disease causing	1	0.00 Damaging	...,134,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.227A>C,RPE65	c.227A>C	p.H76P	Disease causing	0.059	0.11 Tolerat...,135,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.329A>G,RPE65	c.329A>G	p.D110G	Disease causing	0.998	0.31 Tolera...,136,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.7868G>A,... heterozygous mutations (c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E)) (Table 2) in the EYS gene (N...,36,1213,Sci_Rep_2016_Jan_20_6_19432.txt
c.1871G>A,...we found a homozygous single-nucleotide mutation (c.1871G>A (p.S624L)) (Table 2) in ARRP-206. To con...,36,1347,Sci_Rep_2016_Jan_20_6_19432.txt
c.1871G>A,...we found a homozygous single-nucleotide mutation (c.1871G>A (p.S624L)) (Table 2) in ARRP-206. To con...,36,1347,Sci_Rep_2016_Jan_20_6_19432.txt
c.7868G>A,"...ated that the parents were unaffected carriers of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A280...",36,1637,Sci_Rep_2016_Jan_20_6_19432.txt
c.7868G>A,"...ated that the parents were unaffected carriers of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A280...",36,1637,Sci_Rep_2016_Jan_20_6_19432.txt
c.7868G>A,"...ated that the parents were unaffected carriers of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A280...",36,1637,Sci_Rep_2016_Jan_20_6_19432.txt
c.8422G>A,"...cted carriers of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A2808T, mother) in family ARRP-49 and...",36,1670,Sci_Rep_2016_Jan_20_6_19432.txt
c.1871G>A,"....8422G>A (p.A2808T, mother) in family ARRP-49 and c.1871G>A (p.S624L, father) in family ARRP-206. Th...",36,1721,Sci_Rep_2016_Jan_20_6_19432.txt
c.8422G>A,"... found a pair of compound heterozygous mutations, c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E), in ...",48,385,Sci_Rep_2016_Jan_20_6_19432.txt
c.7868G>A,"... heterozygous mutations, c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E), in EYS in family ARRP-49. Bo...",48,410,Sci_Rep_2016_Jan_20_6_19432.txt
c.8422G>T,"...., et al. reported the same heterozygous mutation c.8422G>T in a French RP patient18. This French RP...",48,819,Sci_Rep_2016_Jan_20_6_19432.txt
c.8422G>T,"...., et al. reported the same heterozygous mutation c.8422G>T in a French RP patient18. This French RP...",48,819,Sci_Rep_2016_Jan_20_6_19432.txt
c.1871G>A,... in family ARRP-49. The novel homozygous mutation c.1871G>A (p.S624L) in EYS is likely the causative...,48,1280,Sci_Rep_2016_Jan_20_6_19432.txt
c.8422G>A,... the segregation of compound heterozygous changes c.8422G>A (MU1) and c.7868G>A (MU2). Genotypes are...,76,58,Sci_Rep_2016_Jan_20_6_19432.txt
c.8422G>A,... the segregation of compound heterozygous changes c.8422G>A (MU1) and c.7868G>A (MU2). Genotypes are...,76,58,Sci_Rep_2016_Jan_20_6_19432.txt
c.7868G>A,ARRP-49	40	c.7868G>A	het	p.G2623E	missense	novel	EGF	Damaging...,105,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.7868G>A,ARRP-49	40	c.7868G>A	het	p.G2623E	missense	novel	EGF	Damaging...,105,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.9059T>C,RP:S-14	43	c.9059T>C	hom	P.I3020T	missense	novel	LamG	Damagin...,110,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.9059T>C,RP:S-14	43	c.9059T>C	hom	P.I3020T	missense	novel	LamG	Damagin...,110,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.2971C>T,RP:S-18	19	c.2971C>T	het	p.L991F	missense	novel	EGF	Tolerated...,112,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.2971C>T,RP:S-18	19	c.2971C>T	het	p.L991F	missense	novel	EGF	Tolerated...,112,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.8388C>A,RP:S-22	43	c.8388C>A	hom	p.Y2796X	stopgain	novel	LamG	NA/NA,113,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.3024C>A,RP:S-48	20	c.3024C>A	hom	p.C1008X	stopgain	novel	EGF-CA	NA/N,116,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.3024C>A,RP:S-48	20	c.3024C>A	hom	p.C1008X	stopgain	novel	EGF-CA	NA/N,116,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.5720+1G>A,"...the patient carrying the c.1253del, c.3584G>A and c.5720+1G>A (r.5720_5721ins148) mutations will be ...",15,247,Sci_Rep_2016_Mar_18_6_23213.txt
c.5720+1G>A,"...the patient carrying the c.1253del, c.3584G>A and c.5720+1G>A (r.5720_5721ins148) mutations will be ...",15,247,Sci_Rep_2016_Mar_18_6_23213.txt
c.5720+1G>A,"...the patient carrying the c.1253del, c.3584G>A and c.5720+1G>A (r.5720_5721ins148) mutations will be ...",15,247,Sci_Rep_2016_Mar_18_6_23213.txt
c.5572C>T,"...ill be identified as #1; the patient carrying the c.5572C>T, c.6652G>T and c.7033C>T mutations will ...",15,340,Sci_Rep_2016_Mar_18_6_23213.txt
c.6652G>T,"...tified as #1; the patient carrying the c.5572C>T, c.6652G>T and c.7033C>T mutations will be identifi...",15,351,Sci_Rep_2016_Mar_18_6_23213.txt
c.7033C>T,"...the patient carrying the c.5572C>T, c.6652G>T and c.7033C>T mutations will be identified as #2; the ...",15,365,Sci_Rep_2016_Mar_18_6_23213.txt
c.2187C>A,...e identified as #2; the two patients carrying the c.2187C>A homozygous mutations will be identified ...,15,441,Sci_Rep_2016_Mar_18_6_23213.txt
c.5572C>T,Patient 2 Milan (Italy)	c.5572C>T	#2	34	p.Arg1858*	Nonsense	Paternal,112,25,Sci_Rep_2016_Mar_18_6_23213.txt
c.5572C>T,Patient 2 Milan (Italy)	c.5572C>T	#2	34	p.Arg1858*	Nonsense	Paternal,112,25,Sci_Rep_2016_Mar_18_6_23213.txt
c.6652G>T,c.6652G>T	41	p.Glu2218*	Nonsense	Paternal,113,1,Sci_Rep_2016_Mar_18_6_23213.txt
c.7033C>T,c.7033C>T	45	p.Arg2345Trp	Missense	Maternal,114,1,Sci_Rep_2016_Mar_18_6_23213.txt
c.7033C>T,c.7033C>T	45	p.Arg2345Trp	Missense	Maternal,114,1,Sci_Rep_2016_Mar_18_6_23213.txt
c.667T>G,"...ssion	multiple missense mutationsc.602C>G (T201R),c.667T>G (F223V),c.819G>A,c.872C>G (P291R)	6",166,95,Sci_Rep_2016_Sep_1_6_32317.txt
c.826C>A,"For the FKRP gene, the c.826C>A (p. Leu276Ile) mutation is particularly c...",90,24,Semin_Pediatr_Neurol_2011_Dec_18(4)_277-288.txt
c.826C>A,"For the FKRP gene, the c.826C>A (p. Leu276Ile) mutation is particularly c...",90,24,Semin_Pediatr_Neurol_2011_Dec_18(4)_277-288.txt
c.181C>A,"...so found in one FTC. Two NRAS codon 61 mutations (c.181C>A, p.Q61K) were also found, one in FTC and ...",77,459,Thyroid_2016_Feb_1_26(2)_227-234.txt
